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Summary
The ability of three different 'physical' drug delivery systems: 
liposomes, niosomes and starch microparticles, to increase the 
efficacy of sodium stibogluconate in clearing L.donovani from the liver 
of mice have been characterised. The efficacy of free sodium 
stibogluconate in this model has been used as the standard against 
which to measure the effectiveness of the drug delivery systems.
The two vesicular systems; liposomes and niosomes, gave an 
approximate ten-fold increase in efficacy compared with the free drug. 
Modifying the properties of the vesicles by varying their cholesterol 
content and hence their permeability to the encapsulated drug or 
varying their surface charge by the inclusion of dicetyl phosphate 
appeared to have little effect on their efficacy as carriers of sodium 
stibogluconate. Surprisingly, treatment of infected mice with empty 
vesicles also led to a small decrease in the parasite load.
Testing of the vesicular systems against Leishmania infected 
peritoneal exudate cells (PECs) in vitro gave results similar to those 
obtained using the in vivo model in that they increased the efficacy 
of the sodium stibogluconate. Interestingly, L.m.mexicana and 
L.donovani were equally susceptible to sodium stibogluconate in 
vesicles. Whereas L.m.mexicana is relatively unaffected by the free 
drug as with the in vivo model, empty vesicles had an effect on the 
parasites in exposed PECs, although this effect was difficult to 
quantify as there was also considerable toxicity to the PECs.
The third drug delivery system tested in vivo, starch 
microparticles, resulted in a 100-fold increase in efficacy compared 
with the free drug, thus proving much more potent than either of the 
vesicular systems. This difference could be due to the mechanism of 
drug release within the host cell. Nevertheless, all three drug 
delivery systems tested show potential for the treatment of
XVII
leishmaniasis. Their use ensures that less drug is required, so 
overcoming the problems of drug toxicity associated with sodium 
stibogluconate.
The efficacy of tubercidin in combination with inhibitors of 
nucleoside transport in mammalian cells, nitrobenzoylthioinosine 
(NBMPR) and dipyridamole, in the treatment of experimental 
leishmaniasis was investigated both in vitro and in vivo. The two 
nucleoside transport inhibitors, at concentrations which would protect 
mammalian cells, did not protect promastigotes of L.donovani or 
L.m.mexicana from the toxic effects of tubercidin. Tubercidin, both 
alone or in combination with these inhibitors, was toxic to the 
promastigotes of the two species with approximate LD^qs of 0.1 pM and
0.2 pM , respectively, and an approximate MLC of 1 pM for both 
species. When used alone, tubercidin proved highly toxic to PECs at 
all concentrations tested (1-10 pM) . These cells were protected from 
the toxicity of tubercidin by nitrobenzoylthioinosine and 
dipyridamole. Treatment of infected peritoneal exudate cells with the 
drug combination did not result in a reduction in total parasite 
numbers or the number of cells infected. In vivo studies using 
tubercidin alone or in combination with either dipyridamole or NBMPR 
confirmed that these inhibitors lessened the toxicity of tubercidin to 
mice although there was no reduction in the parasite load of infected 
animals treated with the combination. These results indicate that, 
unlike the situation reported for malaria parasites, Leishmania does 
not appear to change the mechanism of uptake of nucleosides into the 
host cell.
Investigations of conditions prevailing in the parasitophorous 
vacuole of Leishmania infected cells and their importance to parasite 
survival were carried out by the use of methlyamine, ammonium chloride
XVIII
and dextran sulphate to modify them. The use of methylamine and 
ammonium chloride to raise the pH of the parasitophorous vacuoles did 
not affect the growth of L.m.mexicana in PECs but both the growth and 
survival of L.donovani amastigotes was greatly impaired. In similar 
experiments dextran sulphate affected the growth of both species of 
Leishmania equally, but the cause of this effect remains unclear.
In a preliminary study, the effect of pH on the uptake and 
incorporation of adenosine and leucine by different species and stages 
of Leishmania was also determined. Interestingly, the optimum pH for 
uptake by metacyclics of L.major (pH 4-5) differed from that of the 
other promastigotes investigated (pH 6-7) and could represent a 
preadaption of these forms to life in the lysosomal system of 
macrophages. Taken together the results of the uptake and 
incorporation studies and the results of manipulating the lysosomal 
pH, suggest that L.m.mexicana amastigotes may be adapted for life at a 
higher pH than L.donovani. This may reflect differences in the 
survival stratagies of these two species of Leishmania.
The antileishmanial activities of several amino acid esters,
particularly L-leucine methyl ester (leuOMe), and amino acid amides
\
have been characterised in several respects. LeuOMe and 
tryptophanamide both have an effect on the growth in vitro of 
promastigotes of L.major, L.m.mexicana and L.donovani, although the 
effect of leuOMe is more transient. However, using both an in vitro 
viability assay based on the reduction of the tetrazolium salt MTT and 
the Leishmania-infected PECs model, it was shown that leuOMe is 
considerably more potent against amastigotes of L.m.mexicana than 
against promastigotes or L.donovani amastigotes. Tryptophanamide was 
found to have a broader spectrum of activity, although longer exposure 
times and higher concentrations were required to produce similar 
effects as leuOme against intracellular parasites.
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The onset of activity of leuOMe against promastigote-initiated 
infections of PECs was found to be time - dependent. It was shown by
the use of electron microscopy that susceptibility appears to 
correlate well with the appearance of megasomes as promastigotes 
transform to amastigotes. The electron microscopy studies also 
confirmed the lysosomal nature of these organelles as they were shown
to arise from the trans golgi network, in line with current theories
on lysosomal packaging.
Interest in the basis of the antileishmanial activity of leuOMe 
led to the investigation of the esterases of Leishmania. Several 
isoenzymes were identified but there appeared to be no correlation 
between their presence and susceptibility to leuOMe. A potential assay 
for following the hydrolysis of leucine benzyl ester involving
determining the release of phenol was developed. Difficulties with 
this system led to a different approach being followed. This involved 
separation of released amino acid from the parent ester by paper 
electrophoresis. It proved a useful if unwieldly method of assay for 
amino acid ester hydrolysis.
The role of low molecular weight proteinases of L.m.mexicana in 
the action of leuOMe was then investigated. These enzymes were 
purified by an improved two step process involving gel filtration and 
ion exchange chromatography using FPLC methodology to partially purify 
the proteinases. The enzymes were confirmed to be of the cysteine 
type. These were shown, using paper electrophoresis, to be responsible 
for the majority of the hydrolysis of leuOme by the amastigotes of 
L.m.mexicana. Other species and stages of Leishmania could also 
hydrolyse leuOMe, although at a much lower rate. The partially 
purified enzymes from L.m.mexicana amastigotes and homogenates of 
amastigotes of L.donovani and L.m.mexicana were also tested for their
ability to hydrolyse other amino acid esters and amino acid amides, 
some of which are reported as having anti leishmanial activity. Whilst 
most of the compounds were hydrolysed to some degree by the amastigote 
homogenates the purified enzymes appeared only to hydrolyse leuOMe and 
leucinamide, an amino acid amide which is also reported as having 
antileishmanial activity. Tryptophanamide was not hydrolysed by these 
enzymes, but was hydrolysed by the amastigote homogenates. This 
suggests that its antileishmanial activity is mediated in ways 
different from leuOMe. The results show that the cysteine proteinases 
specific to amastigotes of L.m.mexicana are responsible for the potent 
antileishmanial action of leuOMe and confirms the suggestion that 
these enzymes could be exploited as activators of appropriate pro­
drugs .
XXX
1.0 INTRODUCTION
1.1. LEISHMANIA AND THE LEISHMANIASES
The disease leishmaniasis is a result of infection by one of a 
group of parasitic protozoa which are members of the genus Leishmania. 
The disease is widespread throughout large areas of the tropics and 
sub-tropics, affecting the health of many millions of people (Chance, 
1981). The importance of this parasitic disease has been acknowledged 
by its inclusion in the list of six major diseases for study in the 
UNDP/WHO Special Program for Research and Training in Tropical 
Diseases.
This group of parasitic protozoa cause a wide spectrum of 
diseases. These can be classed broadly into three groups; cutaneous, 
mucosal and visceral leishmaniasis. The manifestation of the disease 
depends upon the species of Leishmania infecting and to some extent 
the immune status of the host (Turk and Bryceson, 1971). Although each 
species is similar morphologically, there are large differences 
between them in many aspects including metabolism, development, 
infection and transmission routes and geographical distribution. All 
of these characteristics have been used as aids to classification.
The typical life cycle of leishmania is outlined in figure 1. The 
disease is initiated in the vertebrate host by the bite of an infected 
phlebotomine sandfly in search of a bloodmeal. Extracellular motile 
flagellated forms, called promastigotes, are inoculated into a mammal 
whereupon they are rapidly phagocytosed by mononuclear phagocytes. 
Current evidence suggests that there are at least two types of 
promastigotes one of which, the metacyclic, is particularly adapted 
for surviving in mammals. Having been taken into mononuclear 
phagocytes the promastigotes transform into the non-motile stage, 
known as the amastigote. The amastigote divides by binary fission 
eventually causing the infected cell to rupture and release 
amastigotes which can be , phagocytosed and so infect further
2
Figure 1. Lifecycle of Leishmania
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or
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1. Delivery of promastigotes into human skin by the bite of sandfly 
vector; 2. attachment and engulfment by phagocytosis of promastigotes 
by a macrophage; 3. fusion of phagosome containing a promastigote with 
lysosome in a macrophage; 4. differentiation of promastigote into 
amastigote in the phagolysosome of the infected macrophage; 5. 
multiplication of an amastigote in a parasite - containing or 
parasitophorous vacuole; 6. formation of a large parasitophorous 
vacuole and continuing replication of intravacuolar amastigotes; 7. 
rupture of heavily parasitised macrophage and release of amastigotes; 
8; phagocytosis of released amastigotes by a macrophage; 9. ingestion 
of parasitised macrophage by sandfly after a blood meal taken from an 
infected person or reservoir animal; 10. rupture of the ingested 
macrophage and release of amastigotes in the gut of the sandfly; 11. 
replication of amastigotes and their differentiation into 
promastigotes; 12. replication of promastigotes in the abdominal 
midgut or depending on species; 13. in the pylorus and ileum of the 
sandfly hindgut; 14. forward movement of promastigotes to thoracic
midgut; 15 sessile paramastigotes attached to the stomadeal valve, 
pharynx and cibarium; 16. motile promastigotes found in moutoparts of 
the sandfly.
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macrophages. Amastigotes taken up by a feeding sandfly transform back 
to promastigotes within the midgut of the sandfly. They then multiply, 
undergo developmental changes and migrate to the anterior foregut and 
proboscis of the sandfly where they are found as metacyclics. Some 
deviations from the typical pattern are found with a few species of 
Leishmania.
1.1.1. Ultrastructure of Leishmania
The promastigotes of all Leishmania species are fairly similar in 
size and morphology, possessing a long anterior flagellum and having 
the approximate dimensions of 2 x 20 pm. However, morphologically
distinct forms do occur in both the sandfly (Killick-Kendrick et al., 
1974) and in vitro (Sacks et al., 1985; Howard et al., 1988) and these 
are thought to correspond to different parts of the developmental
cycle. Amastigotes are typically much smaller ( 2 x 5  pm) than the 
promastigotes although there are differences in size between species. 
The typical ultrastructure of promastigotes and amastigotes are shown 
in figures 2 and 3, respectively.
Both of these stages are typical of all trypanosomatids, in 
having many sub-cellular structures in common with most eukaryotic 
cells. They do however, have some unique features (Vickerman and
Preston, 1976). A large single mitochondrion, approximating to 10% of 
the total cell volume in the amastigote (Coombs et al. , 1986) is
present and contains the kinetoplast, which lies just posterior to the 
basal body of the flagellum. The kinetoplast comprises DNA in the form 
of maxi- and mini-circles arranged in a regular manner (Chang et al. ,
1985). Molyneux and Killick-Kendrick (1987) suggested that a 
connection between the basal body and the kinetoplast exists as they 
appear to remain in a constant spatial relationship throughout the 
lifecycle. Ultrastructural evidence for this relationship has not been
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Figure 2. A transmission electron micrograph of a Leishmania major 
promastigote
Scale bar = 0.5 um. (Micrograph courtesy of Dr. L. Tetley)
Key to subcellular stuctures: Basal body, (bb) ; flagellum, (f);
flagelar pocket, (fp); golgi apparatus, (g ) ; glycosome, (g 1y ); 
kinetoplast, (kp); lipid inclusion (1i) ; mitochondria, (m) ; nucleus, 
(n) ; paraxial rod, (par); polyphosphate granule, (pp); subpellicular 
microtubules, (spm).
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Figure 3. A transmission electron micrograph of a Leishmania mexicana
mexicana amastigote
Scale bar = 0.5 um. Micrograph courtesy of Dr.L.Tetley.
Key to subcellular structure: Flagellum, (f); flagellar pocket, (fp); 
kinetoplast, (kp); mitochondria, (m); "megasome", (mg); nucleus, (n) ;
subpellicular microtubules, (spm).
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reported.
The plasma membrane in both promastigotes and amastigotes is a 
normal trilaminar unit membrane 2-4 nm in width. Beneath and 
associated with the plasma membrane is an array of sub-pellicular 
microtubules that encompass the whole organism, making it a very tough 
cell (Dwyer, 1980). At the anterior end of the parasite the plasma 
membrane is invaginated to form the flagellar pocket from which the 
flagellum emerges. Secretion and endocytosis by the parasite appears 
to be limited to the membrane of the flagellar pocket (Chang et al. ,
1985).
Glycosomes are microbody-like organelles that appear to be unique 
to trypanosomatids. They were first identified in Trypanosoma brucei 
(Opperdoes and Borst, 1977), and reported since then in Trypanosoma
cruzi and Crithidia species (Taylor et al., 1980) and several 
Leishmania species (Coombs et al. , 1982; Hart and Opperdoes, 1983). 
They are small, membrane-bound organelles associated with several 
important biochemical pathways such as glycolysis (Opperdoes, 1984; 
Mottram and Coombs, 1985) and de novo purine and pyrimidine
biosynthesis (Hassan et al., 1985; Opperdoes, 1988). There appears to 
be a large variation between trypanosomatids in the abundance of these 
organelles, probably an indication of their importance to different 
species and stages. Bloodstream forms of Trypanosoma brucei have an 
average of 240 (Opperdoes et al., 1984), L.tropica promastigotes are
said to contain 50-100 (Opperdoes, 1987) whilst the amastigotes of 
L.mexicana mexicana were found to have only around 10 (Coombs et al.,
1986).
Alexander and Vickerman (1970) first reported the presence of
megasomes in L.m.mexicana amastigotes. These organelles are variable 
in shape but frequently large and occupy as much as 15% of the 
amastigote cell volume (Coombs et al., 1986). They have been shown to
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be similar in many respects to lysosomes; structurally they have a 
similar 10 nm thick membrane and they contain several putative 
lysosomal enzymes including arylsulphatase and a cysteine proteinase 
(Pupkis et al., 1986). These organelles are apparently unique to the 
L.mexicana species complex and are found only in the amastigote stage 
(Pupkis et al. , 1986). It has been suggested that they may play an 
important role in the survival of L.mexicana amastigotes within the 
host (Coombs, 1982; Coombs and Baxter, 1984; section 1.2.2.).
1.1.2. Developmental changes in Leishmania
Throughout the lifecycle of Le i shmania there are several 
developmental changes that occur. Amastigotes ingested by a sandfly 
appear to undergo at least one cell division cycle before they 
transform and develop to promastigotes (Shortt et al., 1926; Hart et 
al, 1981c; Warburg et al., 1986). This transformation is accompanied 
by an increase in tubulin biosynthesis over a period of two days which 
appears to correlate well with morphological changes in the flagellum 
and the cytoskeleton (Fong and Chang, 1981). Amastigotes readily 
transform to promastigotes in vitro and this has provided a useful 
model system for many experimental studies (see Fong and Chang, 1981; 
Hart et al., 1981c) as well as diagnosis (Chang and Hendricks, 1985). 
A variety of morphological changes also occur within the promastigotes 
as they divide and establish themselves within the sandfly. They move 
from the midgut or hindgut (depending on species) to eventually give 
rise to the infective metacyclics. The different forms that occur have 
been described in detail by Molyneux and Killick-Kendrick (1987). Most 
of the experimental work on the developmental changes that occur in 
promastigotes however, has been carried out using promastigotes grown 
in vitro. The biochemical differences between the developmental stages 
of promastigotes and amastigotes are dealt with in section 1.3..
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The change from infective promastigote to the intracellular 
amastigote is the most important developmental change that occurs in 
terms of the clinical disease. This change precedes the multiplication 
of the intracellular amastigote. This stage appears to be adapted 
specifically for survival in the hostile intracellular environment. 
There are large changes in morphology (section 1.1.1.) and several 
metabolic switches (see section 1.3.) when promastigotes transform to 
amastigotes. Fong and Chang (1981) used changes in the levels of 
tubulin biosynthesis to follow the time scale of this transformation 
in vitro of L.m.mexicana. Surprisingly, based upon these criteria, 
they concluded that this transformation took 7 days to complete; a 
process that at the level of the light microscope occurs within 12-24 
hours (Alexander, 1975; Ardehali and Khoubyer, 1978; personal 
observation).
The factors that initiate the promastigote to amastigote 
transformation have not yet been fully elucidated. Temperature appears 
to be a very important factor, the change in temperature from the 
sandfly (27°C) to the definitive host (37°C) is large. Darling and 
Blum (1987) showed that raising the temperature of a L.braziliensis 
panamemis promastigote culture from 26°C to 35°C resulted in 
amastigote-like forms. A similar effect had been shown previously by 
various other workers with several other species of Leishmania 
(Hendricks et al. , 1978; Hunter et al., 1982; Pan, 1984). This
temperature change also induces the synthesis of several heat shock 
proteins (Hunter et al., 1984; Lawerence and Gero, 1985; Van der Ploeg 
et al., 1985) which are thought to play a part in the transformation 
of the parasite (Alcinia and Fresno, 1988).
Although amastigote type forms can be produced axenically from 
promastigotes in culture (see above) there has been great difficulty 
in attempting to culture these extracellular forms. Probably the most
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succesful has been the growth of L.m.pifanoi in cell free media (Pan, 
1984) although how closely these are related to the intracellular 
amastigotes remains unclear (Evans, 1987).
The in vitro culture of Leishmania species is also temperature 
dependent. L.m.mexicana amastigotes grow best in macrophages at 34- 
35°C (Biegel et al., 1983) as do L. tropica whilst the optimum 
temperature for L.donovani amastigotes is in the range 35-37°C (Berman 
and Neva, 1981). Personal observations with the species used in this 
study confirmed that L.donovani grew best at 37°C whilst L.m.mexicana 
and L.major grew best between 34°C and 35°C. It has been suggested 
that this temperature sensitivity may account for the site specificity 
of the different cutaneous and visceral forms of leishmaniasis, 
presumably a cutaneous site would be several degrees cooler than a 
visceral site (Biegel et al., 1983).
1.1.3. Taxonomy
The taxonomic position of the genus Leishmania is shown in tables 
1 and 2. This genus is a member of the family Trypanosomatidae which 
contains parasitic protozoa found in either vertebrate or invertebrate 
hosts. Monoxenous parasites such as Crithidia and digenetic parasites 
including Trypanosoma and Leishmania are included in this family 
(Molyneux and Ashford, 1983).
As yet there is no definitive classification system for the 
different species of Leishmania which infect man. Proper 
identification of Leishmania species is important in the treatment of 
infected individuals and in understanding how the disease is 
transmitted, so enabling control programmes to be implemented. Table 2 
is based on the WHO Technical Report Series 701, (1984). The
classification of Leishmania species has been based upon many 
different factors including morphology, development in the sandfly and
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Table 1. Classification of Leishmania
Kingdom Protista
Subkingdom Protozoa
Phylum Sarcomastigophora
Subphylum Mastigophora
Class Zoomastigophora
Order Kinetoplastida
Suborder Trypanosomatina
Family Trypanosomatidae
Genus Leishmania
From Molyneux and Ashford (1983).
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Table 2. Species of Leishmania the diseases they cause and their 
distribution
SPECIES DISEASE DISTRIBUTION
L .hraziliensis braziliensis Cutaneous
mucocutaneous
L.braziliensis guyanensis Cutaneous
L.braziliensis panamensis Cutaneous
L.peruviana 
L.mexicana mexicana 
L.mexicana amazonensis
L.mexicana pifanoi 
L . mexi cana ga rnhami 
L.mexicana venezuelensis 
L.aethopica
L . tro pi ca 
L.major
L.donovani donovani 
L .donovani infan turn
Cutaneous
Cutaneous
Cutaneous 
Diffuse cutaneous
Diffuse cutaneous
Cutaneous
Cutaneous
Cutaneous 
Diffuse cutaneous
Cutaneous/
Visceral
Cutaneous
Visceral 
Mucocutaneous 
Post kala-azar dermal
Infantile visceral
L.donovani chagasi Infantile visceral 
Visceral
Brazil
North Amazon/ 
Guyanas
Panama/
Costa Rica
Andes
Central America
Amazon Basin/ 
Brasil
Venezuela
Venezuela
Venezuela
Ethiopia/
Kenya
Urban areas 
of Middle East 
and India
Middle East 
Soviet Asia 
and Africa
China/India/
Kenya/Sudan
Central Asia/ 
Mediterranean/ 
N.W. Africa/ 
Middle East
South/Central
America
Adapted from Molyneux and Ashford (1983), WHO (1984) and Chang et 
al (1985).
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geographical distribution and the clinical features in human infection 
(Lainson and Shaw, 1987).
Some controversy surrounds the trypanosomatids found in various 
lizards. The validity of these parasites as leishmanias has been 
questioned with the finding that Leishmania tarentolae, which infects 
the Moorish gecko, was apparently identical to Trypanosoma 
platydactyli which also infects geckos (Chance, 1985; Wallbanks et 
al., 1985). The evidence produced so far lends considerable support 
for the separation of these lizard parasites from the mammalian 
leishmanias. Nevertheless, this conclusion has been questioned by
Simpson and Holz (1988) who detailed the many similarities between 
these organisms and the mammalian leishmanias.
1.2. LEISHMANIA AND MACROPHAGES
The interaction of Leishmania with its host cell, the macrophage, 
is one of the most interesting aspects of this disease. Macrophages
are involved in several areas of the host immune response to invading
micro-organisms. These cells have a wide array of antimicrobial 
defences which include phagocytosis and the concomitant production of 
oxygen free radicals with subsequent exposure to the degradative
enzymes of the lysosomal system. Thus the cell types that are largely 
responsible for the killing of invading microorganisms are also the 
host cells for leishmaniasis.
1.2.1. Entry of Leishmania into the macrophage
The infection of macrophages is preceded by the inoculation of 
promastigotes during the bite of a sandfly. Ingested promastigotes 
attach to macrophages and are subsequently phagocytosed. There is no 
evidence that chemoattraction of the promastigotes to the potential 
host cell occurs (Bray, 1983). However, in the same study, 
promastigotes were shown to activate complement, thereby becoming
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chemotactic to macrophages by both the alternative and classical 
pathways. At high concentrations of complement cytolysis of the 
promastigotes occurs (Pearson and Steibigel, 1981; Mosser and Edelson; 
1984) .
Attachment of the promastigotes can occur by either serum- 
independent or -dependent mechanisms. Serum-independent mechanisms of 
attachment are thought to be of the ligand-receptor type, similar to 
the mannose/N-acetylglucosamine pathway of receptor-mediated 
endocytosis in macrophages. This pathway appears to be important in 
the retrieval of secreted lysosomal enzymes as well as in the 
targetting and sequestration of lysosomal enzymes within the cell. The 
binding of promastigotes to macrophages is inhibited by mannose 
phosphate and by the plating of macrophages onto a mannan-coated 
surface (Blackwell et al., 1985; Wilson and Pearson, 1986). This 
competitive inhibition indicates the importance of the mannose/N- 
acetylglucosamine receptors in the uptake of promastigotes, although 
this does not appear to be as important for amastigotes (Saraiva et 
al. , 1987) .
The acid phosphatase present on the surface of L.donovani 
promastigotes (Gottlieb and Dwyer, 1981a, b) is a mannose-containing 
glycoprotein (Glew et al., 1982) and may play a role in the uptake of 
the parasite via the mannose/N-acetylglucosamine ligand receptor 
system mentioned above. In his review, Bordier (1987) postulated that 
the glycans of the 63-68 kDa surface proteinase (gp 63) may bind to 
the mannose receptors on the surface of the macrophage. A role in the 
binding of complement to the surface of promastigotes via this 
molecule has also been proposed (Russell, 1987).
Fibronectin is a large dimeric glycoprotein molecule involved in 
a wide variety of physiological processes such as wound healing and
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regulation of monocyte activity as well as several adhesive functions 
including cell attachment. This molecule is composed of nine domains 
responsible for separate functions such as fibrin binding or cell 
adhesion. The particular domain of this macromolecule that is involved 
in the cell attachment activity appears to be the Arginine-Glycine - 
Aspartic acid (RGD) amino acid sequence. This particular sequence is 
implicated in the binding of proteins such as fibrin and the 
complement protein fragment C3bi with their respective cell surface 
receptors. There is an increasing amount of evidence that RGD 
attachment sites are involved in the adhesion and attachment of 
Leishmania to host macrophages. Fibronectin-mediated attachment of 
L.m.amazonensis promastigotes and amastigotes to human monocytes has 
been shown and this attachment could be inhibited by anti-fibronectin 
antibodies (Wyler et al. , 1985; Ouaissi, 1988). The use of peptides 
containing RGD sequences to saturate macrophage fibronectin receptors 
blocked the uptake of promastigotes whilst unrelated peptides failed 
to have the same effect (Rizvi et al., 1988). The role of the surface 
proteinase of Leishmania in binding to macrophages is well known (see 
previous paragraph). The recent molecular cloning and characterization 
of this gene has predicted the presence of the RGD sequence in this 
surface proteinase (Button and McMaster, 1988). This could account for 
the importance of this surface proteinase in the attachment of 
Leishmania to macrophages (reviewed Ouaissi, 1988).
Serum-dependent mechanisms of attachment and phagocytosis of 
promastigotes are thought to be of two types. The promastigotes adsorb 
opsonins onto their surface. These are either antibodies or components 
of complement. Binding to the macrophages then occurs by either the Fc 
receptors for antibodies or C3b receptors for complement. It has been 
reported (Chang et al., 1985) that under serum-free conditions 
complement mediated attachment of the promastigotes can still occur,
presumably as macrophages can secrete complement (Ezekowitz et al.,
1984) . Alternatively there may be C3b type molecules on the surface of 
the promastigotes, so enhancing their attachment to and subsequent 
phagocytosis by the macrophages (Chang et al., 1985).
Leishmanias, promastigotes and amastigotes, attached to 
macrophages are actively phagocytosed, presumably aided by the host- 
parasite surface compatability mentioned above (Chang, 1985). Unlike 
some other intracellular parasites, for example Plasmodium, the 
leishmanias do not actively invade cells. However, some promastigotes 
are known to infect non-phagocytic cells (Chang, 1978) by what appears 
to be induced phagocytosis. These promastigotes reside in and 
transform in phagolysosomes which do not fuse with secondary lysosomes 
and Chang (1978) has suggested that this may be a survival strategy 
that allows the initial transformation of the promastigote to 
amastigote in a less hostile environment.
1.2.2. Survival of Leishmania in macrophages
The mechanism behind the survival of Leishmania in the macrophage 
has been the subject of much conjecture. There are many proposed 
mechanisms although most are not mutually exclusive. It is possible 
that a variety of survival mechanisms are employed and that these vary 
between species and stages of Leishmania. It is important to 
understand how the parasite is adapted to survive as a fuller 
understanding of this mechanism may lead to the development of 
rational new drug therapies.
Before or during phagocytosis of the parasites the macrophage 
respiratory burst may be stimulated. The parasites are then 
potentially exposed to a vast array of microbicidal mechanisms from 
the macrophage and these may result in parasite death. The respiratory 
burst involves an increased oxygen utilisation attributable to the
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production of toxic oxygen metabolites, such as superoxide anion and 
subsequently hydrogen peroxide, and the concomitant stimulation of the 
hexose monophosphate shunt (Buchmuller and Mauel, 1981; Murray, 1982). 
Hydrogen peroxide appears to be the most important oxygen intermediate 
for the control of Leishmania growth in macrophages. However, the 
species and stage of Leishmaia and source of macrophages does also 
play an important role in the size of the oxidative burst stimulated 
(Bray and Alexander, 1987). The precise role of lymphokines, such as 
gamma interferon and macrophage activation factor, in the control of 
Leishmania infections by the hosts immune system remains unclear (see 
review by Hughes,1988).
Both amastigotes and promastigotes stimulate this response by 
macrophages although it is generally accepted that amastigotes 
stimulate a smaller response and not surprisingly amastigotes are 
more infective than promastigotes (Channon et al. , 1984; Murray,
1981). Metacyclics stimulate a respiratory burst which is intermediate 
between amastigotes and non-infective promastigotes in magnitude 
(Mallinson and Coombs, in press).
Acid phosphatase at the surface of leishmanias may also play a 
role in negating the macrophage's respiratory burst. It has been 
reported that the enzyme purified from L.donovani promastigotes 
interfered with the production of superoxide anions by neutrophils and 
macrophages (Remaley et al. , 1984). Saha et al., (1985) showed that
Leishmania surface acid phosphatase is also resistant to inactivation 
by oxygen metabolites. Surprisingly, however, it seems that there is 
little correlation between the presence of surface acid phosphatase 
and infectivity. Such a connection would be expected if the enzyme was 
crucial to survival. There is also a secreted acid phosphatase in 
promastigotes of L.donovani (Bates and Dwyer, 1987) and some evidence 
for both a surface and excreted acid phosphatase in the amastigote
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(Dwyer and Gottlieb, 1983). It has been suggested that these enzymes 
play a role in avoiding the host's defence mechanisms. It is possible 
that this secreted enzyme interferes in the regulation of cellular 
activities by altering the levels of host phosphorylated compounds. 
The precise roles, if any, of leishmanial acid phosphatases in 
parasite survival are yet to be fully understood although there is 
enough evidence to indicate that they are important.
So, avoidance of exposure to oxygen metabolites may be part of 
the survival mechanism. However, some cells that do stimulate a 
respiratory burst manage to survive. The mechanism behind this 
survival against oxidant damage by free radicals, is not yet fully 
understood. Superoxide dismutase and possibly catalase are thought to 
play a role in the detoxification of these radicals by the parasite 
(Murray, 1981; Hadaris and Bonventre, 1982; Locksley and Klebanoff, 
1983). Indeed it has been suggested that differences between mammalian 
and trypanosomatid superoxide dismutase may provide a potential target 
for chemotherapy. The role of gluathione in free radical scavenging is 
well documented in prokaryotes and eukaryotes (Meister and Anderson, 
1983) and recently differences between this and the equivalent in 
tryanosomatids (trypanothione) have been highlighted and may prove 
useful as a chemotherapeutic target (see section 1.5.1.). The role of 
trypanothione in the survival of Leishmania is as yet unclear.
Once phagoytosed the parasites are enclosed in the 
parasitophorous vacuole. Several workers have reported that lysosomal 
fusion with the parasitophorous vacuole occurs (Alexander and 
Vickerman, 1975; Chang and Dwyer, 1976, 1978; Lewis and Peters, 1977) 
thus exposing the parasite to the microbicidal mechanisms of the 
lysosomal system. Other intracellular parasites have direct strategies 
for avoiding the consequences of these microbicidal activities. 
Trypanosoma cruzi escapes from the phagolysosome and resides in the
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cytoplasm whilst Toxoplasma gondii and Mycobacterium tuberculosis 
prevent lysosomal fusion (Blackwell and Alexander, 1983). However 
Coxiella burnetii is in a similar position to that of Leishmania in 
that they are both directly exposed to the lysosomal system and yet 
manage to survive and replicate. However, Alexander (1981) showed that 
inhibition of lysosomal fusion with the parasitophorous vacuole of 
macrophages infected with L.m.mexicana stimulated amastigote growth, 
suggesting that the lysosomal system does inhibit the intracellular 
parasites. So, how do the parasites manage to survive in this 
potentially lethal enviroment?
Several mechanisms have been proposed to account for the survival 
of the leishmanias within the lysosomal system. One is that some 
species of Leishmania, particularly of the L.mexicana complex, may 
survive in the vacuole by secreting amines and so raise the lysosomal 
pH (Coombs, 1982). Other effects of amine secretion would include 
interference with receptor recycling and the packaging of lysosomal 
enzymes by the golgi apparatus (Tietze et al., 1980). It has been 
postulated that the high levels of proteinase activity present in the 
amastigotes of the L.mexicana complex could be responsible for the 
breakdown of proteins and peptides to eventually yield amines, the 
secretion of which into the parasitophorous vacuole would alter the 
lysosomal pH and hence lysosomal function (Coombs, 1982). This theory 
is attractive in that it would also account for the characteristically 
large parasitophorous vacuoles present with the L.mexicana complex. 
However Coombs and Sanderson (1985) found no evidence of higher levels 
of amine secretion by amastigotes than promastigotes of L.m.mexicana 
and published work on the pH of the lysosomal system of macrophages 
infected with either L.donovani or L.m.amazonensis indicates that 
there are no differences between infected and uninfected cells (Chang,
1980).
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Previous work has indicated that L .donovani is adapted to life at 
an acidic pH, similar to that reported for the lysosomal system 
(Mukkada et al. , 1985), inferring that the pH of the parasitophorous 
vacuole is not modified by the parasite. Coxiella burnetii, the 
etiologic agent of Q fever is, like Leishmania, an obligate 
intracellular parasite which remains within the phagolysosomal system. 
It, like L.donovani, appears to be biochemically adapted to living in 
an acidic enviroment. The use of lysosomotrophic compounds (see 
section 1.5.2.2.) like methylamine and ammonium chloride to change the 
pH of the lysosomal system inhibited the growth and survival of this 
intracellular parasite (Hackstadt and Williams, 1981).
One proposed survival mechanism investigated by several groups 
involves so called excreted factors. These glycoconjugates are 
composed of a series of components, each of which may have its own 
specialised function, and appear in all the leishmanias and are 
produced by both promastigotes and amastigotes (Hernandez, 1983; 
Handman et al., 1987). They are known to inhibit lysosomal degradation 
of protein (Rodriguez et al., 1983), erythrocytes (Eilam et al., 1985) 
and to allow the survival of some Leishmania species in macrophages 
that are normally leishmanicidal (Handman and Greenblatt, 1977). El-On 
et al. (1980) reported that whilst an excreted factor from L.donovani 
did not inhibit several lysosomal enzymes, such as acid phosphatase, 
it did cause a large inhibition of jS *galactosidase. The large negative 
charges on these carbohydrate - rich molecules may be involved in the 
inactivation of the lysosomal hydrolases.
Other proposed survival mechanisms include an enzyme-resistant 
cell surface and Chang (1983) has presented evidence that the surface 
antigenic glycoproteins of Leishmania are resistant to lysosomal 
enzymes. Sub-lethal doses of tunicamycin (an inhibitor of N-linked 
protein glycosylation) render promastigotes of L.donovani and
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L.m.amazonensis susceptible to intracellular killing (Kink and Chang, 
1987; Nolan and Farrell, 1985). This indicates that glycosylated 
proteins may play a role in the intracellular survival of 
leishmanias, whether this involves surface antigens or parasite 
enzymes remains to be clarified. The involvement of the surface 
proteinase, gp63, in survival is, as yet, unclear (see section 1.3.5.)
1.3. BIOCHEMISTRY OF LEISHMANIA
There are various reasons for studying the biochemistry of these 
parasites. They can act as an interesting model system of cell 
development as they readily transform in vitro. They are involved in a 
complicated form of intracellular parasitism and an understanding of 
the biochemistry behind the survival mechanism could lead to the 
development of ways of interfering with it. Biochemical differences 
between the host and the parasite are also potential targets for 
chemotherapeutic attack (see section 1.5.1.).
Leishmania amastigotes are difficult to obtain in sufficient 
quantities for biochemical studies, consequently most of the work has 
been carried out on the promastigote stage. In most cases these 
studies have probably involved a mixture containing metacyclics and 
multiplicative forms. Current evidence suggests that there are several 
differences between promastigotes and amastigotes of Leishmania, and 
between the two forms of promastigote (Chang, 1985; Coombs, 1986). 
However, as there is a general lack of information on the amastigote 
stage, most of the work discussed here, except where stated otherwise, 
refers to promastigotes in general.
1.3.1. Energy metabolism
The energy metabolism of Leishmania has been quite extensively 
studied and has been reviewed by Mukkada (1985) and Glew et al. 
(1988). Enzymes of the glycolytic and TCA cycle are present in both
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the amastigote and promastigote and their respiration is cyanide 
sensitive. Promastigotes contain enzymes that allow them to utilise 
either carbohydrates or amino acids as energy substrates. With some 
species, amino acids appear to be used mainly during the earlier 
stages of promastigote growth in vitro whilst glucose tends to be 
utilised more during the stationary phase of growth (Marr and Berens, 
1977; Cazzulo et al. , 1985). Indeed, Mukkada (1985) suggested that
Leishmania promastigotes utilise amino acids rather than carbohydrates 
as their respiratory substrate. It has also been suggested however 
that these findings reflect the length of time that the promastigotes 
have been maintained in continuous culture in vitro. Hart and Coombs 
(1982) reported that low sub-passage promastigotes of L.m.mexicana 
preferentially utilised glucose rather than amino acids whilst the 
reverse was true for high sub-passage promastigotes.
A comparison of some of the enzymes involved in carbohydrate and 
amino acid metabolism in amastigotes and promastigotes of L.donovani 
by Meade et al. (1984) showed that there are quantitative rather than 
qualitative differences between the stages. However, the promastigotes 
and amastigotes of L.m.mexicana do appear to differ considerably. The 
amastigotes, unlike promastigotes, utilise fatty acids in preference 
to glucose for their energy metabolism. There are also higher levels 
of enzymes responsible for the B-oxidation of fatty acids in the 
amastigote than in the promastigote (Hart et al. , 1981b; Hart and
Coombs, 1982). This may reflect differences in the respective 
environments of the different stages: the sandfly gut may be rich in 
amino acids and/or carbohydrates whilst the lysosomal enviroment may 
have a plentiful supply of fatty acids.
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1.3.2. Surface membrane
The surface membrane of both stages of Leishmania is the primary 
site at which the parasite interacts with its hosts. The surface 
membrane is involved in a large number of processes including: uptake 
and transport of essential nutrients, secretion, protection, 
recognition phenomena and membrane biosynthesis. An understanding of 
the events occurring at this parasite/host interface should give an 
insight into the survival mechanisms employed by the leishmanias.
A wide variety of enzymatic activities have been identified, but 
as yet their roles in the parasite have to be fully elucidated. Three 
phosphomonoesterase activities have been shown to be present on the 
external surface of promastigotes (Dwyer and Gottlieb, 1985). There is 
a non-specific acid phosphatase (see section 1.2.2.) as well as 
distinct 5'- and 3'-nucleotidases (Gottlieb and Dwyer, 1981a, 1982;
Dwyer and Gottlieb, 1984). These nucleotidases may play a role in 
fulfilling the purine requirements of the Leishmania (see section
1.3.3.). The 3'- activity is higher than the 5'- activity in 
promastigotes of L.m.mexicana and L.donovani (Dwyer and Gottlieb, 
1981; Hassan and Coombs, 1987). It has been suggested that the 3'- 
nucleotidase acts as a nuclease to hydrolyse exogenous nucleic acids 
and that the resulting nucleotides are further catabolised by the 5'- 
nucleotidase to produce nucleosides which can be readily taken up by 
the cell. Equivalent 3'-nucleotidases are not found in mammalian cells 
and so may prove useful in diagnosis or as a target for chemotherapy.
Several other enzyme activities associated with the surface 
membrane of L.donovani promastigotes have been reported, as reviewed 
by Dwyer and Gottlieb (1985). An ATPase is associated with the 
internal face of the surface membrane. Normally plasma membrane 
ATPases act as part of an ion transport system, however this parasite 
ATPase does not appear to be a Na+/K+- stimulated enzyme but rather is
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thought to be responsible for proton pumping. Adenylate cyclase is 
also associated with the surface membrane and may be involved in the 
regulation of cyclic AMP levels which are generally involved in 
cellular control and signal recognition processes. Three 
phospholipases (lipolytic enzymes), which have been implicated in the 
pathology caused by trypanosomatid infections, are also associated 
with the surface membrane.
There is only a limited amount of information on the transport 
of exogenous materials across the parasite surface membrane. Carrier- 
mediated processes are indicated as being involved in the uptake of 
several nutrients, notably the amino acids methionine and proline 
(Simon and Mukkada, 1977; Law and Mukkada, 1979 ), hexose sugars
(Schaefer et al. , 1974; Zilberstein and Dwyer, 1985) and alpha-
aminoisobutyric acid (Lepley and Mukkada, 1983). Purines and 
nucleosides are also taken up actively, however the rates of uptake of 
the nucleosides is much higher than those of the free bases (Hansen et 
al. , 1982; Aronow et al., 1987).
The finding of a proteinase (gp63) on the surface of 
promastigotes and amastigotes has stimulated much interest in its 
biological function. Its role in parasite attachment (see section
1.2.1.) and survival (see section 1.3.5.) are discussed elsewhere.
1.3.3. Purine and pyrimidine metabolism
Purine and pyrimidine nucleotides can be synthesised de novo in 
mammalian cells from simple precursors (glycine, formate, CC>2 , 
glutamine and aspartate). Alternatively, bases and nucleosides can be 
'salvaged' from exogenous sources or they may be the products of DNA 
and RNA breakdown within the cell. These can be converted to the 
appropriate nucleotides which are then used in the synthesis of DNA 
and RNA.
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There have been extensive reviews recently on the purine and 
pyrimidine metabolism of parasitic protozoa (Hassan and Coombs, 1988) 
and the leishmanias in particular (Marr and Berens, 1985). Like most 
parasitic protozoa, the leishmanias appear to be unable to synthesise 
the purine ring de novo and so are reliant on exogenous sources for 
DNA and RNA synthesis. However they do appear to be able to synthesise 
de novo at least part of their pyrimidine requirements. Leishmania 
purine metabolism has been investigated extensively and several 
differences from the mammalian system have been identified and offer 
opportunities for chemotherapeutic attack (see section 1.5.1.). Work 
on L.m.mexicana amastigotes and promastigotes has shown only 
quantitative differences between the stages in the enzymes involved in 
these pathways. This is in contrast to the situation in L.donovani for 
which differences have been reported. Notably, promastigotes contain 
adenine aminohydrolase whilst amastigotes contain adenosine deaminase.
1.3.4. Polyamines.
Polyamines (spermine, spermidine and putrescine) are present in 
almost all cells, and appear to play an important role in cellular 
phenomena such as replication and differentiation. Polyamines have 
been detected in several species of Leishmania, both promastigotes and 
amastigotes (Bachrach et al., 1979; Morrow et al. , 1980; Coombs and
Sanderson, 1985). Polyamine levels have been found to be higher in 
promastigotes than amastigotes and the relative levels of each 
polyamine do vary with species and stage of Leishmania. The 
biosynthesis of polyamines is proving a good are for drug attack, 
particularly the key enzyme ornithine decarboxylase. This is inhibited 
by difluoromethylornithine (DFMO) which has promising activity as an 
antileishmanial drug (Bacchi, 1981; Henderson and Fairlarab, 1987).
25
1.3.5. Proteinases
Proteinases are degredative enzymes that play a role in the 
hydrolysis of proteins into peptides and subsequently amino acids for 
nutritional purposes. Proteinases have also been implicated in a wide 
range of other cellular processes that include post-translational 
modification of proteins, the rapid turnover of cellular proteins 
which can allow rapid adaptation to changes in the environment and in 
the pathogenicity of various microrganisms (North, 1982).
Proteinases may be classified in several ways; on the basis of 
their pH range, their ability to hydrolyse specific substrates or on 
their similarity to other well - characterised proteinases. These 
methods of classification all have drawbacks. Many proteinases are 
active over a wide pH range and the pH optima of a proteinase will 
often differ with a different substrate. Proteinases can often act on 
several substrates, and the classification of a proteinase by the 
comparison of a few properties can be misleading. The most
satisfactory classification scheme is that of Hartley (1960) based on 
the catalytic mechanisms of the different proteinases. This is 
summarised in table 3. Four main types of proteinase can be
distinguished on the basis of their sensitivity to various inibitors 
(see table 3). There is some overlap in sensitivity to certain
inhibitors, notably many serine and cysteine proteinases are both
inhibited by antipain, chymostatin and leupeptin.
Conclusions concerning the classification of a proteinase do not 
always relate directly to their physiological role as physiological 
substrates are not always used and indeed are frequently not known. pH 
dependence may indicate the localisation of the proteinase, but again 
considerable differences in pH optima are observed with different 
substrates and so results using artificial substrates can be 
misleading.
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Table 3. Classification of proteinases
Type
Aspartic 
(EC 3.4.23)
Metal
(EC 3.4.24)
Serine 
(EC 3.4.21)
Cysteine 
(EC 3.4.22)
Adapted
Specific inhibitors: 
characteristic of 
enzyme type
Pepstatin
S-PI (acetyl pepstatin)
N-Diazoacetyl norleucine 
methyl ester 
N-Diazoacetyl-N-'- 2,4-dinitro- 
phenylethylenediamine 
Epoxy (p-nitrophenoxy) propane
Chelating agents 
EDTA, ethylene glycol-bis-(B- 
aminoethyl ether)-N,N-tetra- 
acetic acid 
o -phenanthro1ine
Phosphoramidon (not acid metalloproteinases)
Other
inhibitors
PMSF TLCK
DIFP TPCK
Leupeptin
Antipain
Chymostatin
Iodoacetamide, 
Heavy metals 
N-Ethyl maleimide
from North (1983)
p-Chloromercuri
benxoate
TLCK
TPCK
Antipain
Chymostatin
Activators
Reducing
agents
DDT
EDTA
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The roles of proteinases have been investigated mostly using 
mammalian and bacterial systems but in the past few years there has 
been a considerable increase in the number of studies on proteinases 
of parasites including, amongst others, Entamoeba histolytica (Luaces 
and Barrett, 1988), Trypanosoma cruzi (Cazzulo et al., 1988), 
Trypanosoma brucei (Lonsdale-Eccles and Grab, 1987) as well as 
schistosomes (McKerrow and Doenhoff, 1988). Several proteinases have 
been identified and partially characterised in Trypanosoma cruzi (see 
Cazzulo, 1984) and recently a cysteine proteinase has been purified 
from the epimastigotes (Cazzulo et al. , 1989) and appears to be
localised in the parasites lysosomes (Bontempi et al., 1989). In many 
respects this is similar to the situation in African trypanosomes 
where there also appear to be several cysteine proteinases (Steiger et 
al., 1979; North et al., 1983) some of which appear to be localised in 
lysosomes (Lonsdale-Eccles and Grab, 1987). Several different species 
of African trypanosomes have been shown to possess a similar activiy 
of molecular weight 28-31 kDa although no proteinase activity could be 
detected in T.vivax (Lonsdale-Eccles and Mpimbza, 1986).
There appears to be a degree of developmental regulation in the 
proteinases of the African trypanosomes, there are lower activities in 
the procyclic forms than in either the metacyclics or the bloodstream 
forms (North et al., 1983; Lonsdale-Eccles and Mpimbaza, 1986).
However Pamer et al. (1989) have shown that there is an increase in 
the activity of a 28 kDa cysteine proteinase as the trypanosomes 
differentiate from long slender forms into short stumpy forms, and 
that this activity is greater than that found in the procyclics.
Interest has been greatly stimulated recently by the findings 
that the major surface antigen of Leishmania is a proteinase (Etges et 
al., 1986). The molecular weight of this proteinase has been variously 
reported as varying between 63 kDa (Etges et al. , 1986) and 68 kDa
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(Fong and Chang, 1982). Similar enzymes appear to be present in all 
species (Bouvier et al. , 1987) and the proteinase has been shown by 
Lockwood et al. (1987), using gelatin SDS-PAGE, to be present in 
promastigotes and amastigotes of L.donovani, L.major and L.m.mexicana. 
The proteinase does not appear to be of the serine type (Etges et al.,
1986) but there is some evidence that it may be a metalloproteinase 
(Pupkis and Coombs, 1984). This has been recently confirmed and shown 
to be a zinc metalloproteinase (Bouvier et al. , 1987). Jahnig and
Etges (1988) determined the secondary structure of this surface 
proteinase and showed that it appears to be a novel kind of membrane- 
anchored proteinase.
The role of this surface proteinase is yet to be elucidated 
although it has been proposed that it plays a role in protecting the 
parasite from microbicidal enzymes in the sandfly gut (Bordier, 1987). 
However the findings that it is more abundant on the surface of 
virulent than avirulent promastigotes of L.m.amazonensis (Chaudhuri 
and Chang, 1987) and that it appears to be more abundant on the 
surface of the more infective stationary phase promastigotes than log 
phase promastigotes of L.braziliensis (Kweider et al. , 1987) argues
that it may play a role in protecting the parasite in the macrophage.
Recently it has been shown that the enzyme incorporated into liposomes
prevents breakdown of protein inside the vesicle by macrophages 
(Chaudhuri et al. , 1989). This strongly supports the theory that the 
enzyme aids survival by protecting the parasites from microbicidal 
attack.
Pupkis aand Coombs (1984) partially purified and characterised
two distinct proteinase activities from amastigotes of L.m.mexicana. 
The first had a molecular weight of approximately 67 kDa, with some of 
the characteristics of a metalloproteinase and was also present in 
promastigotes of L.m.mexicana. It seems likely that this activity
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included the metalloproteinase discussed above. A lower molecular 
weight cysteine proteinase was also purified from the amastigotes of 
L .m.mexicana. This was shown to be stage and species specific, being 
found in only the amastigotes of L.mexicana species and not in any
other stage of either L.donovani or L.major (Pupkis et al., 1986).
This low molecular weight cysteine proteinase was also shown to be 
localised in lysosomal - like organelles termed megasomes (see section
1.1.1.). Coombs and Baxter (1984) indicated the importance of this 
proteinase when they showed that cysteine proteinase inhibitors had 
antileishmnial activity against amastigotes of L.m.mexicana in vitro.
Studies by Lockwood et al (1987) and North et al (1988) using 
gelatin SDS-PAGE have indicated that a large degree of developmental 
regulation of proteinases occurs in different species of Leishmania. 
There appear to be two distinct groups of proteinases. Firstly, a
group of high molecular weight enzymesapparently present, albeit in
different isoenzymes, in all species and stages investigated. This 
group includes the major surface proteinase discussed above. At least 
some of this group appear to be particulate (Coombs, 1982). North et 
al (1988) have reported that the proteinases of this group do not 
appear to fit readily into any of the four well-defined classes of 
proteinases. Secondly, a lower molecular weight group, characteristic 
of the L.mexicana complex, that consists of what appear to be multiple 
isoenzymes. They also showed that stationary-phase promastigotes of 
L.m.mexicana possess lower molecular weight proteinases, similar to 
those found in the amastigote but at much lower activity and with 
slightly different mobilities on gels, whilst log phase promastigotes 
do not. This suggests that the synthesis of these proteinases may be a 
prerequisite for the successful transformation to the amastigote and 
survival in macrophages (see section 1.2.2.). Developmental changes 
were also found with the the other species investigated. The
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appearance of a proteinase in stationary phase promastigotes of 
L.donovani that is not present in the log phase cells or the 
amastigotes is particularly interesting but as yet unexplained.
1.4. CONTROL OF LEISHMANIASIS
Potentially leishmaniasis can be controlled at several points, 
although the interruption and control of the disease at a single point 
has proved difficult to achieve. At present the only feasible approach 
to control would encompass intervention at several points in the 
lifecycle although for several of the diseases this is simply not 
practical. This could include vector and reservoir control, 
immunisation and treatment of infected individuals. Unlike malaria 
there are no chemoprophylactics available which has not helped in the 
prevention of the disease.
1.4.1. Immunisation
Although cutaneous leishmaniasis due to L.major confers a solid 
immunity to infected individuals (Marsden, 1984; Greenblatt, 1985) and 
that live vaccine trials in the U.S.S.R., Iran and Israel have given 
some success (Greenblatt, 1985), there is as yet no good 
antileishmanial vaccine generally available for most of the diseases. 
There is extensive immunological crossreactivity between different 
species but they do not generate crossprotection.
There have been several problems associated with the use of live 
vaccines, chronic lesions being reported with some L.major-vaccinated 
individuals. The risks associated with using live vaccines with more 
virulent species have not been acceptable.
Crude parasite-extract vaccines have been used in preliminary 
trials in Brasil (Antunes et al., 1986) and appear so far to have had 
few side effects. The Special Programme for Research and Training in 
Tropical Diseases (TDR) are currently planning phase I trials using
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killed vaccines similar to those tested in Brasil (Modabber,1986).
The immunogenic major surface glycoprotein (see sections 1.2.1. 
and 1.3.5.) provides one hope of a molecular vaccine. A similar 
surface antigen appears to be present in all species of Leishmania 
(Chang and Chang, 1986; Etges et al., 1985) and so a succesful vaccine 
could have broad spectrum activity. It has been reported that this 
molecule incorporated into liposomes was effective against cutaneous 
leishmaniasis in a mouse model (Alexander and Russel, 1988).
1.4.2. Control of vectors and reservoir hosts
Control of sandfly populations is difficult . At best it is 
feasible only with the adult stages as the immature stages are
normally more difficult to find. Even adult populations have proved 
difficult to control largely due to the variability and
inaccessability of the breeding and resting sites. There is no set 
pattern for controlling every sandfly colony, each requires it's own 
specific control strategy.
Malaria control campaigns using DDT to control mosquitoes have, 
as a side-effect, frequently resulted also in the reduction of 
leishmaniasis. This has been particularly the case in areas where
transmission is peridomestic (Marinkelle, 1980). The destruction of 
sandfly breeding sites, intentionally or not, has provided some
success in the USSR, China and Malta in reducing leishmaniasis (Ward,
1985).
Normally reservoir hosts, such as rodents and dogs, are found in 
the vicinity of the affected population and measures to control the 
disease usually involves eradication of all the potential reservoirs 
or the selection and elimination of infected animals. These measures 
accompanied by insecticide spraying have proved successful in a few 
cases notably in the USSR (Molyneux and Ashford, 1983).
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1.4.3. Chemotherapy
The range of drugs available for the treatment of infected 
individuals has changed little over the last 35 years, The pentavalent 
antimonials, sodium stibogluconate (Pentostam) and methylglucamine 
antimonate (Glucantime) are still the drugs recommended for initial 
systemic therapy (Berman, 1988; Marsden and Jones, 1985). These drugs 
are composed of pentavalent antimony complexed to carbohydrates. The 
classical structures of Pentostam and Glucantime are shown in figure 
4, although the precise structure of these complexes are unknown 
(Berman, 1988).
The mechanism of the antileishmanial action of the antimonials is 
unknown. Recently work by Berman et al (1987) has shown that Pentostam 
inhibits the glycolytic pathway and fatty acid oxidation in L.mexicana 
amastigotes. Berman and Grogl (1988) suggest that the specific binding 
of Pentostam to polypeptides involved in the glycolytic and oxidative 
pathways may contribute to the cytotoxic effect of the drug. They also 
raise the possibility that Pentostam may interact with the parasite 
nucleic acids or with low molecular weight parasite components.
There are several problems associated with the use of the 
pentavalent antimonials, these include toxicity and the rapid 
excretion of the drug. Rees et al. (1980) reported that within 6 
hours of intramuscular administration, 57-84% of the drug was 
excreted. This rate of excretion could rapidly result in 
subthe rapeut ic levels of the drug in the plasma. Recently the 
pharmokinetics and toxicity of Pentostam have been reassessed (WHO 
Technical Report Series, 1984, The Leishmanias) and this has shown 
that more frequent higher doses are better tolerated than was first 
thought and the implementation of these findings has considerably 
reduced the failure rates of treatment.
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Figure 4. Structures of clinically used antimonials
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10-25% of all initial treatments using the standard regimen are 
unsuccessful (Berman, 1983), and treatment is usually continued with 
either the pentavalent antimonials or one of the second line drugs. 
These are Amphotericin B, which is the preferred drug for Latin 
American cutaneous leishmaniasis and Pentamidine, which is used 
mainly in the second line treatment of visceral leishmaniasis
(Bryceson, 1987).
There is a wide variability in the susceptibility of different 
species, and indeed isolates, to antimonials. For instance whilst 
visceral leishmaniasis is usually responsive to antimonial therapy and 
cure rates of 70-100% have been reported, relapsing and diffuse
cutaneous forms of the disease often prove difficult to treat, due 
apparently to defective immunity (Marsden and Jones, 1985).
Little work has been carried out on the problemm of drug 
resistance in Leishmania species. Some isolates, from patients who 
have recieved several courses of treatment with meglumine antimonate,
have been shown to be less sensitive to treatment with the same
compound (Ercoli, 1964, 1966). Variations in susceptibility to
pentavalent antimonials in patients have also been shown to reflect 
this in infected macrophages in vitro (Berman et al., 1982).
There are drawbacks involving all the drugs used. Treatment is 
parental, time consuming often involving hospitalisation and hence 
expensive, and is often toxic with symptoms ranging from malaise to 
heart dysfunction and even death. Patients infected with kala-azar may 
exhibit signs similar to drug toxicity, such as liver, renal and bone 
marrow dysfunction, so making therapy difficult to manage (Marsden and 
Jones, 1985). For these reasons, not all forms of leishmaniasis are 
routinely treated. For instance with some Old World cutaneous species 
and the L.mexicana complex the skin granulomas produced will heal 
naturally and so patients with these may not be treated, unless for
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cosmetic reasons.
There is a pressing need for new therapies which will overcome 
the problems associated with current treatments. At present several 
new formulations have reached phase I trials, including several purine 
analogues, WR 60206 (an 8-aminoquinoline) and some antidepressant 
drugs (TDR report ) . Others are at a more preliminary stage but show 
promise in experimental models, for example DFMO. However it seems 
unlikely that effective new treatments will be available in the near 
future.
1.5. THE SEARCH FOR NEW TREATMENTS
1.5.1. Biochemical strategies
There are several approaches that can be followed in attempts to 
develop, on a rational basis, new forms of treatment for 
leishmaniasis. Biochemical strategies, at their simplest, usually 
involve selecting differences at the enzyme level between host and 
parasite and designing compounds to specifically inhibit the parasite 
enzyme system. Unfortunately, relatively little is known about the 
biochemistry of the amastigotes of Leishmania and so only a few 
possible targets have been recognised. Rather more information is 
available on the promastigotes and this has been used to identify 
other possibilities.
There are several areas of leishmanial metabolism that are being 
investigated with a view to drug development. The ones most relevant 
to this study are summarised here. Most parasitic protozoa so far 
studied, including the leishmanias, are incapable of synthesising 
purines de novo, and in this way differ from most other organisms (see 
section 1.3.3.). Thus the parasites rely on the salvage of preformed 
purines from their hosts and several of the enzymes involved have been 
shown to differ from their isofunctional mammalian counterparts
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(Hassan and Coombs, 1988). This has led to the discovery that several
purine and purine nucleoside analogues, including allopurinol and
formycin B, have potent antileishmanial activity (Nelson et al., 1979; 
Carson and Chang, 1981). These commpounds are believed to be
metabolised to nucleotide analogues by the parasites and prove toxic 
by either inhibiting the purine salvage pathway or by their ultimate 
incorporation into nucleic acids (Nelson et al., 1979; Rainey and
Santi, 1983; Marr, 1983). Initial trials using allopurinol against
antimony-resistant cases of visceral leishmaniasis (Kager et al. ,
1981) showed some success. Clinical trials of the more active
ribonucleoside analogues have also proved promising and are being 
followed up (Modabber, 1986).
There is another approach to the treatment of leishmaniasis which 
also involves the parasite's requirements for preformed purines. It
has been shown that promastigotes of L.donovani possess two 
nucleoside transport mechanisms both of which are refactory to 
nitrobenzoylthioinosine (NBMPR) and dipyridamole (Aronow et al.,
1987). These compounds are potent inhibitors of nucleoside transport 
into mammalian cells (Aronow et al., 1985). Tubercidin, a cytotoxic 
analogue of adenosine, has already been used succesfully in 
combination with NBMPR against experimental infections the
extracellular parasites Trypanosoma gambiense (Ogbunude and Ikediobi,
1982) as well as Schistosoma mansoni and S . japonicum (El Kouni et 
al., 1983, 1985). The toxicity of tubercidin towards mammalian cells 
is well documented as is the use of NBMPR to lower tubercidin's 
toxicity to mammalian cells in vitro and in vivo (Cass and Paterson, 
1977; Lynch et al. , 1978; Paterson et al., 1979). But is such an 
approach relavent to intracellular parasites?
It has been shown recently that Plasmodium falciparum exerts a 
stage-specific effect on the permeability of infected erythrocytes to
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nucleosides. This allows cytotoxic nucleosides, such as tubercidin, to 
be targetted towards parasitised cells whilst using inhibitors of 
nucleoside transport to protect non-infected cells (Gero et al.,
1988). It seemed possible that similar use of tubercidin in 
conjunction with these inhibitors may be succesful against 
leishmaniasis. This approach would work if macrophages undergo changes 
in their permeability to nucleosides upon infection with leishmanias 
such that inhibitors would protect uninfected cells from the effects 
of the tubercidin whilst allowing the parasitised cells to be 
targetted and killed.
Even if such changes do not occur, however, it could still be 
possible to use these combinations, providing that the tubercidin can 
access the parasitophorous vacuole despite the inhibitory activities 
of NBMPR and dipyridamole. This could be achieved for instance by 
pinocytosis. Then, providing that the amastigote has a similar 
nucleoside transport mechanism to that reported for the promastigote, 
the parasites would be killed whilst the host cells were unaffected. 
This approach is one pursued in this study.
Inhibitors of dihydrofolate reductase (an enzyme involved in 
tetrahydrofolate production and so indirectly in DNA synthesis), such 
as the antimalarial pyrimethamine, have been found to have activity 
against a variety of parasites such as Pneumocystis carinii and 
Toxoplasma gondii. (Roth, 1983). The finding that the dihydrofolate 
reductase inhibitor cycloguanil pamoate was of some value in the 
treatment of cutaneous leishmaniasis demonstrated the potential of 
this area in the search for new anti -leishmanials (McCormack, 1981). 
This idea was reinforced by the discovery that the dihydrofolate 
reductase activity of Crithidia fasiculata and L. tropica is mediated 
by a bifunctional protein that also has thymidylate synthetase 
activity (Ferone and Roland, 1980). This differs from the situation in
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mammals in which two separate enzymes are present. Several novel 2,4- 
diaminopyridamines have recently been shown to have good 
anti leishmanial activity in vitro against both amastigotes and 
promastigotes (Hunter and Coombs, 1987; Scott et al., 1987).
A most interesting recent discovery has been that the roles 
played by glutathione in most prokaryotic and eukaryotic cells, 
including the scavenging of free radicals and peroxide metabolism, are 
carried out in trypanosomatids by a glutathione - spermidine complex 
given the name of trypanothione (see Henderson and Fairlamb, 1987). It 
has been suggested that trypanothione plays a role in protecting the 
parasites from oxidative damage by the host, and it has been 
postulated that trypanocidal drugs which produce free radicals may be 
potentially synergistic with inhibitors of trypanothione synthesis. 
This is an approach which is being vigorously pursued, especially with 
the use of DFMO as the inhibitor of polyamine metabolism.
1.5.2. Drug targetting
The targetting of drugs in a highly specific manner has many 
theoretical advantages. All drugs are potentially hazardous and the 
doses used are normally a compromise between the constraints of drug 
toxicity and the therapeutic index of the drug. Often a drug is only 
needed in one specific area of the body or one cell type and yet the 
drug frequently becomes diluted in the body fluids, large amounts may 
be degraded, the drug may be excreted rapidly or be concentrated in 
cells that do not require treatment. Efficient targetting of a drug 
can considerably improve the efficacy of the compound and overcome 
many of the problems mentioned. Ideally this results in the use of 
lower concentrations of the drug whilst improving the therapeutic 
index. There are several approaches to the physical targetting of 
drugs. Some of these are discussed below, with particular attention
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given to the methods relevant to intracellular parasites.
Many types of site-specific drug delivery systems have been 
proposed and these were reviewed by Poznansky and Jul iano (1984) . 
These included the use of soluble carriers, such as monoclonal 
antibodies and plasma proteins, that can be directed to particular 
sites. Several microparticulate carrier systems have also been 
proposed and these are discussed below. The ideal drug carrier should 
meet several criteria. It should be non-toxic, bio-degradable, non- 
immunogenic, have a high drug load yet still give a controlled release 
of the drug, be cheap to manufacture and, of course, give the desired 
selective drug delivery.
Site - specific drug delivery can occur at three levels. A 
particular organ may be targetted, or a particular cell type and 
subcellular targetting of a specific cell compartment can occur. One 
example which would involve all three levels is the targetting of the 
lysosomal compartment of phagocytic cells of the liver.
There are also two types of targetting that can occur, passive 
and active. Passive targetting refers to the natural distribution of 
the carrier. Possibly the best example of this is the clearance of 
colloidal material from the circulation by cells of the 
reticuloendothelial system (RES) located in the sinusoids of the 
spleen, liver and bone marrow. Active targetting on the other hand 
involves altering the normal distribution of the carrier so that other 
specific cells, tissues or organs are targetted. An example of this is 
the use of antibody-linked drugs (Poznansky and Juliano, 1984).
1.5.2.1. Pro-drugs
Pro-drugs are compounds composed of two parts, the drug itself a 
"carrier" to which it is linked. The whole pro-drug lacks any 
appreciable biological activity except those properties that allow the
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compound to be targetted. Once the pro-drug has been successfully 
targetted, thereby increasing the specificity of the drug, the pro­
drug is cleaved so releasing the carrier molecule and the toxic form 
of the drug at the required site. There are many types of possible 
carrier, including many of those mentioned in subsequent sections. The 
increased specificity of pro-drugs over the drug themselves can be due 
either to specific targetting but can also be due to the cleavage of 
the pro-drug within the parasites environment, perhaps even by the 
parasite itself.
With reference to Leishmania, two examples of this approach have 
been suggested. Hart (1986) proposed that drugs entrapped in low 
density lipoproteins may become concentrated in the parasitophorous 
vacuole of Leishmania infected cells. This could occur because 
macrophages possess specific receptors for low density lipoproteins. 
Once within the parasitophorous vauole the enzymes of the lysosomal 
system would release the entrapped drug which could then affect the 
amastigote. A second suggestion (Coombs, 1986) was that the use of a 
carefully chosen peptide link between the carrier and the drug could 
be cleaved by parasite specific proteinases and not by host enzymes. 
This could lead to the activation and release of the drug by the 
parasite and not the host.
1.5.2.2. Lysosomotropic drugs.
Intracellular parasites are in a unique position as the host's 
membrane intervenes between drugs in the body fluids and the parasite 
itself. In many cases this makes chemotherapy more difficult than 
against extracellular parasites. However there are possible ways of 
exploiting the parasites intracellular existence. For instance 
parasites may change their host cell in a way which allows infected 
cells to be targetted, e.g. tubercidin and Plasmodium (see section
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1.5.1.) or the parasites may be dependent on an aspect of the 
intracellular environment w h i c h  can be modified by drugs e.g. the acid 
pH in a phagolysosome. Many compounds become concentrated in 
lysosomes, i.e. they are lysosomotropic and parasites that live in 
lysosomal systems are ideal targets for such lysosomotropic 
formulations. Such compounds are of particular interest in 
leishmanias.
Lysosomotropism, as defined by de Duve et al (1974), includes 
"all substances that are taken up selectively into lysosomes, 
irrespective of their chemical nature or mechanism of uptake". This 
property can be conferred on almost any substance by coupling to an 
appropriate carrier. This method can, in theory, target compounds not 
just to lysosomes but also to specific cell types. This area of drug 
targetting offers a large range of possibilities in the treatment of 
not just intracellular parasites but also leukemia and cancer.
There are several classes of lysosomotropism which are summarised 
in figure 5. Endocytosis is the main route of entry of compounds into 
the lysosomal system. A variety of molecules can be taken up in this 
manner, including small molecules, some groups of macromolecules, 
insoluble particles and parasites. Endocytosis can be highly specific, 
different materials may be taken up at different rates and these rates 
may vary between cell types. Dextran sulphate is one compound that is 
endocytosed and has proven useful in the investigation of the 
lysosomal system (see below).
Piggyback endocytosis refers to the uptake of an endocytizable 
complex which on being processed by the lysosomal system releases the 
active compound. Probably the best example of this is the use of 
liposomes to deliver drugs to cells of the RES (see section 1.5.3.).
Several substances are known to accumulate against their 
concentration gradient by permeation and this will be dealt with more
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Figure 5. Mechanisms of entry and mode of action of lysosomotrophic 
agents
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fully below. Lysosomotrophic compounds that access the lysosomal 
compartment by permeation include the antimalarial chloroquine, many 
weak bases such as methylamine and ammonium chloride and certain amino 
acid esters such as L-leucine methyl ester (leuOMe). The rates of 
uptake of these substances indicate that the intralysosomal 
accumulation occurs by permeation coupled to a trapping mechaniam (de 
Duve et al. , 1974). Intralysosomal trapping by protonation is the most 
likely mechanism for the majority of substances in this category. In 
exceptional circumstances other mechanisms may be involved.
Trapping by protonation relies on the different properties of 
ionized and unionized compounds. Many weak bases and acids will 
readily cross biological membranes in their unionized state but will 
not cross the same membrane when ionized. If the membrane separates 
two regions of different pH, for example a lysosomal membrane, then 
acids will accumulate on the basic side (the cytosol) whilst the bases 
will accumulate on the acidic side (the lysosome). This is thought to 
be the mechanism behind the lysosomotrophic properties of methylamine 
and ammonium chloride.
The lysosomotropism of amino acid esters is less straightforward. 
Goldman and Kaplan (1973) showed that the L-stereoisomers of certain 
amino acid methyl esters caused disruption of isolated lysosomes when 
added at concentrations of 0.1 to 10 mM whilst the D-stereoisomers 
were much less effective. They also showed using paper 
electrophoresis, that the potent esters were readily hydrolysed by 
lysed lysosomal preparations. They suggest that the amino acid esters 
enter the lysosomes by passive diffusion whereupon they are 
enzymatically hydrolysed. Thus a concentration gradient is maintained 
and influx of the ester continues. Because of their high polarity, the 
liberated amino acids cannot easily permeate back out of the lysosome 
and so they will accumulate within the lysosomal system. The
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continuation of this process eventually leads to osmotic lysis of the 
lysosome (see figure 6). Results presented by Reeves (1979) strongly 
supported this hypothesis and the use of the proteinase inhibitor TPCK 
indicated that proteinases may be involved in the hydrolysis of the 
amino acid methyl esters. Reeves (1979) suggested that more than one 
enzyme may be involved in hydrolysing the compounds and that an 
extralysosomal esterase may also be hydrolysing these esters.
From studying the effects of lysosomotropic compounds upon 
Leishmania amastigotes survival in macrophages, Rabinovitch et al. 
(1986) reported that, several L-amino acid esters notably L-leucine 
methyl ester (leuOMe) had potent leishmanicidal activity. Initially 
they postulated that the amino acid esters accumulated in the 
parasitophorous vacuole at such high concentrations that the 
intracellular parasite was damaged. However they did not rule out the 
possibility that the amino acid esters may be concentrated and 
hydrolysed within the amastigote lysosomes and that this led to damage 
of the parasite. Subsequently they (Rabinovitch et al., 1987) 
investigated the effect of different amino acid esters on isolated 
amastigotes of L.m.amazonensis. They showed, using compounds known to 
raise the intracellular pH, that an acidified compartment appeared to 
be involved in the destruction of the parasites. They also observed 
that the sensitivity of isolated amastigotes was similar to that of 
intracellular parasites. Alfieri et al. (1987) showed that the 
destruction of L .m .amazonensis amastigotes by leuOMe could be 
prevented by other amino acid esters. This protective activity occured 
with both leishmanicidal and non-leishmanicidal esters. Overall this 
work was compatable with the hypothesis that the antileishmanial 
activity of the amino acid esters was a reflection of their 
lysosomotropism and is dependent upon their hydrolysis by parasite
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Figure 6. The mechanism of lysosomal disruption by amino acid esters
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enzymes.
Lysosomal function can be manipulated in several ways using 
lysosomotrophic compounds. For instance, weak bases such as 
methylamine and ammonium chloride have been shown to raise lysosomal 
pH over short exposure times (Ohkuma and Poole, 1978) whilst dextran 
sulphate decreases lysosomal pH (Kielan and Cohn, 1982). These 
compounds can also exert a variety of other effects on the lysosomal 
system, however, there are some uncertanties as to the full effects 
and modes of action of these compounds, especially over long exposure 
periods.
1.5.3. The reticuloendothelial system in drug delivery.
Cells of the reticuloendothelial system are highly phagocytic 
and consequently are potential host cells for Leishmania. Several 
workers have shown that if colloids are injected intravenously then 
the phagocytic cells of the liver, spleen and bone marrow will rapidly 
remove the colloid from the circulation (Saba, 1970; Poste, 1983). 
Colloid particles have been used for many years to study the RES and 
it is only relatively recently that the potential of these colloidal 
systems for the delivery of drugs was realised.
Liposomes are vesicles composed of phospholipids. They behave as 
colloids in being rapidly phagocytosed by cells of the RES. 
Hydrophobic drugs, such as amphotericin B, can be incorporated into 
the membrane of the liposomes whilst hydrophilic compounds, for 
example sodium stibogluconate, can be entrapped in the aqueous 
compartment. Gregoriadis and Ryman (1972) used liposomes 10 years 
after their initial discovery to deliver enzymes to the RES. 
Subsequently erythrocytes (Ihler et al., 1974) and microspheres 
(Kramer, 1974) have been tested as vehicles for the delivery of drugs 
to the RES.
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Several diseases are localised in the RES of the liver, spleen 
and bone marrow and this makes them ideal candidates for the use of 
colloidal-mediated drug therapy. By far the greatest amount of work 
has been carried out using liposomes and several diseases of the RES 
have already been treated in experimental models. These include 
systemic fungal infections in cancer patients (Lopez - Bernstein et al., 
1985), Candidia infections (Lopez - Bernstein et al., 1984) and 
bacterial infections (reviewed Ostro, 1986).
Liposomes provide a good delivery system in many respects. There 
appears to be little if any toxicity associated with liposomes 
although they are weakly immunogenic. The composition of liposomes can 
be modified by inclusion of other lipids and so their properties 
altered to suit the intended purpose. They can adsorb to almost any 
type of cell and having done so may release the drug in a controlled 
manner through their lipid membrane. Liposomes can also exchange 
appropriate lipids with the plasma membrane and if drugs could be 
conjugated to an exchange lipid then potentially it can enter the 
targetted cell. Endocytosed liposomes are degraded within the 
lysosomal compartment and release their drug there. What happens to 
the drug then depends on many factors but a water soluble drug, like 
sodium stibogluconate, may diffuse down its concentration gradient and 
out of the cell.
Despite these positive points liposomes have several drawbacks. 
It is difficult to target liposomes to cells outside the circulation. 
Liposomes are too large to pass through the capillaries of most organs 
and may be trapped by mechanical filtration. The size of the particles 
will determine to some degree the area in which they are trapped. For 
instance, particles greater than 7 pm in diameter will be trapped 
mainly in the lungs, particles greater than 100 nm will be ingested 
mainly by the liver and spleen whilst only particles with a diameter
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of less than 100 nm have any chance of reaching extravascular sites 
(Ilium and Davis, 1982). Also, the cells of the RES will rapidly 
remove liposomes from the circulation, no matter what their size. This 
makes cells of the RES ideal targets for passive vectoring, but also 
makes targetting of other cells very difficult. Liposomes have 
appeared to be weakly immunogenic which may be a positive point if 
they are to be used to present antigens as part of a vaccine but 
creates several difficulties for their use as a drug delivery system.
Several workers have used liposome - encapsulated drugs 
successfully in the treatment of experimental visceral leishmaniasis 
(Black et al. , 1977; Alving et al., 1978; New et al., 1978). Berman et 
al. (1986) also used pentamidine in human red cell ghosts in the 
successful treatment of experimental visceral leishmaniasis. It has 
also been shown that the efficacy of various other drugs is increased 
significantly when they are used in liposomal form. This increase may 
be due to several factors. The most likely is that direct targetting 
is occuring at all three levels mentioned above. The drug is being 
targetted to the appropriate organs giving higher levels of antimony 
in the spleen and liver than is achieved when the free drug is used. 
The drug is also being targetted to the potential host cells, the 
macrophages. Work by Heath et al. (1984) also showed that liposomes 
are not only targetted to the macrophage lysosomal system but may also 
end up in the parasitophorous vacuole. This was a little surprising as 
the general finding of other workers was that whilst endocytosis of 
large objects by Leishmania infected cells does occur they do not 
readily gain access to the phagolysosome (Dedet et al. , 1982, personal 
observation).
Another way in which liposomes can increase drug efficacy is that 
they can help to prevent rapid excretion of the drug. Encapsulated 
sodium stibogluconate, trapped in the liver or spleen (these organs
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could act as drug depots), is released at a slow rate giving an 
extended plasma half life. This may allow therapeutic levels to be 
maintained for a longer period of time without necessarily increasing 
the drug dose (Rao et al., 1983).
These encouraging results have been obtained using experimental 
models of visceral leishmaniasis with the parasite loads in the liver 
of infected animals being assessed. Unortunately, if predictably, the 
use of liposomes does not appear to be as effective against cutaneous 
disease although there is an increase in the efficacy of Pentostam 
when used in liposomal form (New et al. , 1983). This lower efficacy 
with cutaneous disease was not surprising as most of the liposomes 
would have been removed by cells of the RES in the liver, spleen and 
bone marrow. Presumably the liver depot effect, which extends the half 
life of the drug in the plasma may account for the small increase in 
efficacy. Alternatively, these workers suggest that uptake of these 
liposomes by a circulating blood component, presumably monocytes, that 
subsequently become activated in the vasculature surrounding the 
lesion and migrate as macrophages to the site of infection. There they 
would be protected from parasitism by the liposomal Pentostam and so 
be free to help control the infection.
In the years immediately preceding this project, another 
vesicular system in many ways similar to liposomes had been developed. 
This system involves synthetic non-ionic surfactants, rather than the 
biological amphiphiles used for liposomes. The vesicles are called 
niosomes (Vanderberghe et al., 1978). Baillie et al. (1985) showed 
that niosomes have similar properties to liposomes in that they are 
osmotically active, can form small unilaminar and large multilaminar 
vesicles and show differing degrees of permeability depending on the 
cholesterol content of the bilayer. These vesicles can act as a 
delivery system for methotrexate (Azim et al., 1984), with potential
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applications in cancer chemotherapy . In a preliminary study Baillie 
et al. (1986) showed that they may also have potential in the 
chemotherapy of visceral leishmaniasis.
Microspheres, prepared using various macromolecules as the matrix 
material, are also attractive as carriers for delivering drugs to the 
RES (Poznansky and Juliano, 1984). Microspheres differ from liposomes 
and niosomes in that they are composed of a matrix material to which 
the delivery load is attached. Tomlinson (1983) lists several types of 
possible matrix material ranging from lipoproteins and albumin to 
polyacrylamide. Polyacryl starch microparticles, prepared by radical 
polymerisation of acryloylated starch and so composed in part of a 
natural biodegradable macromolecule, have been shown to be capable of 
delivering enzymes to the RES (Artursson et al., 1984). These have 
been studied in vitro as carriers of low molecular weight drugs 
(Laakso et al., 1987b). This system is an ideal candidate for use in 
the treatment of visceral leishmaniasis.
1.6. THE AIMS OF THIS PROJECT.
The overall aim of this project was to investigate several new 
potential strategies for the chemotherapy of leishmaniasis. It was 
expected that these investigations would also improve our 
understanding of how leishmanias interact with their host cell, the 
macrophage.
The initial part of the project involved an investigation of the 
usefulness of two relatively new carrier systems, niosomes and starch 
microparticles, in the treatment of experimental leishmaniasis. Their 
efficacy was compared to that of liposomes.
Another approach followed was to use the cytotoxic nucleoside 
tubercidin, in conjunction with inhibitors of mammalian nucleoside 
transport, to investigate whether or not Leishmania changes the
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nucleoside permeability characteristics of infected cells. Such 
changes could be exploited in chemotherapy but might also give an 
insight into part of the survival mechanism of parasites in the
parasitophorous vacuole.
It was with the same aim that studies involving the manipulation 
of the environment of the parasitophorous vacuole were pursued . This 
involved testing the affects of manipulating the phagolysosomal 
environment using compounds thought to modify lysosomal pH. The effect 
of treatment upon survival and growth of the amastigote was 
investigated. The role of pH on the uptake and incorporation of
leucine and adenosine into different species and stages of the 
parasites were also determined. A greater knowledge of the conditions 
prevailing within the parasitoporous vacuole with different species 
could lead to new strategies in the chemotherapy of leishmaniasis.
A major part of this project was to characterise the 
antileishmanial activity of amino acid esters and to gain a better 
understanding of how this activity is mediated. This involved
determining the spectrum of activity of the compounds and 
investigating the parasite properties essential to the compounds
toxicity. This led to a study of the proteinases of L.m. mexicana 
amastigotes and their role in drug activation and the possibilities 
they provide for further drug development.
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2.0 MATERIALS AND METHODS
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2.1. PARASITES: CULTIVATION AND MAINTENANCE
2.1.1. Amastigotes
Leishmania mexicana mexicana (MNYC/BZ/62/M379) amastigotes were 
maintained by sub-passage in female CBA mice (Zoology Department, 
University of Glasgow). Amastigotes were isolated from an infected 
mouse and washed twice in PSGEMKA buffer by centrifugation (see 
section 2.2.1.). The cell density was assessed using an Improved 
Neubauer Haemocytometer. Approximately 3 x 10^ amastigotes in 0.2 ml 
were injected subcutaneously into a shaved rump of each mouse to 
initiate new infections. The area surrounding the site of inoculation 
was subsequently shaved at regular intervals. Subcutaneous lesions 
became apparent by 2 months after inoculation of parasites and 
developed into large lesions within 3 to 5 months. These lesions were 
routinely used as the source of amastigotes for both transformation to 
promastigotes (see section 2.1.2.) and for experimental work.
Leishmania donovani (MHOM/ET/67/L82) amastigotes were maintained
by sub-passage in female Golden Syrian hamsters (Bantin and Kingman
Ltd., Grimsden, Hull, England.). Amastigotes were released by
homogenising the spleen from an infected hamster using a glass-glass
hand tissue grinder. The spleen in approximately 25 ml of PSGEMKA was
homogenised untill all but connective tissue was disrupted. The
resulting suspension was then washed twice, by centrifugation and
resuspension in PSGEMKA buffer at 4°C, before being used to infect 4-
810 week old hamsters by intraperitoneal inoculation of 2-4 x 10 
amastigotes in 0.4 ml per animal. Infected animals were killed within 
2-5 months, the spleen excised and used as a source of amastigotes for 
experimental work or for the transformation to promastigotes (section
2.3.1.). The condition of the hamsters was a good indicator of the 
progress of the infection: hamsters remained healthy until a few days 
before death caused by the parasites. Hamsters were routinely used at
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the first signs of ill health to obtain the maximal yield of 
parasites.
Leishmania major (HMOM/SA/83/RKK2) infections were maintained by 
the subcutaneous inoculation into the footpads of male or female 
Balb/c mice (Zoology Department, University of Glasgow) of
approximately 5 x 10^ promastigotes suspended in 0.05 ml of Hanks1 
balanced salt solution (HBSS). These promastigotes were the infective 
metacyclic forms obtained by peanut lectin agglutination (see section
2.2.2.). Within 4 - 8 weeks lesions were apparent, and parasites were 
harvested from them before they ulcerated. The lesions were excised 
and used to obtain small numbers of amastigotes for transformation to 
promastigotes (see section 2.1.2.). When larger numbers of amastigotes 
were required, Golden Syrian hamsters were infected subcutaneously in 
the footpad with aproximately 1 X 10 metacyc1ic-enriched
promastigotes in 0.1 ml HBSS. The resulting lesions were used 4-5 
weeks later for the purification of amastigotes (see section 2.2.1.).
2.1.2. Promastigotes
Promastigotes of each species were obtained by the transformation 
in vitro of amastigotes obtained from an infected animal. A small 
piece of infected tissue was aseptically removed and placed in 5
ml of transformation medium: HOMEM medium (Berens et al., 1976)
supplemented with 20% (v/v) heat - inactivated foetal calf serum (HIFCS) 
and antibacterials (25 pg gentamycin sulphate ml 1 , 1 mg streptomycin 
sulphate ml'1 and 1000 units benzylpenicillin ml 1). The infected
tissue was then incubated at 25°C for 48-96 hours during which 
transformation and replication of promastigotes occurred. 
Promastigotes were sub-passaged and cultured in HOMEM medium with 10% 
HIFCS and 25 pg gentamycin sulphate ml"1 at 25°C. Cultures were
normally initiated at a density of 1 x 10^ promastigotes ml and sub-
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passaged upon reaching early to mid - logarithmic phase of growth 
(density of approximately 106 ml*1). For some experimental work, batch
cultures of up to 300 ml were grown in 500 ml tissue culture flasks
(Labtek). For some experiments, stationary phase promastigotes were 
required. This involved harvesting parasites after they had been in 
culture for longer than 7 days and were at a density of greater than 1 
x 107 viable promastigotes ml'1.
2.2. HARVESTING PARASITES
2.2.1. Amastigotes
Amastigotes used for the in vitro infection of peritoneal exudate 
cells (PECs, see section 2.3.2.) were obtained from the appropriate 
tissue of infected animals. The infected tissue was excised 
aseptically and placed in a sterile dounce hand-held homogeniser with 
10-15 ml of RPMI 1640 supplemented with 10% (v/v) HIFCS (see section
2.3.1.). The amastigotes were released by several strokes of the
homogeniser pestle and were then harvested by centrifugation (2100 x g 
for 10 minutes) at 4°C and washed twice in RPMI medium before being 
used to infect the PECs.
Purified amastigotes for use in biochemical studies were isolated 
according to Hart et al. (1981) with slight modification. The infected 
tissue was gently homogenised, at room temperature, between two pieces 
of gauze mesh in approximately 50 ml of PSGEMKA buffer (20 mM sodium 
phosphate buffer, pH 7.3, 104 mM NaCl, 10 mM MgC^, 10 mM KC1, 0.5 mM 
D-glucose, 1 mM ethylenediaminetetraacetic acid [EDTA] 0.02% [w/v]
bovine serum albumin). The suspension was then filtered through a N° 1 
Whatman filter paper to remove large debris. Fresh buffer was added to 
the tissue remaining which was further homogenised and the process 
repeated untill approximately 400 ml of buffer had been used. The 
preparation at this stage was called the crude homogenate. Saponin was
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then added to a final concentration of 0.5% (w/v) to lyse
contaminating erythrocytes and the amastigotes freed from debris by 
three up and down strokes of a Potter homogeniser at a low speed (2000 
rpm). The amastigotes were pelleted by centrifugation as above, washed 
three times and resuspended in PSGEMKA at a cell density of 1 x 10® 
ml *. The suspension was then passed through an ion exchange column to 
remove remaining host cells. Such columns were composed of a mixture 
containing 0.1 g of Sigmacell type 50 and 0.1 g of alpha cellulose 
which were layered on top of 2.5 g CM-Sephadex C25. All components 
were pre-swollen overnight in 0.02 M phosphate buffered saline (PBS), 
pH 7.3, before being resuspended in PSGEMKA. The columns were prepared 
in 50 ml syringe barrels which were then pre-washed with approximately 
50 ml of PSGEMKA to give an even packing. The amastigote suspension
was applied at a flow rate of approximately 5 ml per minute per column
and the eluted amastigotes pooled. These were washed twice by
centrifugation and resuspended in 25 ml of PSGEMKA and finally washed 
in 25 ml of 0.25 M sucrose. The parasites were finally pelleted in 
small capped tubes (eppendorfs) at approximately 5 x 10 amastigotes 
per eppendorf by a few minutes centrifugation at 10000 x g. They were 
then either used immediately or stored at -70°C. The yield of purified 
amastigotes varied between preperations but for L. m. mexicana was 
approximately 1 x 10*® amastigotes for a single large lesion, for 
L.donovani 5 x 10® amastigotes from a single spleen and for L.major 3 
x 10® from 4 lesions. The level of host cell contamination was checked 
at the end of the preparation and routinely gave less than 0.1 % 
cell/cell contamination.
For electron microscopy studies amastigotes were only partially 
purified, the crude homogenate (prepared as above) being washed three 
times, by centrifugation and resuspension, in PSGEMKA buffer.
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2.2.2. Promastigotes
Promastigotes were harvested by centrifugation in an MSE Chilspin
centrifuge at 2100 x g for 10 minutes at 4°C. The pellets obtained
were then resuspended in HBSS, pH 7.5, washed twice by centrifugation
and resuspension in HBSS and finally resuspended in 0.25 M sucrose
before either being used immediately or pelleted and stored at -70°C.
Promastigotes at different phases of in vitro culture were harvested
at appropriate times; normally 2-3 days after inoculation of the
culture for logarithmic phase cells (normally a density of
f\ ~ 1
approximately 5 x 10 ml ) and beyond 7 days for stationary phase
cells (approximately 2 x 10^ ml . Leishmania major metacyclics were
isolated from stationary phase cultures by the method of Sacks et al. 
(1985). The promastigotes were harvested and washed three times in
HBSS before being resuspended in HBSS containing 100 ug peanut
-1 • 8 • -1 agglutinin (PNA) ml to a density of 4-5 x 10 promastigotes ml
Such .suspensions were incubated for 30 minutes at room temperature to
allow agglutination to occur. To separate those cells agglutinated by
the PNA (PNA positive) from those remaining free (PNA negative cells),
the cell suspension was carefully layered over a 50/50 mixture of
HIFCS and HBSS and incubated for a further 30 minutes to allow the
agglutinated cells to sediment. The PNA negative cells left above the
interface were then removed and harvested as normal. A small amount
of the supernatant was left above the interface as this often
contained smaller aggregates of agglutinated parasites. A typical
8yield from a 200 ml stationary phase culture was approximately 5 x 10 
purified metacyclic promastigotes. The purity of the preparation was 
assessed microscopically for clumps of PNA positive cells.
2.2.3. Preparation of parasite homogenates
Pellets of purified parasites were lysed either by resuspension
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in 0.25 M sucrose containing 2.5% (v/v) Triton X100 or by a cycle of 
freezing and thawing three times using liquid nitrogen and a water 
bath at 37°C. Fractionation of L.m.mexicana amastigotes into soluble 
and insoluble fractions for the purification of the low molecular 
weight proteinases (see section 2.10.1.), was achieved by 
centrifugation at 200000 x g at 4°C for 1 hour in an MSE Prepspin 50.
2.3. MACROPHAGE-PARASITE INTERACTIONS IN VITRO
2.3.1. Macrophage maintenance
The medium used for macrophage culture was RPMI 1640, pH 7.2-7.3, 
supplemented with 10% (v/v) HIFCS, 50 pg benzylpenicillin ml'1, 50 pg 
streptomycin sulphate ml 1 , 25 pg gentamycin sulphate ml 1 , 2 mM L-
glutamine, 25 mM HEPES and 20 mM sodium hydrogen carbonate. The medium 
was adjusted to the appropriate pH using 1 M sodium hydroxide.
Mouse resident peritoneal exudate cells (PECs) were obtained from 
male Balb/c mice by peritoneal lavage using 5 ml of complete medium 
(RPMI 1640, with all the supplements) per mouse . The number of mice 
used in each experiment varied between 3 and 14, depending upon the 
number of PECs required. The lavages from the mice were pooled and 
diluted with complete medium to give a cell density of 2.5 x 10^ PECs 
ml Eight - chamber Lab-Tek tissue culture slides were used for the 
maintenance of the PECs: 1 x 10^ PECs in 0.4 ml were plated into each 
chamber. The cells were allowed to adhere overnight by incubation at 
either 34°C or 37°C, depending on the experiment, with a gas phase of 
95% air, 5% CO2• Cells to be infected with L.donovani were incubated 
at 37°C whilst those to be infected with either L. major or 
L.m.mexicana were incubated at 34°C. Non-adherent cells were removed 
the next day by vigorous washing with complete medium and the adherent 
cells remaining were then used. These cells were mainly macrophges but 
other cell types were present and such preparations will be referred
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to as PECs for the remainder of this thesis.
2.3.2. Infection of PECs
In calculating the ratios of parasites to PECs for experiments, 
the initial number of PECs plated out was taken to be the number of 
PECs present after washing, despite the removal of non-adherent cells. 
PECs were infected by adding appropriate numbers of L.donovani 
(amastigotes) , L.major (amastigotes) or L.m.mexicana (amastigotes or 
promastigotes) in the complete RPMI medium used for PEC culture. The 
number of parasites used varied depending upon the time used for the 
infective period (4-24 hours) and the species and stage of the 
parasite used. When amastigotes were used the ratio was always between 
1 PEC: 2-3 amastigotes whilst with promastigotes of L.m.mexicana the 
ratio varied between 1:3 for 24 hour exposures and 1:5 for a 4 hour 
exposure period. At the end of the exposure period, the free parasites 
were removed by washing with RPMI medium and 0.4 ml of fresh RPMI 
medium added to each well. The cells were incubated at 34°C or 37°C as 
appropriate and at the end of the experimental periods the PECs were 
either fixed in methanol and stained with 10% Giemsa's stain for 10 
minutes, or alternatively were fixed in glutaraldehyde for electron 
microscopy (see section 2.8)
2.4. DETERMINING ANT I LEISHMANIAL DRUG ACTIVITY
2.4.1. In vivo models
The activity of potential antileishmanial agents was determined 
using several in vivo experimental model systems. In these studies 
using the visceral leishmaniasis model, 2 x 10^ L.donovani amastigotes 
isolated from hamster spleens and resuspended in 0.2 ml PSGEMKA were 
inoculated intravenously, via the tail vein, into each female Balb/c 
mouse (Department of Zoology, University of Glasgow). On day 7 post­
infection, the appropriate treatment regimen was started and on day 14
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the animals were sacrificed. Impression smears of the first prominent 
lobe of the liver were made, air dried and fixed in methanol before 
being stained for 20 minutes in 10% Giemsa's stain. The number of 
amastigotes per 100 infected cell nuclei were counted in duplicate 
smears for each experimental animal. The results for each treated 
animal were compared with the mean of the pooled results of an 
untreated control group.
A similar procedure was used to test different treatments against 
Balb/c mice infected with amastigotes of L.m.mexicana. Mice were 
infected via the tail vein with amastigotes and the parasite load in 
the liver two weeks later was determined. Several inocula of 
amastigotes were tested to ascertain the most useful course of 
infection for drug treatment experiments, and mice were sacrificed 
over a 4 week period to determine the parasite load of the liver at 
different times. The most suitable inoculum was found to be 8 x 10^ 
amastigotes which gave a mean parasite load of 128 parasites per 100 
host cell nuclei 2 weeks post - inf ection. There was a high level of 
variability in this model which made it only of limited use.
Activity against L.m.mexicana was also determined using sub­
cutaneous inoculation of parasites which resulted in the growth of a 
cutaneous lesion. An inoculum of either 3 x 10^ or 3 x 10^ amastigotes 
in 0.2 ml was injected into the shaven rump of female CBA mice 
(Department of Zoology, University of Glasgow) and the course of 
infection monitored by measuring the size of the resultant cutaneous 
lesions. In studying different forms of therapy, treatment was 
commenced 7 days post-infection.
Several routes of administration were investigated for 
treating animals. Water soluble drugs and suspensions of carrier 
formulations were given either intravenously (i.v.), via the tail 
vein, or intraperitoneally (i.p.). Other drugs were suspended in
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0.375% (w/v) gum tragacanth and given either i.p. or orally.
2.4.2. In vitro models
2.4.2.1. Amastigotes in vitro
In vitro investigations using PECs infectd with Leishmania 
species were carried out using standard conditions (see section 2.3.). 
Compounds under investigation were added during preparation of the 
standard medium. Drugs were dissolved in water wherever possible but 
several were dissolved in dimethyl sulfoxide (DMSO) or ethanol, as 
indicated. In such cases controls were caried out to ensure that the 
final concentrations of these solvents had no effect on the PECs or 
the parasites. Where experimental procedures involved culture for 
longer than 48 hours, the medium was replenished at this point and the 
incubation continued for up to a further 72 hours before the 
experiment was terminated. Cells were then fixed and stained (section
2.3.2.) and the number of amastigotes per 100 infected cells and the % 
of cells infected determined by microscopic observation. The results
for treated cells are expressed as either a % of the mean of the
controls or as a % reduction compared to the controls, so allowing the
degree of antileishmanial activity to be quantified.
2.4.2.2. Promastigotes in vitro
The activity of a compound against promastigotes, of all three 
species used in this study, was assessed by monitoring its effect on 
promastigote growth or using the MTT assay (see section 2.4.2.3.). In 
the former case, promastigotes;were inoculated, to a density of 1 x 105 
cells ml'1, into 5 ml of medium (see section 2.1.2.) containing the 
appropriate concentration of the compound being tested. The cell 
density of each culture was measured daily for a period of seven days 
using an Improved Neubauer Haemocytometer. Stock solutions of the
compound being tested were normally filter sterilised (0.22 um pore
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size filter) and diluted to give the necessary concentration so that 
the drugs were added as 0.1 ml volumes at the start of the experiment 
in all cases. 0.1 ml distilled, deionised water was added to control 
cultures.
2.4.2.3. In vitro viability assay
The effects of different compounds on the viability of cultured 
promastigotes and isolated amastigotes was measured using a method 
based on the metabolism of a tetrazolium salt, MTT(3-(4,5,- 
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide), by living 
cells (Mossman, 1983). Briefly, parasites were suspended at
Q _ 1 I
approximately 1 x 10 ml (amastigotes) or 2 x 10 ml 
(promastigotes) . The cells were then washed free from the drug and 
incubated with MTT at 450 ug ml  ^ (in distilled, deionised water) for 
3 hours at the appropriate temperature. The blue formazan product, 
produced by the action of various dehydrogenases reducing the MTT, was 
quantified by dissolving it in 0.5 ml acid (0.04 M HC1) isopropanol 
and measuring the absorbance at 570 nm. The results obtained are 
expressed as the reduction of MTT by the treated parasites as a 
percentage of that by untreated parasites. The absorbance change in 
control cultures was normally in the range 0.8 - 1.5.
2.5.. LIPOSOME AND NIOSOME PREPARATION
2.5.1. Niosome preparation
The preparation of niosomes containing sodium stibogluconate was 
carried out using the ether injection method described by Baillie et 
al (1985). Three surfactants (see fig. 7) were used in the preparation 
of the niosomes, in which 450 pi of surfactant or surfactant - ash free 
cholesterol (CHOL) or surfactant-CHOL-dicetyl phosphate (DCP) mixture 
dissolved in diethyl ether was injected slowly into 5 ml of 300 mg 
sodium stibogluconate ml  ^ aqueous solution at 60 C. Both niosomes and
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Figure 7. Structure of non-ionic surfactants
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liposomes (see section 2.5.2.) were either 'drug-loaded' and contained 
sodium stibogluconate or were 'empty' and contained 30mM glucose 
solution.
2.5.2. Liposome preparation
The peparation of liposomes containing sodium stibogluconate was 
carried out by hydrating, under a N2 atmosphere, 114 pmol dipalimotyl 
(DPPC)-CHOL or DPPC-CHOL-DCP mixture with 8 ml aqueous 300 mg sodium 
stibogluconate ml  ^ at 45-50°C for 2 hours with gentle agitation.
2.5.3. Final vesicle preparation
The mean diameter of the niosomes was 333-381 + 80 nm whilst the 
liposomes were much larger at 860 ± 50 nm. Unentrapped drug was 
removed from the vesicle suspensions by dialysis against a 300 mM 
glucose solution, the dialysed vesicles were adjusted to the required 
drug concentration by dilution with 300 mM glucose.
2.5.4. Determination of drug content of vesicles
The drug concentration in the vesicles was measured by estimating 
the antimony content by flame atomic spectrometry, a Pye Unicam SP90 
Atomic absorptiometer was used to determine the antimony content of 
vesicle preparations which had been disrupted in propanol. The 
antimony standard was a solution of SbCl^ in dilute HC1 and the 
sensitivity of the method 1 pg Sb ml ^.
2.6. PREPARATION OF STARCH MICROPARTICLES
2.6.1. Synthesis of microparticles
The procedure followed was that described by Laasko et al (1986)
and the microparticles were supplied by these workers. Purified
acryloylated starch (0.12 acrylic groups/glucose residue) and N-
acryloyl-1,6-diaminohexane (ADH) were dissolved in 5 ml of 0.2 M
- 3sodium phosphate buffer, pH 8.5, containing 10 M EDTA. After
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addition of 0.08 M ammonium peroxydisulphate, the aqueous phase was 
emulsified in 300 ml chloroform-toluene (1:4) with 32 uM Pluronic F68. 
The monomer present in the the water-oil emulsion was polymerised by 
the addition of 0.1 ml N,N,N',N'-tetramethyl-ethylenediamine to give 
the ADH polyacryl starch microparticles. N2 was bubbled through the 
system throughout the procedure. The microparticle composition was 
characterised using the D-T-C nomenclature of Edman et al (1980). D 
denotes the acrylolated starch concentration (g 100 ml *), T is the 
total acrylol groups (g 100 ml )^ and C the proportion (% w/w of 
acrylic monomer) of cross-linker present. The D-T-C ratio of the ADH 
polyacryl starch microparticles was 10-1.5-0, whilst for 'empty' 
microparticles it was 10-0.5-0.
2.6.2. Coupling of sodium stibogluconate to the ADH microparticles
Sodium stibogluconate was coupled via a cationic ligand to the 
ADH-polacryl starch micropaticles (see fig. 8) by mixing 50 mg ADH 
microparticles with 200 mg sodium stibogluconate in 10 ml of 1 M 
NaHCO^ buffer, pH 8.0. Five ml of the same buffer containing 100 mg N- 
hydroxysuccinamide and 250 mg 1 -ethy1 - 3 -(3-
dimethylaminopropyl)carbodiimide were added and the whole suspension 
stirred overnight at room temperature. Unreacted drug and the coupling 
agents were removed by centrifigual (200 x g for 10 minutes) washing 
in saline. The antimony content of the microparticles was determined 
as previously described.
2.7 MEASUREMENT OF UPTAKE AND INCORPORATION OF NUCLEOTIDES AND 
NUCLEOSIDES BY LEISHMANIA
3
The uptake and incorporation of tritiated ( H) leucine and 
adenosine (Amersham) by different species and stages was measured 
essentially using the methodology described by Mukkada et al (1985). 
Parasites were suspended, to give an approximate protein concentration
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Figure 8. Coupling of sodium stibogluconate to starch microparticl es
Nucleophilic attack occurring in 2 steps, a) and b)
NH2 + HOOC-Sb-OH 
• •
Stibogluconate
NH
a)
OH-Sb-COOH +
(NHSI)
pH 8
OH-Sb-C
EDC
NH-C-Sb-OH + NHSI
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of 25 pg ml in 0.1 M Mcllvanes buffer (pH 3-7) containing 5.2 g 
NaCl and 0.5 g KC1 per litre, with 10 mM glucose as an energy source. 
These were incubated at either 25°C (promastigotes), 34°C (L. m.
mexicana amastigotes) or 37°C (L . donovani) , as appropriate, for 10 
minutes before the addition of either leucine or adenosine to 
give a final concentration of 0.4 mM and a specific activity of 1 pCi 
pmol ^. At various points during the incubation of up to two hours, 1 
ml samples were removed and the cells washed twice by centrifugation 
and resuspension in 0.1 M sodium phosphate buffer, pH 7.3. The 
suspensions of cells were then collected by filtration using glass- 
microfiber filters (1.2 um porosity, Whatman GF/C) and vacuum and the 
cells immediately washed either with 10 ml of ice cold 10% TCA 
followed by 4 ml 95% ethanol if incorporation into macromolecules was 
being estimated, or alternatively with 14 ml of ice cold phosphate 
buffer, pH 7.3, if total uptake by the cells was being estimated. The 
filters were then air dried for 10 minutes an transferred to vials 
containing 15 ml Ecoscint scintillation fluid (National Diagnostics) . 
The vials were agitated for 30 seconds with a whirlymixer before the 
amount of radioactivity was determined using an Isocap 1300 Liquid 
Scintillation System (N.C.D.). Counting efficiencies were determined 
using the external standard channels ratio method and was 
approximately 30%.
Several different procedures were tested to ensure that 
background radioactivity was minimal; these involved varying the 
number of washes and the volume of buffer or TCA used. The procedure 
described above proved to be the most consistent. Time courses were 
carried out to ensure that uptake and incorporation was linear over 
the incubation periods used. Promastigotes were examined 
microscopically to ensure that they were viable over the incubation 
periods used.
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2.8. ELECTRON MICROSCOPY
Infected PECs were released with a rubber policeman from the 
bottom of tissue culture flasks, after the removal of the medium, and 
fixed by irrigation with 10 ml of 2.5% glutaraldehyde in 0.1 M 
potassium phosphate buffer, pH 7.4, at 33°C. During the 40 minutes 
fixation, the temperature was allowed to drop to 20°C after which the 
fixed suspension of released, infected PECs was centrifuged at 1500 x 
g for 15 minutes at room temperature. The fixed cells were washed 
twice in 0.1 M potassium phosphate buffer containing 2% (w/v) sucrose 
and post-fixed in 1% buffered, pH 7.4, osmium tetroxide for 1 hour. 
Following removal of osmium with 3 changes of distilled water, the 
cells were encapsulated in 1% Seaplaque agarose at 40°C and
-3
subsequently processed as small (< 1.0 mm ) blocks through 0.5%
aqueous uranyl acetate for 30 minutes, dehydrated in a series of 
alcohols and finally embedded via propylene oxide in araldite.
After two days polymerisation at 60°C, 350 nm or 60 nm sections 
were mounted on 300 mesh grids, stained with 2% methanolic uranyl 
acetate for 5 minutes and examined or further stainedwith lead citrate 
for 5 minutes before examination. Exposures were recorded on 70 mm 
Kodak MP11 roll film using a Zeiss transmission electron microscope 
902 incorporating an electron energy spectrometer for contrast 
enhancement and thick section imaging.
2.9. DETECTION OF ESTERASES OF LEISHMANIA
2.9.1. The use of starch gel electrophoresis to detect esterase 
activity
Starch gels were prepared using the method described by Tait et 
al (1984). Gels were made by heating 250 ml of an 8% (w/v) Connaught 
hydrolysed starch solution, made up in the gel buffer (0.1 M Tris-HCl, 
pH 7.5), until the solution was clear. This was then degassed, using a
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vacuum pump, poured into a setting mould and left for an hour at 4°C 
to set. Samples were prepared in homogenisation buffer (10 mM Tris- 
HC1, pH 7.5, ImM DTT, 1 mM EDTA, 2% Triton X100) , agitated with a
whirlymixer and left for 10 minutes at room temperature before being 
centrifuged at 10,000 x g for 15 minutes. Small pieces of Whatman 3MM 
paper (10 x 3 mm) were then soaked in the clear supernatant and 
applied to the gel in cuts made with a razor blade. The samples were 
then subjected to electrophoresis, using 1 M Tris-borate, pH 7.5, as 
the running buffer, at 8 V cm'1 for 5 hours with cooling. Esterase 
activity on the gels was detected using 4-methyl umbilliferyl 
propionate (Harris and Hopkinson, 1976). Ten mg of the substrate was 
dissolved in a few drops of acetone and then mixed with 100 ml of 0.1 
M phosphate buffer, pH 6.5. This was then applied to the gel on a 
filter paper overlay for approximately 5 minutes. The overlay was then 
removed and the gel viewed under a long wave UV lamp for fluorescent 
bands. This visualises the fluorescent hydrolysis product 4-methyl 
umbilliferone.
2.9.2.The detection of phenol as an assay for measuring the hydrolysis 
of L-leucine benzyl ester
The method of Pilz (1974) describing the use of phenylacetate as 
a substrate for the measurement of arylesterase activity was used 
after modification. This assay is based on the hydrolysis product 
phenol reacting with 4-aminoantipyrine, with potassium ferricyanide, 
K-^FetCN^]), as a catalyst, to give a condensation product that is 
extracted with n-pentanol and can be determined colorometrically. It 
was thought that a similar method could be used to measure the 
hydrolysis of leucine benzyl ester.
It was reported that the reaction mixture should be maintained at 
pH 7.5-8.6 to ensure that the reaction of phenol and 4-aminoantipyrine
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was not reversible (Pilz and Johann, 1966). To enable assays to be
performed at lower pH the method was modified. Low concentration
buffers (1 mM) at lower pHs were used in the incubations for the
esterase reactions themselves. The subsequent addition of 4-
aminoantipyrine and K^CFefCN^]) was added giving final concentrations
of 14 mM and 35 mM respectively. The mixture was then allowed to stand
at room temperature for 15 minutes before the addition of 5 ml of n-
pentanol and rapid agitation using a whirlymixer. This mixture was
then allowed to stand for a further 10 minutes. The upper organic
phase was then removed and centrifuged at 10000 x g for 2 minutes and
the resulting clear solution used for colorimetric measurements. The
absorbances of the samples were read against a blank which contained
no substrate or sample. The difference between the absorbances of the
sample and the control was used to calculate the amount of the
condensation product formed, and thereby the amount of phenol
produced. Standard concentrations of phenol were used to calibrate the
assay and check that it was sufficiently sensitive to detect low
concentrations of phenol at different pHs. The extinction coefficient
2 -1of the condensation product at 465 nm was taken as 21.7 cm pmol 
(Pilz, 1974).
2.10. PURIFICATION OF AMASTIGOTE PROTEINASES
2.10.1. Chromatogenic assays of proteinase activity
Chromatogenic fractions were assayed for proteinase activity 
using the nitroanilide substrate N-benzoyl-proline-phenylalanine- 
arginine nitroanilide (BzPPANan). The subsrate was used at a final 
concentration of 0.075 mM in a 110 }il reaction volume containing 10 mM 
DTT and 100 ul of each fraction. The change in absorbance at 405 nm 
over 10 minutes incubation at room teperature was measured on a 
Titertek Multiscan MCC/340. To determine the specific activities of
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samples towards BzPPANan at 37°C, assays were carried out in 0.15 M 
sodium phosphate buffer, pH 6.0, containing 0.1 mM BzPPANan and 1 mM
DTT in a total reaction volume of 1.2 ml. The reaction mixture was
pre - incubated at 37°C for 10 minutes before the addition of the
BzPPANan and DTT to initiate the reaction. The release of the 4- 
nitroanilide caused by the hydrolysis of BzPPANan was monitored on a 
Perkin-Elmer Lambda 5 spectrometer, at 405 nm. the molar absorbtion 
coefficient of 4 -nitroanilide was taken as 9500 1 mol ^cm  ^ (Pupkis 
and Coombs 1984).
2.10.2. Gel filtration
Lysates of L.m.mexicana amastigotes were produced by either a 
cycle of freezing and thawing or by the use of Triton X100 (see
section 2.2.3.). Approximately 1 x 1 0 ^  amastigotes were lysed in 1.2 
ml volumes. These were then fractionated into soluble and insoluble 
fractions by centrifugation at 240000 x g for one hour at 4°C in a 
Prepspin 50 ultracentrifuge. One ml of the resulting supernatant was 
then applied to a gel filtration column (1 cm x 1 cm) of Superose 12 
previously equilibrated with 0.15 M sodium phosphate bufer, pH 6.0, 
and fractionated using fast protein liquid chromatography (Pharmacia). 
Fractions were eluted with the equilibration buffer at room 
temperature using a flow rate of 1 ml per minute. One ml fractions 
were collected at 4°C using a Pharmacia Frac 100 fraction collector. 
The protein concentration of eluted fractions was monitored by 
measuring the absorbance at 280 nm with a Pharmacia Single Path 
Monitor Optical Unit, UV-1, spectrophotometer.
2.10.3. Ion exchange chromatography
A column of DEAE-cellulose (HR5/5 mono Q, 1 ml volume, Pharmacia) 
was used as a second step in the purification of the proteinases. 
Fractions from gel filtration containing the lower molecular weight
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proteinases were concentrated (see section 2.10.4) and applied in 
either 1 ml or 2 ml volumes to the mono Q column which had been 
previously equilibrated with 0.025 M sodium phosphate buffer, pH 6.0. 
Unbound protein was eluted with 5 ml of equilibration buffer. Elution 
was then continued using a salt gradient of 0-0.35 M sodium chloride 
in sodium phosphate buffer, pH 6.0, to elute bound proteins. Normally 
the gradient was commenced at fraction 6 and rose to 0.35 M sodium 
chloride by fraction 25. At this stage the sodium chloride 
concentration was increased to 1 M and maintained such that fractions 
26-30 contained any proteins still bound to the column at 0.35 M 
sodium chloride. Fractions were collected as for gel filtration and 
assayed for proteinase activity as described previously (see section
2.10.1.). Protein elution was followed at 280 nm as described above.
On one occassion the salt gradient concentration was altered such 
that the gradient commenced as above but between fractions 20 and 30 
was shallower. Between fractions 20 and 30 the gradient changed from 
0.25 M NaCl to 0.35 M NaCl, whereupon the salt concentration was 
raised to 1 M and maintained such that fractions 31-35 contained any 
proteins still bound to the column at 0.35 M NaCl.
2.10.4. Pooling and concentration of low molecular weight proteinases
Proteinase activity in the chromatographic fractions was measured 
as described previously (see section 2.9.1.) and the fractions 
containing the low molecular weight proteinases identified using 
gelatin SDS-PAGE (see section 2.12.3). These fractions were then 
pooled and concentrated under nitrogen pressure, on ice, using an 
Amicon Ultrafiltration Cell. A PM 10 membrane filter was used, 
allowing molecules with an approximate molecular weight of less than 
10 kDa to pass through the membrane whilst retaining those of higher 
molecular weight. The pooled and concentrated preparation of low
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molecular weight proteinases i.e. those recovered from ion exchange 
chromatography, were termed the purified proteinases and were used to 
characterise these enzymes.
2.11. PROTEIN ESTIMATION
Protein estimations were carried out using the method of Sedmak 
and Grossberg (1977) using bovine serum albumin as standard. This 
method was shown to be appropriate for protein concentrations in the 
range 5-40 pg ml *. A standard curve was determined for each fresh 
batch of reagents used.
2.12. POLYACRYLAMIDE GEL ELECTROPHORESIS
2.12.1. Preparation of samples for polyacrylamide gel electrophoresis
Parasite homogenates were prepared using detergent lysis as 
described in section 2.2.3. and diluted 1:1 with 2 x sample buffer 
(125 mM Tris-HCl, pH 6.8, 4% (w/v) SDS, 5% (v/v) 2-mercaptoethanol, 
20% (v/v) glycerol; Laemmli, 1970). Chromatographic fractions were 
also diluted with the sample buffer at a ratio of 1 : 1, but
occasionally (as specified) at a ratio of 2 : 1. Samples were only
boiled where stated. In some cases, samples were pre-incubated with 
inhibitors for 30 minutes at room temperature before the addition of 
sample buffer.
2.12.2. Preparation and running of gels
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS- 
PAGE) was used to separate proteins and estimate their molecular 
weight. Gels were prepared and run as described by Hames and Rickwood 
(1981). The % of acrylamide used in the separating gel was either 5,
7.5 or 12.5% (w/v) but was always 5% (w/v) in the stacking gel. Gels 
were normally run overnight at 8 mA per gel, except where mini-gels 
were used. These were run for approximately 45 minutes at 100 volts
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per gel. Acrylamide gels were used to identify the molecular weights 
of proteins which correlated with proteinase activity and to determine 
the purity of samples after different chromatographic procedures. 
Protein bands were detected by using either Coomassie Blue staining 
(0.05% [w/v] PAGE blue 83, 25% [v/v] isopropanol and 10% [v/v] acetic 
acid) for three hours before destaining in 10% (v/v) acetic acid or by 
the use of silver staining as described by Oakley et al (1980).
2.12.3. Gelatin SDS-PAGE
Proteinase activity was detected and analysed using gelatin SDS- 
PAGE (Lockwood et al., 1987). These gels contained 0.2% (w/v) gelatin 
which was copolymerised into the separating gel. After 
electrophoresis, the gels were incubated in 2.5% (v/v) Triton X100 for 
30 minutes (mini-gels) or 1 hour (large gels) to remove SDS. The gels 
were then incubated in 0.1 M acetic acid/sodium acetate buffer, pH 
5.5, with 1 mM DTT at 37°C during which time the proteinases 
hydrolysed the gelatin present in the gel. This incubation lasted up 
to 4 hours depending on the level of proteinase activity present. 
After incubation, the gels were stained with Coomassie Blue as 
described above, and then destained with 10% (v/v) acetic acid. Clear 
bands indicated the position of proteinases.
2.12.4. Determination of molecular weights from gel electrophoresis
The molecular weight of individual proteins and proteinases were 
determined by comparing their electrophoretic mobility with that of 
standard proteins, either high or low molecular weight standards 
(Sigma Chemical Co. Ltd.).
2.13. CHARACTERISATION OF THE L.M.MEXICANA AMASTIGOTE LOW MOLECULAR 
WEIGHT PROTEINASES
2.13.1. The effect of inhibitors and competing substrates
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Enzyme samples were pre-incubated with inhibitors for either 30 
or 60 minutes at room temperature before the addition of the substrate 
and DTT whereupon the activity of the sample towards the BzPPANan was 
determined and compared with a control. The assay was as described in 
section 2.10.1. to determine specific activities. Several proteinase 
inhibitors were used to characterise the type of proteolytic 
activities being studied.
Several amino acid esters and amino acid amides were used to 
investigate their possible effect on the hydrolysis of BzPPANan by the 
purified proteinases. The purified enzymes and the amino acid 
derivatives were added together to the reaction mixture, which already 
contained the DTT and the BzPPANan and the effect on the hydrolysis of 
the BzPPANan compared to a control. The assay used was as described in 
section 2.10.1. to determine specific activities. Some of these 
compounds were dissolved in ethanol or DMSO and appropriate controls 
were carried out to compensate for any potential effects of these 
solvents.
2.13.2. Determination of the effect of pH on enzyme activity
The pH optimum of the activity of the purified enzymes towards 
BzPPANan, was calculated using the assay for determination of the 
specific activities (see section 2.10.1.). Two buffers were used, 0.1 
M citric acid (pH 3-6) and a 0.1 M sodium phosphate (pH 6-8). These 
buffers replaced the 0.15 M phosphate buffer used in the standard 
assay. These buffer systems were also used in determining the pH 
optimum for the hydrolysis of leucine methyl ester by the purified 
enzymes (see section 2.13.3).
2.13.3. Activity towards amino acid esters and amino acid amides 
detected using paper electrophoresis
Paper electrophoresis was used to separate the products of the
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hydrolysis of amino acid esters and amino acid amides from the parent 
compounds. The reaction mixture was a total volume of 0.3 ml 
containing 0.15 M sodium phosphate buffer, pH 6.0, 1 mm DTT, the
appropriate homogenate or purified enzyme and normally 20 mM of the 
ester or amide. The reaction mixture was incubated for three hours at 
37°C and applied immediately, in either 10 or 40 ul volumes, to strips 
of Whatman 3 MM paper (3 cm x 25 cm) for electrophoresis. The 
hydrolysis products of the amino acid esters and amino acid amides 
were then separated by paper electrophoresis, using an electrophoresis 
constant power supply (Pharmacia, ECPS 3000/150). Electrophoresis was 
carried out at 8V cm  ^ for 3 hours in an electrophoresis tank using a 
pyridine acetate buffer, pH 3.5 (glacial acetic 
acid:pyridine:water/10:1:89, by volume). This buffer was also used to 
pre-soak the paper before sample application, a step which appeared to 
help in the separation of the various hydrolysis products. After 
electrophoresis the paper was air dried and stained by immersion in a 
solution of 0.2% (w/v) ninhydrin in 75% (v/v) acetone. In some
experiments, after drying to develop the colour, the stain was fixed 
by dipping the paper in a C u ^ O ^ ^ ,  0.02% HNO^ in acetone: ethanol
[2:1]) (Goldman and Kaplan, 1973). Alternatively, the reaction 
products were quantified by eluting them with 10 ml of 0.4% (w/v)
cadmium acetate prepared in a water-glacial acetic acid-ethanol (1:5:4 
by volume) solution for 30 minutes and measuring the absorbance at 505 
nm of the eluted solution. This method was used to generate a standard 
curve with L-leucine.
2.13.4. Detection of glycoproteins on gels
The procedure used was essentially that of Zacharius et al 
(1969). After electrophoresis, the gel was immersed in 12.5% (w/v) TCA 
for 30 minutes, then rapidly rinsed with distilled, deionised water
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and immersed in a solution of 1% periodic acid in 37. acetic acid for a 
further 50 minutes. The gel was then washed a minimum of 6 times by 
immersion in distilled, deionised water with motion before being 
immersed in 50 ml of fuchsin-sulphite stain (Sigma, UK), in the dark, 
for 50 minutes. Freshly prepared 0.5% (w/v) metabisulphite was used 
for 3 rinses, of 10 minutes each, before being replaced with 
distilled, deionised water to remove the excess stain. Pink bands 
appear at the site of glycosylated proteins. Fetuin and ovalbumin 
(Sigma, UK) were used as glycoprotein standards.
2.13.5. Studies using endoglycosidase treatment
The method used was modified from ref. 20 ul of purified enzyme 
(0.01 units see 3.8.5.) was added to 40 ul of incubation buffer
comprising 150 mM NaPO^, 75 mM EDTA, 1.5% Nonidet P40 and 1.5%
mercaptoethanol at pH 6.1. Leupeptin was also included to give a final 
concentration of 100 ug ml * and 2 ul of Endoglycosidase F was added 
(Sigma, UK). The reaction mixture was then incubated at 37°C for 8
hours before duplicates of the sample were run on SDS-PAGE to detect
any changes in the banding pattern of the proteinases.
2.14. STATISTICAL ANALYSIS OF DATA
One-way and two-way analysis of variance tests in conjunction
with the Student-Newman-Keuls procedure were used to analyse the 
significance of data. The F value, on which the significance is based 
is given with the degrees of freedom in subscript. The probability (P) 
was taken as significant when P<0.05.
2.15 MATERIALS
Sodium stibogluconate (Pentostam) equivalent to 0.32 mg Sb ml 1 
was a gift from the Wellcome Foundation, UK. The three non-ionic 
surfactants (see fig 7) were a gift from L'Oreal, France. These are
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the vesicle-forming non-ionic surfactants as synthesised by 
Vanlerberghe et al (1978). In each case the number of units in the 
hydrophilic portion is a number average value. Surfactant 3 is not 
ether-linked, and contains the isomers in the proportion A:B, 92:8.
Soluble starch (maltodextrin, molecular weight = 5000) was a gift 
from Dr Lars Svensson, Stadex AB, Malmo, Sweden. ADH was synthesised 
essentially as described by Stahl et al (1978). Acrylic acid 
glycicidyl ester, N-t-butyloxycarbonyl-1, and 6-diaminohexane were 
obtained from Fluka AG, Switzerland, 1-ethyl-3 -(3-dimethylminopropyl) 
carbodiimide from Sigma, UK, and N-hydroxysuccinamide and N,N,N',N'- 
tetramethylethylene diamine from Merck, FRG.
BzPPANan, was prepared as a stock solution of 1 mM in water and 
dissolved by heating to 90°C for sveral minutes. It was stored at - 
20°C. No loss of stability was noted over the periods of time it was 
stored. The proteinase inhibitors pepstatin (1 mg ml *), N-tosyl-L- 
phenylalanine chloromethyl (TPCK, lOmM), and chymostatin (1 mg ml *) 
were all dissolved in DMSO whilst phenylmethylsulfonyl fluoride (PMSF, 
10 mM) was dissolved in ethanol. All the other proteinase inhibitors 
leupeptin, trans-epoxysuccinyl L-leucylamido-(4-guanidino)-butane 
(E64) and antipain (1 mg ml"*), N-p-tosyl-1-lysine chloromethyl ketone 
(TLCK) , iodoacetic acid (IAA) and phenanthro 1 ine (10 mM) were 
dissolved in water. Stock solutions were stored at -20°C except PMSF 
which was made up freshly each time it was used. All chemicals were 
obtained from Sigma unless otherwise stated.
The principal components of the growth culture medium for 
Leishmania promastigotes i.e. foetal calf serum, MEM Eagle Suspension 
powder, MEM (50x) amino acids, MEM (50x) amino acids solution and MEM 
(lOOx) non-essential amino acids solution were obtained from Gibco- 
Biocult, Scotland. RPMI 1640 and Lab-Tek 8-chamber tissue culture 
slides for PEC culture were obtained from Flow laboratories, England.
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3.0 RESULTS
3.1. THE EFFICACY OF CARRIER SYSTEMS IN THE CHEMOTHERAPY OF 
EXPERIMENTAL VISCERAL LEISHMANIASIS
The first aim of this project was to test two novel carrier 
systems, niosomes and microparticles, in a direct comparison with the 
well characterised liposomal system, for the delivery of sodium 
stibogluconate to treat experimental leishmaniasis.
3.1.1. The use of free sodium stibogluconate against L.donovani in 
mice
In order to compare the efficacy of carrier systems for sodium 
stibogluconate with that of free sodium stibogluconate it was 
necessary to evaluate the effect of the free drug in the experimental 
animal model of leishmaniasis. The infection and treatment regimen was 
as described earlier (see section 2.4.1.), drug administration was by 
tail vein inoculation of 0.2 ml on days 7 and 8 post - inf ection. The 
data in table 4 and figure 9 show the effect of the free drug (sodium 
stibogluconate concentration expressed in terms of Sb) on the parasite 
burden in the liver.
The estimated dose required to give 50% suppression of parasite 
numbers in the liver (ED^q) was approximately 300 ug antimony per 
mouse (see fig. 9). Complete clearance of parasites from the liver was 
achieved with a total dose of 2 mg antimony per mouse. This is 
equivalent to 100 mg antimony per kg. This differs considerably from 
the figure of approximately 1000 mg kg  ^ previously reported (Black et 
al. , 1977; Alving et al., 1978).
3.1.2. The efficacy of vesicular systems containing sodium 
stibogluconate against L.donovani in mice
The infection and treatment regimen that had been used to measure 
the efficacy of free stibogluconate (see sections 2.4.1 and 3.1.1.) 
was also used to test the different vesicular systems. This allowed a
81
Table 4. The efficacy of free sodium stibogluconate against
experimental visceral leishmaniasis.
Sb dose
(pg/mouse) % suppression
66 10.4 + 7.7(5)
200 35.6 + 16.3 (5)
400 65.6 ± 5.8 (13)
660 72.2 + 7.9 (11)
800 91.0 ± 3.7 (16)
1320 97.6 t 0.8 (30)
1600 90.7 + 4.3 (24)
2000 100 n.a. (20)
Mice were infected on day 1 with 2 x 10^ amastigotes of 
L.donovani and treated on days 7 and 8 via the tail vein with free 
sodium stibogluconate solution. The total dose of drug (expressed as 
antimony) given per mouse is shown. Liver parasite burdens were 
determined on day 14 and % suppression calculated for individual drug 
treated animals relative to the mean parasite burden for an 
appropriate untreated control group. The mean + standard error of 
mean are given and the number of animals is shown in parentheses.
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Table 5. The effect of vesicle composition on the efficacy of
vesicular sodium stibogluconate on experimental visceral leishmaniasis
Reduction in liver parasite-burden, % suppression, 
and type of vesicular carrier used.
Sb dose
0/g/mouse) Amphiphile Vesicle composition
Surfactant I 100% + C H O L  30% + C H O L  50% +  C H O L 20%, DCP 10%
10 n.d. -2 7 -4  +  6-6(4) n.d. 14-2 +  8-8(5)
20 24-5 +  7-1 (10) -3 1 -9 + 1 0 -4 (4 ) 38-7 ±7 -6  (6) 5-3 +  6-1 (8)
40 69-5+1-9(8) 30-2 +  5-3 (4) 79-1 +  5-8 (8) 26-5+11-5(8)
80 92-9 +  2-1 (9) 76-5 +  2-3 (5) 88-1+3-4 (3) 65-2+1-6 (7)
160 96-5+1-4 (7) 91-4 ±2 -7  (4) 96-8 +  0-9 (7) 84-5+1-9 (8)
320 99-1 ±0-3 (10) n.d. 99 -2±0  2 (9) 97-6±0-6 (7)
Surfactant II
20 20-2+14-3(4) 41-0 +  5-3 (7) 53-2 +  7-7 (9) n.d.
40 7-2 +  7 2 (4 ) 68-0+4-0 (9) 77-8±4-3 (6)
80 37-2 n.a. (2) 83-9 +  3-8 (8) 91-0+1-6 (8)
160 53-7+13-3(4) 96-5+1-1 (8) 96 6 +  0-9 (9)
320 95-4 +  0-9(4) 99-2 ±0-1 (9) 99-2 ±0-1 (9)
640 99 0  ± 0 (4 ) n.d. n.d.
Surfactant H I
10 n.d. 13-9+14-2 (6) n.d. n.d.
20 45-0+ 11-7 (15)
40 57-6+10-4(12)
80 86-6 +  3-5 (12)
160 93-1 +  1-9(12)
320
Phospholipid
97-4±0-8 (10)
8 n.d. n.d. n.d. 1 -2 + 11-9 (4)
10 n.d. 4-2+ 7-6 (6)
16 n.d. 0 + 1 0 -5 (4 )
20 63-4 ±6 -2  (4) 18-1+5-1 (3)
32 n.d. 33-3 +  3-7 (4)
40 59-1 ±11-4 (5) 90 -1+2-7(5)
64 n.d. 69-1 + 6  3 (5)
80 89-7 +  1-8 (5) 89-9+1-4 (5)
160 98-0 +  0-3 (4) 90-6 ± 4 -1 (4)
320 99-3+0-4 (5) n.d.
n.a. =  not applicable, n.d. =  not determined.
Mice were infected on day 1 with 2 x 107 amastigotes of 
L.donovani and treated on days 7 and 8 via the tail vein with sodium 
stibogluconate in several vesicular forms. Vesicles comprised 
amphiphile, non-ionic surfactant or phospholipid, with and without 
admixture of cholesterol (CHOL) and dicetyl phosphate (DCP). Molar 
composition is shown. The total dose of drug (expressed as antimony) 
given per mouse is shown. Liver parasite burdens were determined on 
day 14 and % suppression calculated for individual drug treated 
animals relative to the mean parasite burden for an appropriate 
untreated control group. For any treatment, the mean A suppression + 
standard error of the mean, with the number of animals in parenthesis, 
is given.
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Figure The efficacy of free and vesicular sodium stibogluconate on 
experimental visceral leishmaniasis
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L.donovani and treated on days 7 and 8 via the tail vein with free 
sodium stibogluconate solution (■) or a vesicular form of the drug; 
liposomes ($), niosomes composed of surfactant I (•), II (▼) or III 
( A l ) • Vesicles comprised amphiphile, non-ionic surfactant or 
phospholipid, with the admixture of 30 mol % cholesterol. The total 
dose of drug (expressed as antimony) given per mouse is shown. Liver 
parasite burdens were determined on day 14 and % suppression 
calculated for individual drug treated animals relative to the mean 
parasite burden for an appropriate untreated control group. The 
figures are means + standard errors of mean.
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Mice were infected on day 1 with 2 x 10^ amastigotes of
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direct comparison of the results achieved with the vesicular systems 
to those with the free drug.
Various types of vesicles were used to deliver the drug. They 
differed in the type of surfactant (either phospholipid or non-ionic 
surfactant, see figure 7), the % of cholesterol, and the inclusion or 
not of DCP. The results are summarised in table 5 and figure 9. They 
show that the use of vesicles to entrap the sodium stibogluconate 
improved the efficacy of the drug in this experimental model. There 
appeared to be little difference between the efficacy of liposomes and 
niosomes as vehicles for the drug.
There were some differences between the efficacy of the different 
types of niosomes tested. For example, it is evident that niosomes 
composed of surfactant I with 30 mol % cholesterol were less 
effective, particularly at low dosage, than niosomes with the same 
cholesterol content but prepared from surfactant II or III. Based on 
the ED^q S for the niosomes and the free drug (300 jig per mouse) , the 
increased efficacy of these formulations were a 6-fold increase for 
surfactant I niosomes (ED^q=50 jig Sb) , a 12.5 fold increase for
surfactant II niosomes (ED^q=24 jig Sb) and a 15 fold increase for
surfactant III niosomes (ED^q=20 jig Sb) . The basis for these between
vesicle differences is not known. At higher doses of drug (160-320 jig
Sb per mouse), all non-ionic surfactant vesicle formulations were 
equally effective.
At antimony doses of 10 and 20 pg per mouse, infected mice 
treated with niosomes composed of surfactant I and 30 mol / 
cholesterol showed an increase in their parasite burden. This was not 
observed with any other form of treatment and has not been 
investigated further. These results may simply be a product of the 
natural variation inherent in this type of experiment.
The administration of vesicles which contained 300 mM glucose to
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infected mice also resulted in parasite suppression as high as 42% 
(see table 6). The 'empty' niosomes could be ranked in the order 
surfactant I > surfactant II > surfactant III in terms of inhibitory 
activity. The 'empty' liposomes used in these investigations were as 
active as empty surfactant III niosomes against the liver parasites. 
The mechanism behind this anti-parasitic activity of the empty 
vesicles was not investigated further. There did not appear to be any 
toxicity to mice with the vesicle preparations tested.
3.1.3. Microparticles as a delivery system for sodium stibogluconate
Two batches of drug-loaded microparticles were used, one 
containing 8.4 pg Sb/mg beads and the other 3.3 pg Sb/mg beads. Each 
preparation was diluted with HBSS or concentrated by centrifugation to 
give the required Sb concentration before treatment. Doses of 
microparticulate stibogluconate used were equivalent to 12, 9, 6, 3 
and 1.5 pg Sb per mouse.
The procedure for the treatment of infected mice was the same as 
that used for the vesicular preparations (see section 2.4.1. and
3.1.1.), except that one group was treated only on day 7. The 
experiment was repeated twice and the results are shown in figure 10. 
The control, undosed liver burdens were different in the 2 experiments 
with means of 197 and 352 amastigotes per 100 host cell nuclei. When 
expressed in terms of % suppression, relative to the control, the two 
microparticulate preparations had similar activities, indicating the 
importance of dose rather than the efficiency of bead loading with 
drug.
The ED5q was found to be approximately 6 pg microparticulate 
antimony per mouse. Total suppression of the parasites in the liver 
was not achieved in these experiments but the results can be 
extrapolated to give an indication of the dose needed to clear the
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Table 6. The effect of empty vesicles on experimental visceral 
leishmaniasis
Vesicle type Dose level % suppression
Surfactant I high 41.6 ± 4.9 (17)
low 30.5 ± 5.1 (8)
Surfactant II high 39.1 +4.1 (13)
low 11.3 ± 10.4 (11)
Surfactant III high 14.4 ± 9.5 (7)
low n.d.
Phospholipid high 17.6 + 9.4 (18)
low _8.1 + 4.9 (12)
Mice were infected on day 1 with 2 x 10^ amastigotes of 
L.donovani and treated on days 7 and 8 via the tail vein with a 
suspension of vesicles containing 300 mM glucose. In all cases, non­
ionic surfactant vesicles comprised 70% amphiphile and 30% 
cholesterol, and liposomes 70% phospholipid, 20% cholesterol and 10% 
DCP (molar compositions). Vesicles were given at two dose levels, high 
and low, equivalent to the amount of vesicular material administered 
to achieve a total dose of 320 and 160 ug Sb per mouse in niosomal or 
liposomal form. Liver parasite burdens were determined on day 14 and % 
suppression calculated for individual drug treated animals relative to 
the mean parasite burden for an appropriate untreated control group. 
For any treatment, the mean % suppression + standard error of the 
mean, with number of animals in parenthesis is gven.
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Figure 10. The efficacy of microparticulate sodium stibogluconate on
experimental visceral leishmaniasis
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Mice were infected on day 1 with 2 x 10^ amastigotes of 
L.donovani and treated on days 7 and 8 via the tail vein with 
microparticulate sodium stibogluconate at either 8.4 jig Sb/mg beads 
(•) or 3.3 pg Sb/mg beads (■). The total dose of drug (expressed as 
antimony) given per mouse is shown. Liver parasite burdens were 
determined on day 14 and % suppression calculated for individual drug 
treated animals relative to the mean parasite burden for an 
appropriate untreated control group. The mean parasite suppressions + 
standard deviations are shown.
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liver: 14 pg Sb per mouse. A comparison with the results found with 
the free drug (see section 3.1.1.) shows that the carrier-bound drug 
appears to be 100 x as potent as the free drug.
Unlike the situation with the vesicular systems, neither 'empty' 
polyacryl starch microparticles or ADH-polyacryl starch microparticles 
without drug attached appeared to affect the parasite burden of the 
liver at the doses used here. It would appear then that the 
microparticles had no inherent antiparasitic activity in vivo and that 
the parasite suppression reported here is a function of the drug 
content of the microparticles. No toxic effects were observed with 
drug loaded microparticles.
3.1.4. Activity of carrier systems for sodium stibogluconate against 
L.donovani and L.m.mexicana in PECs
Experimental procedures were as described in section 2.4.2.1., 
with promastigotes of L.m.mexicana and amastigotes of L.donovani used 
to initiate infection of the PECs.
Both types of vesicular carrier increased sodium stibogluconate 
efficacy against L. donovani and L. m. mexicana in PECs. The effect 
was most pronounced against the latter species, which was unaffected 
by a 24 hour exposure to the free drug at concentrations of up to 1 mg 
Sb ml 1. A 24 hour exposure to liposomal (DPPC:CH0L, 70:30 mol ratio) 
and niosomal (surfactant I:CH0L, 70:30 mol ratio) stibogluconate of 
L.m.mexicana infected PECs led to a large reduction in the number of 
infected cells (see fig. 11). The liposomal drug at 80 pg Sb ml"1 gave 
total clearance of the parasites whilst the niosomal drug (80 pgSb ml 
*) gave a 61% reduction in the number of infected cells. A two hour 
exposure to the vesicular drug resulted in fewer PECs being cleared of 
parasites (see fig. 12), indicating that activity of the carrier- 
mediated form of the drug was time - dependent. Stibogluconate - loaded
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Figure 11. The effect of 24 hour exposure to free and vesicular sodi
stibogluconate on PECs infected with L.m.mexicana
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PECs were exposed for 24 hours to L .m.mexicana stationary phase 
promastigotes before a 24 hour incubation with either free
stibogluconate ( ■  ) , or drug encapsulated in niosomes composed of
surfactant I and 30% cholesterol ( ♦  ) or liposomes composed of 70% 
phospholipid, 20% cholesterol, 10% DCP ( •  ). The drug dose is
expressed in terms of antimony content. Cells were washed thoroughly 
after the exposure period, the medium replenished and the cells 
incubated for a further 24 hours before they were fixed, stained and 
the number of infected PECs assessed. The results for the free sodium 
stibogluconate are from 3 experiments* carried out in duplicate,
whilst the vesicular results from, a single experiment carried out in 
duplicate. In the control, 80% of the cells were infected.
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Figure 12. The effect of 2 hour exposure to free and vesicular sodium
stibogluconate on PECs infected with L.m.mexicana
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PECs were exposed for 24 hours to L.m.mexicana stationary phase 
promastigotes before a two hour incubation with free stibogluconate 
( ■  ), or drug encapsulated in niosomes with 30% cholesterol composed 
of surfactant I ( •  ), surfactant II ( ▼ ) ,  surfactant III (A) or 
liposomes composed of 70% phospholipid, 20% cholesterol, 10% DCP (♦). 
The drug dose is expressed in terms of antimony content. Cells were 
washed thoroughly after the exposure period, the medium replenished 
and the cells incubated for a further 46 hours before they were fixed, 
stained and the number of infected PECs assessed. The results for the 
free sodium stibogluconate are from 3 experiments, carried out in 
duplicate, whilst the vesicular results are from single experiments 
carried out in duplicate except for the niosomes comprised of 
surfactant I which are from two experiments. In these experiments 64- 
84% of the control cells were infected.
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Figure 13. The effect of 2 hour exposure to free and vesicular sodium
stibogluconate on PECs infected with L.donovani
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PECs were exposed for 24 hours to L.donovani amastigotes before a 
2 hour incubation with either free stibogluconate ( ■  ) , or drug 
encapsulated in niosomes with 30% cholesterol composed of surfactant I 
(•), surfactant II (▼) , surfactant III (A) or liposomes composed of 
70% phospholipid, 20% cholesterol, 10% DCP ). The drug dose is 
expressed in terms of antimony content. Cells were washed thoroughly 
after the exposure period, the medium replenished and the cells 
incubated for a further 46 hours before they were fixed, stained and 
the number of infected PECs assessed. The results for the free sodium 
stibogluconate are from 2 experiments, carried out in duplicate, 
whilst the vesicular results are from single experiments carried out 
in duplicate. In these experiments the % of cells infected in the 
controls were between 96% and 100%.
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niosomes prepared from surfactants II and III, when used in a two hour 
exposure, showed similar activity to surfactant I niosomes (see fig. 
12) .
Leishmania donovani amastigotes in PECs were found to be more 
sensitive than those of L.m.mexicana to free sodium stibogluconate. 
Only two hour treatments were tested against L.donovani-infected 
PECs, but these experiments involved all the different vesicular 
systems (30% mol CHOL) and free drug (see fig 13). Free stibogluconate 
at 100 pg Sb ml  ^ resulted in an 18% reduction in the number of 
infected cells, whilst at the same concentration the liposomal 
preparation used gave a 53% reduction and the three types of niosomes 
gave reductions of the order of 60%. Thus the relative resistance of 
L.m.mexicana to treatment by sodium stibogluconate in vitro appears to 
be overcome to an extent by using these carrier systems such that its 
susceptibility is similar to that of L.donovani.
The use of empty vesicles for a two hour exposure period had no 
effect on parasite viability. However with treatment periods greater 
than four hours, significant suppression of both species was observed 
with empty niosomes. Toxicity to the PECs was also observed at higher 
concentrations of niosomes and liposomes with longer exposure times 
although the degree of toxicity did vary between batches of vesicles.
3.2. THE POTENTIAL OF TUBERCIDIN IN CONJUNCTION WITH INHIBITORS OF 
NUCLEOSIDE TRANSPORT AS ANTILEISHMANIAL AGENTS
The use of tubercidin with inhibitors of nucleoside transport to 
treat Leishmania infected cells was carried out as a potential 
therapeutic strategy and to investigate the possibility that the 
nuleoside permeability characteristics of potential host cells are 
altered when infected with Leishmania.
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3.2.1. Activity against promastigotes of L.donovani and L.m.mexicana
The effect on promastigote growth of tubercidin, dipyridamole and
nitrobenzy1thioinosine (NBMPR) on their own and combinations of 
tubercidin with NBMPR and dipyridamole were determined, as described 
in section 2.4.2.2. with an exposure time of 48 hours.
NBMPR and dipyridamole had no apparent effect on growth at 
concentrations up to 50 pM. Tubercidin however had a marked effect 
against L.donovani and L.m.mexicana with ED^qS of approximately 0.1 pM 
and 0.2 pM respectively. With both species, concentrations of 
tubercidin above 1 pM resulted in the death of > 99% of the
promastigotes. The use of combinations of NBMPR and dipyridamole at 50 
pM in conjunction with tubercidin at concentrations from 0.05 to 50 pM 
showed that neither NBMPR or dipyridamole protected the promastigotes 
from the toxicity of tubercidin.
3.2.2. Activity against amastigotes of L.donovani and L.m.mexicana in 
PECs
A series of experiments similar to those carried out with the 
promastigotes were performed using amastigote-initiated infections of 
PECs in vitro, as described in section 2.4.2.1..
Uninfected PECs treated with tubercidin alone were all killed by 
the end of the two days exposure at all concentrations of tubercidin 
tested (1-10 pM) . Similar results were found with infected cells; all 
were killed by tubercidin itself when used in the range 0.1-5 pM. The 
inhibitors NBMPR and dipyridamole on their own, at concentrations as 
high as 20 pM, had no effect on uninfected cells. These inhibitors at 
concentrations of either 10 or 20 pM, fully protected uninfected PECs 
from tubercidin at concentrations up to and including 2.5 pM. Some 
protection was still evident with 5pM tubercidin, but marked toxicity 
was observed particularly with the 10 pM inhbitor concentrations.
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The results of treating infected PECs with different combinations 
of tubercidin and inhibitors are given in table 7. The protective 
activity of NBMPR and dipyridamole towards PECs infected with 
amastigotes of Leishmania appeared to be the same as for uninfected 
cells. No difference was noted between the susceptibility of PECs 
infected with the species tested here. There did not appear to be an 
increase in the percentage of cells that were uninfected as would be 
expected if infected cells were being targetted, nor a decrease in the 
number of amastigotes per 100 infected cells. Thus it appears tht the 
parasite did not affect the characteristics of nucleoside transport 
into the PECS, nor was the parasite directly exposed to tubercidin.
3.2.3. Efficacy against L.donovani and L.m.mexicana in mice
Drug testing in vivo using the two visceral models was carried 
out as described in section 2.4.1. with several routes of drug 
administration being tested.
The results (table 8) show that a single tubercidin dose of 5 mg 
kg 1 i.p. resulted in death of 4 out of 5 mice, although the surviving 
mouse had an 83% reduction in its parasite burden. All mice survived 
treatment with tubercidin at 1 mg kg’1 i.p. for 5 days but this
regimen did not reduce the parasite burden. Attempts to lessen the 
toxicity by oral administration of the drug proved successful, with 
only 30% of the mice dying after 3 daily doses of 5 mg kg 1, However, 
there was no affect on the parasite load. The co■administration of 
NBMPR with tubercidin in i.p. treatment alleviated the toxicity to 
mice of the tubercidin, although the complete protection previously 
reported (Ogbunude and Ikediobi, 1982) was not apparent. 50% of the 
mice died after being subjected to a combination of 5 mg kg
tubercidin and 25 mg kg'1 NBMPR on 4 consecutive days. This treatment
did not reduce the parasite burden in the surviving mice.
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Table 7. The effect on Leishmania infected PECs of tubercidin in
combination with nucleoside transport inhibitors
L.m. mexi cana
Tubercidin
(pM)
1.25
2.5
5.0
L. donovani
Tubercidin
(pH)
1.25
2.5
5.0
Number of amastigotes per 100 infected cells 
(% of control)
Dipyridamole 
(10 pM)
85 + 10
118 ± 6
96 ± 14
Dipyridamole 
(20 pM)
98 + 26
116 + 18
95 ± 30
Dipyridamole 
(20 pM)
9 2 + 7
81 + 13
9 4 + 2
NBMPR 
(20 pM)
91 + 24
106 ± 6
NBMPR 
(20 pM)
9 0 + 6
104 + 35
86 + 10
PECs were exposed for 24 hours to amastigotes of the appropriate 
species and washed thoroughly before treatment commenced. Infected 
PECs were treated for 48 hours then fixed, stained and the parasite 
load assessed. The number of amastigotes per 100 infected cells varied 
between 1000-1200 for L.m.mexicana and 1400-2000 for L.donovani 
controls; the infection rates were between 91% and 97% for 
L.m.mexicana and 95% and 100% for L.donovani. All experiments were 
done a minimum of 4 times, the figures given are the means +. the 
standard deviations.
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Table 8. The efficacy against Leishmania in mice of tubercidin alone
and in combination with the nucleoside transport inhibitor NBMPR
L.donovani infections
1) Control
Treated, 1 mg tubercidin 
kg 1 , i.p., 5 days.
2) Control
Treated, 5 mg tubercidin 
kg 1 , i.p., 1 day.
3) Control
Treated, 5 mg tubercidin 
kg'1 , 25 mg NBMPR kg'1 
i.p., 4 days. 
L.m.mexicana infections.
4) Control
Treated, 5 mg tubercidin 
kg ^  orally, 3 days.
Parasite load in liver 
(number of parasites per 
100 host cell nuclei)
178 + 41 (n=5)
184 ± 34 (n=5)
227 ± 64 (n=5)
39 (n=5, 4 dead)
194 ± 67 (n=6)
283 + 33 (n=6, 3 dead)
115 ± 113 (n=6)
142 + 89 (n=l0, 3 dead)
Balb/c mice were infected with amastigotes of either L.donovani 
(2 x 107) or L.m.mexicana (3 x 10**) on day 0 and treatment commenced 
on day 7 with the mice sacrificed on day 14 and the parasite load of 
the liver assessed. For administration, the drugs were suspended in 
0.375% gumtragacanth. The results are the means ± standard deviations 
from single experiments, the number of animals in each group are given 
in parenthesis.
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3.3. THE EFFECT OF MANIPULATING THE PHAGOLYSOSOMAL ENVIRONMENT UPON 
PARASITE GROWTH IN VITRO
In an attempt to improve our knowledge of the phagolyosomal 
environment and the role that it plays in the parasite-macrophage 
interaction, a series of experiments were designed involving the 
manipulation of the lysosomal environment of infected cells. 
Methylamine, ammonium chloride and dextran sulphate were used as they 
are known to affect vacuolar pH, although they do also affect other 
lysosomal functions (see section 1.5.2.2.).
3.3.1. The effect of methylamine, ammonium chloride and dextran 
sulphate upon growth of promastigotes
Promastigotes of L.m.mexicana and L.donovani were incubated at 
25°C in the presence of 10-50 mM concentrations of dextran sulphate, 
methylamine or ammonium chloride in complete HOMEM medium (see section
2.4.2.2.). After 48 hours incubation, the cultures were assessed and 
compared to a control. Growth of L.m.mexicana was unaffected by the 
ammonium chloride at the concentrations tested whereas an ED^q of 
approximately 30 mM was found with the methylamine. In contrast, 
L.donovani was greatly affected by both methylamine and ammonium 
chloride with an ED^q of approximately 10 mM for both of these 
compounds. When methylamine was used at 50 mM promastigotes were not 
detectable after 48 hours. Dextran sulphate did not affect the 
multiplication of either of the species at the concentrations tested.
3.3.2. The effect of methylamine, ammonium chloride and dextran 
sulphate upon the growth of L.donovani and L.m.mexicana amastigotes in 
PECs
PECs were infected with amastigotes of either L.donovani or 
L.m.mexicana and incubated for up to 5 days under standard conditions, 
except for the addition of either methylamine, ammonium chloride or
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dextran sulphate. At appropriate time points during treatment, cells 
were fixed, stained and the parasite load assessed as described in 
section 2.4.2.1.. One way and two way analysis of variance was used to 
analyse the differences between the observed results.
The results of treatment of infected PECs with methylamine and 
ammonium chloride are given in table 9. PECs infected with 
L .m .mexicana and treated with either compound were unaffected over the 
first 72 hours whereupon there was a slight but not significant 
increase in the number of amastigotes compared to the controls. 
However, the L.donovani infection was suppressed for the whole of the 
period by methylamine treatment whereas ammonium chloride treatment 
affected the infection only in the later stages. Results from a 
typical experiment with L .donovani-infected PECs treated with 
methylamine or ammonium chloride are shown in figure 14. These results 
indicate that the suppression achieved with methylamine was mainly due
to an inhibition of growth of the amastigotes although it appears that
some amastigotes were killed.
The results of exposure of L.m.mexicana infected PECs for 5 days
to methylamine or ammonium chloride at various concentrations are 
given in table 10. No effects were apparent with the compounds at 5mM 
or lOmM in agreement with the results in table 9. However, treatment 
with either 20 mM ammonium chloride or 20 mM methylamine did inhibit 
the infection. In similar experiments L.donovani growth was affected 
by both ammonium chloride and methylamine at all concentrations 
tested. There was no significant difference between the effects of 10 
mM and 20 mM ammonium chloride, although at both concentrations the 
effect was significantly greater than the affect at 5 mM. Methylamine 
at both 5 mM and 10 mM significantly reduced the number of amastigotes 
present and there was also a concentration-dependent effect with the 
reduction in parasite load being greater with 10 mM methylamine than
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Table 9. The effect of methylamine and ammonium chloride on the number 
of amastigotes of L.m.mexicana and L.donovani in PECs
Time post - infection (hours)
24 48 72 96 120
L.donovani Number of amastigotes in PECs as a % of the control
Methylamine 6 5 + 7  56 +15 7 5 + 1 5  4 1 + 9  2 4 + 0 . 5
(10 “M) (n=6) (n=6) (n=4) (n=2) (n=2)
NH4C1 103 + 9  79 + 16 104 + 45 6 3 + 8  54 ± 7
(10 mM) (n=6) (n=6) (n=4) (n=2) (n=6)
L .m .mexicana
Methylamine 95 ± 1 7  92 ± 31 116 ± 27 133 ± 47 106 ± 36
(10 mM) (n=8) (n=10) (n=8) (n=4) (n=8)
NH4C1 90 ± 38 103 ± 28 110 ± 21 126 + 31 115 + 44
(10 mM) (n=7) (n=10) (n=8) (n=4) (n=9)
PECs were exposed for 24 hours to either L.donovani or
L.m.mexicana amastigotes and then washed thoroughly before the
addition of fresh medium containing either 10 mM ammonium chloride or
methylamine. At different time points the cultures were fixed, stained
and assessed for the effect of treatment on the infections. Cultures
maintained beyond 48 hours treatment had their medium replenished as
appropriate. Results are the number of amastigotes per 100 infected
cells expressed as a % of the untreated controls. They are given as
means + standard deviation and the number of experiments given in
parenthesis. Experiments were carried out in duplicate. For
L.donovani-infected controls 89%-100% of PECs were infected at the
different time points with 700-4000 amastigotes per 100 infected
cells, whilst with L.m.mexicana 78%-100% of PECs were infected at the
different time points with 900-1400 amastigotes per 100 infected
cells. Statistically, for L.m.mexicana infected PECs there was no
difference between treated and untreated cells (F 2 99==0.50), whilst
for L.donovani there was a significant difference between treated and
untreated cells (F2 4j=2.64, P<0.001).
100
Figure 14. The effect of methylamine and ammonum chloride on the
course of L.donovani growth in PECs
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PECs were exposed for 24 hours to L.donovani amastigotes at a 
ratio of 1 : 2, and then washed thoroughly before the addition of
fresh medium alone (■) or containing either 10 mM methylamine (A) or 
10 mM ammonium chloride (•). At different time points thereafter the 
cultures were fixed, stained and assessed for the effect of treatment 
on the infection. Results are expressed as the number of amastigotes 
per 100 infected cells. These are the results from a single experiment 
carried out in duplicate. The figures given are the means with the 
ranges shown. Cultures maintained beyond 48 hours treatment had their 
medium replenished at this point.
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Table 10. The effect of 5 day exposures to methylamine and ammonium 
chloride on the number of amastigotes of L.m.mexicana and L.donovani 
in PECs at different concentrations
L.donovani infections:
Ammonium chloride. Number of amastigotes in experimental PECs
as a % of the numbers in the control. 
Control 5 mM 10 mM 20 mM
100 + 1 8  7 6 + 1 0  5 4 + 7  58 + 12
Methylamine:
Control 5 mM 10 mM
100 + 3 2  51 + 17 24 + 0.5
L.m.mexicana infections.
Ammonium chloride:
Control 5 mM 10 mM 20 mM
100 + 18 125 + 33 115 + 4 4  79 + 30
Methylamine:
Control 5 mM 10 mM 20 mM
100 +6 114 + 23 106 + 3 6  81 + 23
PECs were exposed for 24 hours to amastigotes of the appropriate 
species before the addition of fresh medium containing either 
methylamine or ammonium chloride. The medium was replenished 48 hours 
after treatment commenced. After 5 days treatment the cultures were 
fixed, stained and assessed for the effect of treatment on the 
infections. The results are expressed as a % of the mean of the
controls. Experiments were carried out 6-9 times, in duplicate, except 
for the 10 mM methylamine treatment of L.donovani which was carried 
out twice. For L.donovani infected controls 89%-100% of PECs were 
infected with 1100-4000 amastigotes per 100 infected cells, whilst 
with L.m.mexicana 78%-100% of PECs were infected with 900-1400 
amastigotes per 100 infected cells. Statistically, L.m.mexicana was 
inhibited by treatment with 20 mM methylamine (F3 2 -28, P<0.05)
and 20 mM ammonium chloride (F^ 28=^ ' ^ ’ l><®-05) but not at lower
concentrations. However, with L.donovani there were differences 
between infected controls and treated groups at all levels,
(F2 41=22.64, P<0.001). Using 10 and 20 mM ammonium chloride results 
were comparable but differed from the 5 mM treatment (^ 3 20“ 19.29, 
P<0.01). Treatment with 5 mM and 10 mM methylamine of L.donovani 
infections differed from each other (F2 14=10.75, P<0.001).
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Table 11. The effect of dextran sulphate on L.m.mexicana and
L.donovani in PECs
Number of cells infected as % of control.
L.donovani Dextran sulphate concentration (pg ml'1)
Control 6.25 12.5 25
100 ± 4  7 8 + 1 3  54 ± 23 5 2 + 2
(n=4> (n=4) (n=4) (n=2)
L.m.mexicana
Control 6.25 12.5
1 0 0 + 4  95 ± 8 62 + 28
(n=6) (n=4) (n=2)
Number of amastigotes per 100 infected cells, % of control.
L.donovani Dextran sulphate concentration (pg m l _1)
Control 6.25 12.5, 25
100 ± 1 0  64 ± 9 58 ± 16 42 + 16
(n=4) (n=4) (n=4) (n=2)
L.m.mexicana
Control 6.25 12.5
100 ± 20 96 ± 18 68 + 29
(n=6) (n=4) (n=2)
PECs were exposed for 24 hours to amastigotes of the appropriate 
species before the addition of fresh medium containing dextran
sulphate. After 48 hours treatment the cultures were fixed, stained
and assessed for the effect of treatment on the infections. The
results are expressed as a % of the mean of the controls, with the 
number of experiments, carried out in duplicate, in parenthesis. For 
L.donovani infected controls 90%-100% of PECs were infected with 1300- 
2200 amastigotes per 100 infected cells, whilst with L.m.mexicana 95%- 
100% of PECs were infected with 900-1400 amastigotes per 100 infected 
cells.
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A: L.donovani infected PEC, no treatment, infected for 5 days. Densely 
stained PEC nucleus is arrowed, note the 'tight' parasitophorous 
vacuoles. B: L.donovani infected PEC, treated with 10 mM methylamine 
for 48 hours. PEC is highly vacuolated, arrowed. The parasitophorous 
vacuoles appear to be less 'tight'. C: L.m.mexicana infected PEC, no 
treatment, infected for 5 days. The charecteristica1ly large 
parasitophorous vacuoles are arrowed. D: L.m.mexicana infected PEC,
treated with 12.5 pg ml'1 dextran sulphate for 48 hours. Densely 
staining granules are arrowed. All these cells were fixed in methanol 
and stained in 10% giemsa.
Figure 15. The effect on Leishmania infected PECs of treatment with 
methylamine and dextran sulphate
\
104
with 5 mM.
Dextran sulphate affected the growth of both species, resulting 
in a reduction in the /» of macrophages infected and in the number of 
amastigotes per 100 infected cells (see table 11). Again, L.donovani 
appeared to be affected more than L.m.mexicana. It was interesting to 
note that infected PECs treated with dextran sulphate were often 
filled with densely staining granules, possibly the remains of dead 
parasites. This was not observed in uninfected cells treated with 
dextran sulphate and appeared more often in cells infected with 
L.m.mexicana than with L.donovani (see fig. 15).
Treatment of either infected or uninfected cells with these 
lysosomotrophic compounds caused extensive changes in the morphology 
of the lysosomes. The large differences between uninfected cells 
treated with methylamine and an untreated control group are shown in 
figure 15. Interestingly L. donovani-infected cells treated with 
methylamine were morphologically quite similar to untreated L. m. 
mexicana-infected cells. The characteristic 'tight' parasitophorous 
vacuole of L.donovani became somewhat similar in appearance to the 
'looser' vacuole in which L.m.mexicana characteristically resides. 
This affect was more pronounced in cells treated with methylamine than 
ammonium chloride and only at concentrations of 10 mM and greater. The 
onset of this change in morphologyaf ter treatment was rapid.
3.4. THE EFFECT OF pH ON THE UPTAKE AND INCORPORATION OF LEUCINE AND 
ADENOSINE BY DIFFERENT SPECIES AND STAGES OF LEISHMANIA
The results in section 3.3. raised the possibility that 
L.donovani and L.m.mexicana may be adapted to living at different pHs. 
One method of further investigation was to look at the optimal pH for 
the uptake of leucine and adenosine in different species and stages of 
the parasites. This could give an indication of the pH to which these
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parasites are adapted. Here, representative results of a preliminary 
study are presented.
The uptake of leucine and adenosine by stationary phase 
promastigotes of L.donovani and L.m.mexicana (see figs. 16 and 17) was 
greatest around pH 6 or 7 whilst the greatest uptake by L.major 
metacyclics was at pHs 5 and 6, uptake at pH 7 was much less. The pH 
of the growth medium (HOMEM) was also measured at the time the cells 
were harvested and varied between 5.3 and 6.8 with the majority being 
in the 6.3 range. This represented a change in the pH of the growth 
medium from 7.3 at the start of the cultures to 6.3, presumably caused 
by the excretion of acid end products by the promastigotes. Thus from 
these preliminary results it appears that the pH optimum for uptake of 
adenosine by metacyclics of L.major is below the measured pH of the 
medium and also lower than that of multiplicative promastigotes.
The results for amastigotes of L.donovani and L.m.mexicana are 
given in figure 18. There was a similar effect of pH on the 
incorporation of adenosine as reported by Mukkada et al. (1985) for 
uridine and thymidine incorporation by L.donovani amastigotes i.e. a 
sharp peak at pH 5. However the results for L.m.mexicana do not show 
as sharp a peak as for L.donovani, with a relatively small difference 
between the incorporation at pHs 5 and 6.
The results from this and the previous section (section 3.3.) 
raised the question as to whether or not the pH of the parasitophorous 
vacuole differs between species of Leishmania. Attempts were made to 
measure the pH of the parasitophorous vacuole of cells infected with 
L.m.mexicana and uninfected cells. This was done using a fluorescent 
probe (FITC labelled dextran) which is endocytosed and accumulates in 
lysosomes. The fluoresence spectrum of this compound changes in the pH 
range 3-8 and by using light at 620 nm and 480 nm a ratio can be 
determined and from this the lysosomal pH can be estimated using a
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Figure 16. The uptake of H3-leucine at different pHs by Leishmania
promastigotes
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The uptake of H -leucine by stationary phase promastigotes of 
L .m.mexicana ( ■  ) and L. donovani ( •  ) over a 2 hour period was 
measured at different pHs. The cells were washed twice with the 
incubation buffer by centrifugation, collected by filtration using 
glass microfiber filters and washed thoroughly with ice cold HBSS. The 
filters were air dried and transferred to scintillation vials 
containing Ecoscint scintillation fluid and the radioactivity counted. 
These are the means from 4-5 experiments carried out in duplicate.
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Figure 17. The uptake of H3 -adenosine at different pHs by Leishmania
promastigotes
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The uptake of H -adenosine by stationary phase promastigotes of 
L.m.mexicana ( ■ ) and L.major metacyclics ( ▼ )  over a 2 hour period 
was measured at different pHs. The cells were washed twice with the 
incubation buffer by centrifugation, collected by filtration using 
glass microfiber filters and washed thoroughly with ice cold HBSS. The 
filters were air dried and transferred to scintillation vials 
containing Ecoscint scintillation fluid and the radioactivity counted. 
These are the means from 4 experiments (L .m .mexicana) and 2 
experiments (L.major) carried out in duplicate.
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Figure 18. The incorporation of H3 -adenosine into Leishmania
amastigotes
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The incorporation of H -adenosine into amastigotes of 
L.m.mexicana ( ■ ) and L.donovani ( •  ) over a 2 hour period was 
measured at different pHs. The cells were washed twice with the 
incubation buffer by centrifugation, resuspended in 5% TCA and 
collected by filtration using glass microfiber filters and washed 
thoroughly with 10 ml ice cold TCA. The filters containing the TCA- 
insoluble material were then washed with 4 ml of 95% ethanol, air 
dried and transferred to scintillation vials containing Ecoscint 
scintillation fluid and the radioactivity counted. These are the means 
from 2 experiments done in duplicate.
109
calibration curve (Ohkuma and Poole, 1978). Initial results suggested 
that the lysosomal pH of infected and uninfected PECs is different, 
however the equipment was not sufficiently sensitive or consistent to 
allow quantification of the intial results any further.
3.5. THE ANTILEISHMANIAL ACTIVITY OF AMINO ACID ESTERS AND AMINO ACID 
AMIDES
One of the aims of this project was to characterise the 
anti leishmanial activity of the amino acid ester L-leucine methyl 
ester (Rabinovitch et al. 1986) and to investigate the potential 
antileishmanial activity of other similar compounds. This was carried 
out by testing these compounds against different species, both 
amastigotes and promastigotes, in a variety of models.
3.5.1. Activity against promastigotes of L.donovani, L.major and 
L.m.mexicana
L-leucine methyl ester (leuOMe) and L -tryptophanamide both 
partially inhibited the growth of promastigotes of all 3 species 
tested. With leuOMe the effect was transient (see fig. 19), even when 
the compound was present initially at 10 mM. With L-1ryptophanamide at 
10 mM, many promastigotes were killed during the first 24 hours and 
there was no subsequent cell multiplication, although not all 
parasites were killed even by 8 days (see fig. 20). A concentration- 
dependent effect was evident and promastigotes treated with 
concentrations < 5 mM of either compound were much less effective. 
Similar results were achieved with the other two species (data not 
shown).
3.5.2.1. Activity against amastigotes of L.donovani, L.m.mexicana and 
L.major in PECs
Experiments to determine the activities of the above compounds
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Figure 19. The effect of L-leucine methyl ester on the growth of
L.m.mexicana promastigotes in vitro
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Promastigotes of L.m.mexicana, at an initial density of 5 x 10^ 
ml were incubated in H0MEM medium in the presence of different 
concentrations of leuOMe: 10 mM( O ) , 5mM( #  ) , 2mM( ■ ) , control ( □ ) 
and the growth of the promastigotes monitored over an 8 day period. 
These results are the means of duplicate counts.
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Figure 20. The effect of L -tryptophanamide on the growth of
L.m.mexicana promastigotes in vitro
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Promastigotes of L.m.mexicana, at an initial density of 5 x 10^ 
ml *, were incubated in H0MEM medium in the presence of different 
concentrations of tryptophanamide: 10mM(O), 5mM( #  ) , 2mM( ■ ) , 0.5mM 
(V), control(D) and the growth of the promastigotes monitored over 
an 8 day period. These results are the means of duplicate counts.
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against amastigotes in PECs in vitro were carried out as described in 
section 2.4.2.1.. Treatment with leuOMe was generally for 1 hour 
whilst exposure to the amides was normally for a longer period. The 
PECs were fixed, stained and assessed for parasite load 48 hours post­
infection.
With a 1 hour exposure to 2 mM leuOMe, the numbers of PECs 
infected with L.donovani and L.major were unaffected in the 
experiments carried out (n=5 and 2 respectively), whereas with 
similar exposure there was a 99% reduction in the number of PECs 
infected with L.m.mexicana. These results are in accordance with those 
of Rabinovitch et al. (1986) for amastigote initiated infections of 
L.m.amazonensis in PECs.
The antileishmanial activity of L-tryptophanamide differed from 
that of leuOMe in that both L. donovani and L .m .mexicana were 
susceptible. Exposure of PECs infected with either species to 
concentrations of 2, 5 and 10 mM tryptophanamide for 2 hours resulted 
in marked reductions in the number of infected PECs (see fig. 21). 
Leishmania donovani appeared to be slightly more susceptible than 
L.m.mexicana. Thus when L. donovani-infected PECs were treated with 2 
mM tryptophanamide for 1, 2 or 24 hours there was a reduction in the 
number of infected macrophages of 0.5%, 48% and 93%, respectively (see 
fig. 22). Under the same conditions the reductions achieved with 
L.m.mexicana promastigote initiated infections were 0%, 18% and 44%,
respectively. Clearly with both species, the effect produced was 
related to exposure time. Toxicity of tryptophanamide towards PECs was 
noted at the higher concentrations tested, especially with exposure 
times of 4 hours and greater. This was evident in the altered 
morphology of treated cells, relative to the controls, and with longer
exposures the death of all the cells.
L-arginamide was also tested against L.m.mexicana promastigote-
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Figure 21. The effect of L-tryptophanamide concentration on 
L.m.mexicana and L.donovani infections of PECs
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PECs were exposed for 24 hours to either L.donovani amastigotes 
or L.m.mexicana stationary phase promastigotes, washed and then 
exposed to different concentrations of tryptophanamide for 2 hours. 
Cells were washed thoroughly after the exposure period, the medium 
replenished and the incubation continued for a further 46 hours before 
the PECs were fixed, stained and the number of infected PECs assessed. 
The results for L.donovani (#) and L.m.mexicana (■ ) are the means + 
the standard deviations from 3 experiments done in duplicate. The 
infection rates of the controls for L.donovani were between 974 and 
100% and for L.m.mexicana 65% to 87%; these controls are expressed as 
100%.
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Figure 22. The time dependent effect of L-tryptophanamide on
L .m.mexicana- and L. donovani-inf ected PECs
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PECs were exposed for 24 hours to either L.donovani amastigotes 
or L.m.mexicana stationary phase promastigotes, washed and then 
exposed for different lengths of time to .2 mM tryptophanamide. Cells 
were washed thoroughly after the exposure period, the medium 
replenished and the incubation continued untill 48 hours after the 
initial exposure to drug and the PECs fixed, stained and the number of 
infected PECs assessed. The results for L.donovani ( ■ ) and 
L.m.mexicana ( •  ) are the means + the standard deviations from 3 
experiments done in duplicate. The infection rates of the controls for 
L.donovani were between 97% and 100% and for L.m.mexicana 65% to 87%; 
these controls are expressed as 100%.
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initiated infections of PECs for exposure times of up to 5 days at 3 5
and 7 mM. There were no effects on the parasite load.
3.5.2.2. Activity of L-leucine methyl ester against L.m.mexicana 
promastigote initiated infections of PECs
PECs infected with L.m.mexicana by exposure to stationary phase
promastigotes did not respond in the same way to leuOMe as PECs
initially infected with amastigotes. Promastigote initiated infections 
were relatively resistant to leuOMe for the first 24 hours whereupon 
their susceptibility increased, in a time dependent manner, over a 
period of 5 days post - infection (see fig. 23). It was found that only 
after this period were all the amastigotes arising from promastigote 
initiated infections consistently killed by leuOMe. A similar protocol 
was used against amastigote-initiated infections of L.donovani to see 
if there was a time dependent onset of leuOMe susceptibility. The 
compound had no apparent effect at any time.
3.5.3. Use of the tetrazolium salt (MTT) reduction assay to assess the
effects of compounds on the viability of isolated parasites
The effects of a 1 hour exposure of isolated parasites to either 
leuOMe or tryptophanamide was assessed using the procedure involving 
the tetrazolium salt MTT, as described in section 2.4.2.3..
Amastigotes and promastigotes of L.m.mexicana and L.donovani were 
all affected by leuOMe, as measured by their reduction of MTT (see 
fig. 24). The amastigotes of L. m. mexicana, however, were the most 
susceptible to leuOMe. Exposure of the parasites to tryptophanamide 
also resulted in diminished MTT reduction (fig. 25) With this compound 
however, both forms of the two species were affected similarly and 
large effects were observed only when concentrations were 5 mM or
more. These results concur with the general findings in section
3.5.2.1. that amastigotes of L.m.mexicana are less susceptible to
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Figure 23. The effect of L-leucine methyl ester on L.m.mexicana 
promastigote-initiated infections of PECs
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PECs were exposed for 24 hours to stationary phase L.m.mexicana 
promastigotes before being exposed to 2 mM leuOMe at different time 
points for 1 hour. After the exposure period the cells were washed 
thoroughly, the medium replenished and the incubation continued. PECs 
were fixed, stained and assessed for the number of infected PECs at 5 
days post-infection. The results are the means ± standard deviations 
from 5 experiments, done in duplicate. The infection rates varied 
between 65% and 84%. The results are expressed as the % reduction in 
the number of infected PECs with the controls taken as 100%.
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Figure 24. The effect of L-leucine methyl ester on the viability of
different species and stages of Leishmania, as measured by their
ability to reduce MTT
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approximately 1 x 10 ml ^aniascigotes) or z x iu mi 
(promastigotes) in complete HOMEM medium and exposed to different 
concentrations of tryptophanamide for 1 hour at 25°C (A, L.m.mexicana; 
B, L.donovani promastigotes) or either 35°C (C, L.m.mexicana
amastigotes), 37°C (D, L.donovani amastigotes). The cells were then 
washed free of the drug and incubated at the appropriate temperature 
with MTT at 450 jig m l f o r  3 hours. The formazan product produced by 
the reduction of the MTT was then quantified by dissolving it in acid 
isopropanol and measuring the absorbance at 570 nm. The results 
obtained are expressed as the reduction of MTT by the treated 
parasites as a % of that by untreated parasites. Each of these results 
are the means from 3 experiments.
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suspended at a cell density of
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Figure 25. The effect of L-tryptophanamide on the viability of 
different species and stages of Leishmania, as measured by their 
ability to reduce MTT
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Isolated parasites w r< 
approximately 1 x 10 ml 
(promastigotes) in complete HOMEM medium and exposed to different 
concentrations of tryptophanamide for 1 hour at 25°C (A, L.m.mexicana; 
B, L.donovani promastigotes) or either 35°C (C, L.m.mexicana
amastigotes), 37 C (D, L.donovani amastigotes). The cells were then 
washed free of the drug and incubated at the appropriate temperature 
with MTT at 450 ug ml for 3 hours. The formazan product produced by 
the reduction of the MTT was then quantified by dissolving it in acid 
isopropanol and measuring the absorbance at 570 nm. The results 
obtained are expressed as the reduction of MTT by the treated 
parasites as a % of that by untreated parasites. Each of these results 
are the means from 3 experiments.
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tryptophanamide than leuOMe.
3.5.4. The effect of L-leucine methyl ester against L.donovani and
L.m.mexicana in mice
Leucine methyl ester was tested against L.donovani using the 
standard mouse model (see section 2.4.1.). The dose regimen was 1 mg 
per mouse, intravenously, on days 7 and 8. Activity against 
L.m.mexicana was assessed using the 2 experimental mouse models of 
leishmaniasis (section 2.4.1.). The effects on the liver parasite load 
of leuOMe, at 2 mg per mouse administered subcutaneously on days 7-11, 
were determined. Also the efficacy agaist L.m.mexicana growing 
subcutaneous ly in mice was tested using a dose regimen of 5 mg per 
mouse given subcutaneously on days 7-11 post - infection.
There was no detectable effect on the parasite load using any of 
the regimens described above. Intravenous administration of leuOMe at 
dose levels above 1 mg per mouse resulted in severe toxicity to the 
mice.
3.6. THE APPEARANCE OF MEGASOMES DURING THE TRANSFORMATION IN VITRO OF 
L.M.MEXICANA FROM PROMASTIGOTE TO AMASTIGOTE
In an attempt to correlate the presence of megasomes with the 
onset of the antileishmanial activity of leuOMe in promastigote 
initiated infections (see section 3.5.2.2.) the transformation from 
promastigote to amastigote was investigated using transmission 
electron microscopy.
PECs were cultured and exposed to stationary phase promastigotes 
of L.m.mexicana for 4 hours as described in section 2.3.2. . 
Subsequently they were harvested, at 4, 23, 47 and 73 hours post-
infection, and processed for electron microscopy (see section 2.8.).
There was a time - dependent increase in the number of megasomes 
apparent in the sections. None were seen in the samples taken at 4
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Figure 26. Transmission electron micrograph of a transforming parasite
23 hours after infection of a PEC in vitro
The extracellular flagellum is being resorbed: the posterior
end of the flagellate contains abundant lipid globules; an elongate 
megasome is visible alongside the kinetoplast. Scale bar = 500 nm.
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Figure 27. Transmission electron micrograph of a transforming parasite
23 hours after infection of a PEC in vitro
iSEnr S'
Detail of the golgi apparatus of a transforming parasite showing 
subtending endoplasmic reticulum at a cis face and swollen clear 
saccules at the trans-face.
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Figure 28. Transmission electron micrograph of a transforming parasite
23 hours after infection of a PEC in vitro
Megasomes and swollen clear saccules lie alongside one another in 
the trans-golgi region. Megasomes are continuous within the trans- 
golgi network (arrow); clathrin-coated vesicles (arrowhead) are 
associated with the clear saccules but not the megasomes. Scale bar = 
500 nm .
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Figure 29. Transmission electron micrograph of a transforming parasite
23 hours after infection of a PEC in vitro
it.*'.
A chain of megasomes extends from the golgi apparatus to the 
posterior end of the cell. Lipid droplets are also present in the 
posterior region. Smooth clear vesicles of the trans-golgi region abut 
onto the flagellar pocket. Scale bar = 500 nm.
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hours post-infection. By 23 hours, however, the megasomes were present 
m  substantial numbers in the trans-golgi region, although the 
parasite still retained an extracellular flagellum (fig. 26). The 
trans-golgi region contained swollen, empty looking sacs and a network 
of smooth-membraned tubules (fig. 27). The megasomes appeared to arise 
among the latter as irregular bloated tubule segments (fig. 28) and to 
extend from the prenuclear golgi region into the posterior part of the 
cell where they assumed their more characteristc shape (fig. 29). At 
times subsequent to 23 hours, the transforming parasites had megasomes 
resembling those of fully transformed amastigotes (see fig. 3). No 
attempt was made to quantify the numbers of megasomes at the different 
time points.
The timescale of the appearance of the megasomes correlates well 
with the onset of activity of leuOMe against promastigote-initiated 
infections (see section 3.5.2.2.). This would suggest that the 
appearance of these organelles is related to the antileishmanial 
activity of leuOMe.
3.7. ESTERASES OF LEISHMANIA
3.7.1. The use of starch gel electrophoresis to detect esterases of 
different species and stages of Leishmania
In an attempt to identify the enzymes involved in the hydrolysis 
of amino acid esters by L.m.mexicana amastigotes the esterase 
isoenzyme patterns of different species and stages of Leishmania were 
investigated using starch gel electrophoresis (see section 2.9.1.) to 
separate the isoenzymes and 4-methyl umbilliferone as substrate. The 
results are summarised in figure 30. Clear differences between the 
banding patterns of different species and stages were found. There 
were, however, several bands in common; one present in promastigotes 
of both L .m.mexicana and L.donovani and also the metacyclics of
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Figure 30. Esterase banding patterns of different species and stages
of Leishmania
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Samples of Leishmania species were run for 5 hours at 8 V cm *, 
with cooling, on an 8% starch gel and esterase activity visualised by 
incubating the gel with 4 -methyl umbiliferyl propionate and viewing 
under an ultraviolet light source. Some samples had leupeptin present 
(10 pg ml whilst being prepared for electrophoresis. The results 
presented are a summary of those obtained in the many experiments 
conducted. Sample 1: L.major metacyclics + leupeptin. 2: L.major 
metacyclics - leupeptin. 3: L.m.mexicana promastigotes - leupeptin. 4: 
L.donovani promastigotes - leupeptin. 5: L.m.mexicana amastigotes + 
leupeptin. 6: L.m.mexicana - leupeptin. 7: L.donovani amastigotes 
leupeptin.
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L.major and the amastigotes of L. donovani, and another present in 
both amastigotes and promastigotes of L.m.mexicana.
Interestingly the addition of the proteinase inhibitor leupeptin 
resulted in the appearance of 2 extra bands in the L.major metacyclic 
samples and the appearance of a single band in the L.m.mexicana 
amastigotes whereas none was detected in samples without leupeptin. 
This finding with the amastigotes is not particularly surprising given 
their high proteinase activity (Pupkis and Coombs, 1984 and the 
results given in section 3.8.3.1.). Nevertheless there was no 
indication that this esterase activity was greater in amastigotes of 
L.m.mexicana than in promastigotes, whereas activity towards leuOMe 
is. Therefore the possible role of this isoenzyme in the hydrolysis of 
amino acid esters was not investigated further.
3.7.2. The detection of phenol as a means of following the hydrolysis 
of L-leucine benzyl ester
In order to characterise the activity of the amino acid esters it 
was necessary to develop an assay to quantify the products of amino 
acid ester hydrolysis. The assay system described in section 2.9.2. 
was satisfactory for detection of phenol in the concentration range 10 
uM-50 uM in buffers at pHs from 4-8.6 (see fig. 31). However, it was 
unable to detect the hydrolysis of leucine benzyl ester by any samples 
used (L. m. mexicana amastigote lysates and the purified low molecular 
weight proteinases [see section 3.8.]). To check the assay system, 
horse serum, which is known to contain arylesterases, was used with 
phenylacetate as substrate to determine the specific activities of 
arylesterase at different pHs. The results obtained are shown in 
figure 32. The greatest activity was at pH 7, as would be expected for 
a serum enzyme, and so these results showed the potential use of the 
assay. Subsequent work with the purified low molecular weight
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Figure 31. Detection of different concentrations of phenol at
different pHs
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Phenol was made up at concentrations from 10 pM to 50 pM in 2.5 
ml of 1 mM Mcllvanes buffer at different pHs. 0.5 ml of 4- 
aminoantipyrine (98.5 M) and 0.5 ml of K^(Fe[CN^]) (0.243 M) dissolved 
in 1 M Veronal buffer, pH 8.6, were added. The condensation product 
was extracted with 5 ml of n-pentanol and the absorbance at 465 nm 
read against a blank. The absorbance of the control, in the range 0.8 
■0.9, was then subtracted from that of the sample to give the 
absorbance due to the phenol.
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Figure 32. The effect of pH on arylesterase activity of horse serum
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Five jil of horse serum was added to 2.5 ml of the appropriate 
buffer (either 1 mM Mcllvanes buffer at pHs 4,5,6 and 7 or 1 M Veronal 
buffer, pH 8.6) which contained the arylesterase substrate 
phenylacetate, 1.33 mM. After 30 minutes incubation at 37°C 0.5 ml of 
4 -aminoantipyrine (98.5 M) and 0.5 ml of K^FefCN^]) (0.243 M) 
dissolved in 1 M Veronal buffer, pH 8.6, were added. The condensation 
product was extracted with 5 ml of n-pentanol and the absorbance at 
465 nm read against a blank. The absorbance of the control, in the 
range 0.8-0.9, was then subtracted from that of the sample to give the 
absorbance due to the phenol. Using the standard curve phenol 
concentration was estimated and the specific activities calculated. 
These are the results from a single experiment done in triplicate.
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proteinases of L. a. mexicana showed them to be sensitive to DMSO (see 
section 3.8.3.1), the solvent in which leucine benzyl ester was 
dissolved in attempts to detect its hydrolysis using this assay. No 
further attempts were made to measure the hydrolysis of leucine benzyl 
ester in this manner or to measure the levels of esterase activity in 
Leishmania.
3.8. THE POTENTIAL OF L.M.MEXICANA CYSTEINE PROTEINASES AS ACTIVATORS 
OF PRO-DRUGS
The findings in the previous sections indicated that enzymes in 
the amastigotes of L. m. mexicana, probably localised within the 
megasomes, were responsible for the hydrolysis of leuOMe which would 
lead to osmotic lysis of the amastigotes. A personal communication 
from Dr. Rabinovitch, now published (Alfieri et al., 1988) showed that 
several inhibitors of cysteine and serine proteinases inhibited the 
anti 1 eishmania 1 activity of several amino acid esters including 
leuOMe. This, in combination with the previous evidence indicated that 
the low molecular weight cysteine proteinases, unique to the 
amastigotes of L.mexicana and purified by Pupkis and Coombs (1984), 
were possibly involved in the hydrolysis of leuOMe. The role of these 
enzymes in the antileishmanial activity of leuOMe was investigated.
3.8.1. Purification of amastigote proteinases
Partial purification of the low molecular weight proteinases from 
amastigotes of L .m. mexicana was carried out using gel filtration 
followed by ion exchange chroatography. Proteinase activity was 
detected using the nitroanilide substrate BzPPANan. Initially two 
methods of cell lysis were compared to determine which was the most 
satisfactory in releasing the proteinase activity into the soluble 
fraction (see table 12). The results clearly show that detergent lysis 
was more efficient than the freeze and thaw method tested, especially
130
Table 12. Comparison of freezing and thawing and the use of detergents 
as methods of solubilising the amastigote enzymes responsible for the 
hydrolysis of L-leucine methyl ester and BzPPANan
Hydrolysis of leuOMe 
Triton X100 Freeze-thaw 
Lysate 100% 100%
Pellet 9% 54%
Supernatant 82% 41%
Hydrolysis of BzPPANan 
Triton X100 Freeze-thaw 
100% 100%
5% 32%
110% 97%
The distribution of the different hydrolysing activities towards 
leuOMe and BzPPANan was measured using the paper electrophoresis 
method for leuOMe and the spectrophotometric assay for BzPPANan. 
Lysates were prepared in 0.25 M sucrose and then either frozen and 
thawed 3 times using liquid nitrogen and a water bath at 37°C or 
detergent lysis using Triton X100 at a final concentration of 0.25%. 
These results, from a single experiment, show the activity recovered 
in each fraction expressed as a % of the activity in lysates.
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for the enzymes responsible for the hydrolysis of leuOMe. Consequently 
this method of cell lysis was used in the majority of subsequent 
experiments and the freezing-thawing method was used only where 
stated.
3.8.1.1. Gel filtration
Gel filtration was carried out as described in section 2.10.2.. 
The procedure used was based on the method described by Pupkis and 
Coombs (1984) , except that FPLC equipment was used and horoogenates 
were normally produced by detergent lysis instead of freezing and 
thawing.
A typical elution profile is shown in figure 33. Pupkis and 
Coombs (1984) reported that two main, but distinct peaks of proteinase 
activity were eluted from gel filtration when using the soluble 
fraction from homogenates obtained by freezing and thawing. Using the 
soluble fraction from homogenates obtained with the detergent Triton 
X100 several peaks were eluted (see fig. 33). However, when using the 
soluble fraction from amastigotes lysed by freezing and thawing, two 
well separated peaks of proteinase activity were eluted as shown in 
figure 34. These results suggest that additional proteinases may be 
released by detergent lysis compared to freezing and thawing and that 
the structure of some of the proteinases is modified by the lysis 
method used.
The use of gelatin SDS-PAGE to detect the proteinase activity 
clearly demonstrated the distribution of enzymes in the fractions. The 
use of 5% acrylamide gels shows the presence of at least 7 high 
molecular weight proteinases (see fig. 35) which would normally appear 
as 3-4 bands on a 7.5% acrylamide gel (see fig. 36). However the low 
molecular weight proteinases, which normally appear as 7 8 bands on a 
7.5% acrylamide gel appear as a single band on a 5% gel. It is clear
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Figure 33. Gel filtration of L.m.mexicana amastigote proteinases
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The supernatant from Triton X100 lysed cells was applied to a gel 
filtration column of Superose 12. The protein profile, measured as 
^280'^—  ^ an^ distribution of proteinase activity towards BzPPANan
(-•-) in the eluant of the column is shown. The AUFS is 2.0.
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Figure 34. Gel filtration of L.m.mexicana amastigote proteinases
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The supernatant from freeze-thawed cells was applied to a gel 
filtration column of Superose 12. The protein profile, measured as 
A280 —^ ) and the distribution of proteinase activity towards BzPPANan 
(-•-) in the eluant of the column is shown. The AUFS is 0.5.
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Figure 35. The distribution of high molecular weight proteinases of
L.m.mexicana amastigotes, in fractions from gel filtration
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Samples (25 ]il) from fractions 12-19 of the gel filtration 
eluant, from a Triton X100 lysed sample, were run on a 5% acrylamide 
gelatin SDS-PAGE mini-gel and the activity developed, after washing in 
2.5% (v/v) Triton X100 for 30 minutes, by incubation in 0.1 M acetate 
buffer at 37°C, pH 5.5. for 30 minutes in the presence of 1 mM DTT. 
The numbers in each lane correspond to the fraction number. 
Approximate molecular weights in kDa are given on the right hand side.
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Figure 36. The proteinases of L.m.mexicana amastigotes, separated by
gel
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Samples (50 pi) from alternate fractions 17-27 (lanes 5-10) of 
the gel filtration eluant, the pooled fractions containing low 
molecular weight proteinases from gel fitration (50 pi, lane 4) from a 
Triton X100 lysed sample (5 pi, lane 2) and the pooled proteinase 
activity from ion exchange (75 pi, lane 3), were run on a 7.5% 
acrylamide gelatin SDS-PAGE gel and the activity developed, after 
washing in 2.5% (v/v) Triton X100 for 1 hour, by incubation in 0.1 M 
acetate buffer at 37°C, pH 5.5. for 1 hour in the presence of 1 mM 
DTT. Molecular weight markers were run in lane 1 and approximate 
molecular weights, in kDa, are given.
filtration and detected on 7.5% acrylamide gelatin SDS-PAGE gel
1 2 3 4 5 6 7 8 9  10
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from these results that gel filtration gave a partial but in no way 
complete separation of the high molecular weight proteinases from the 
low molecular weight proteinases, as is clearly seen in figures 35 and 
36. Typically fractions 17-27 contained the majority of the low 
molecular weight proteinases and these fractions were pooled before 
further processing.
This gel filtration step resulted in a 57% recovery of proteinase 
activity in fractions 17-27 and on average a six-fold increase in 
specific activity, compared to the homogenate (see table 13).
3. 8.1.2. Ion exchange chromatography
Ion exchange chromatography was carried out as described in 
section 2.10.3.. A typical elution profile obtained using the pooled 
and concentrated (see section 2.9.4.) proteinases from gel filtration 
fractions 17-27 is shown in figure 37. The proteinase activity 
detected using BzPPANan correlated with a large protein peak and the 
use of gelatin SDS-PAGE to detect the proteinase activity (see fig. 
38) confirmed that this peak contained at least 7 low molecular weight 
proteinases, which appeared to have been seperated from the remaining 
high molecular weight proteinases. Silver staining of proteins 
separated by SDS-PAGE showed that there were several protein bands
which correlated with the proteinase activity detected on gelatin SDS- 
PAGE (see fig. 39). By comparing the relative mobilities of these 
proteins and those of several low molecular weight standards, 
approximate molecular weights of the proteinases were calculated. 
Those of the main enzymes were 25,400., 26,300. , 27,850. , 29,850. ,
31,250., and 33,900 kDa (see fig. 38). Several other proteins were
detected in the sample indicating that the enzymes were only partially 
purified. An attempt was made to investigate if these proteinases
could be separated from each other by altering the salt gradient at
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Table 13. Data from the purification of amastigote low molecular 
weight proteinases by gel filtration and ion exchange
Stage % Recovery Specific activity
Lysate 100 176 + 35
Pellet 5 + 2  2 6 + 8
Supernatant 103 + 14 534 + 185
Gel filtration 57 ± 17 930 + 362
Ion exchange 35 + 18 1511 ± 348
These are the mean results of 7-9 full purifications carried out 
on separate occasions. The lysates were obtained using Triton X100 and 
the pellet and supernatant fractions obtained by centrifugation at 
200000 x g for 1 hour. Fractions 17-27 from gel filtration were pooled 
and concentrated using ultrafiltration and fractions in the range 14- 
24 from ion exchange were pooled and if necessary concentrated using 
ultrafiltration. The loss of activity during ultrafiltration was not 
included when calculating the % recovery. The activity towards 
BzPPANan is in nmoles min * mg protein
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Figure 37. Ion exchange chromatography of L.m.mexicana amastigote low
molecular weight proteinases
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Ion exchange chromatography of the low molecular weight 
proteinases, separated by gel filtration, was carried out using a mono 
Q column. The protein profile, Measured as A2gQ (— ), the distribution 
of proteinase activity towards BzPPANan (-•-) and the NaCl gradient (0- 
1 M,*— •■) in the eluant from the column is shown. The AUFS is 0.2.
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Figure 38.  ^ The distribution of low molecular weight proteinases of 
L.m.mexicana amastigotes, separated by ion exchange chromatography and 
detected using 10% acrylamide gelatin SDS-PAGE gels
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Samples (75 pi) from fractions 15-22 (lanes 1-8) and the pooled 
fractions (lane 9) of the ion exchange eluant, were run on a 10% 
acrylamide gelatin SDS-PAGE gel and the activity developed, after 
washing in 2.5% (v/v) Triton X100 for 1 hour, by incubation in 0.1 M 
acetate buffer at 37°C, pH 5.5. for 1 hour in the presence of 1 mM 
DTT. Approximate molecular weights in kDa are given on the right hand 
side.
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Figure 39. The protein bands detected using silver staining, in the 
fractions of the eluant from the ion exchange chromatography
containing proteinase activity
Samples (75 pi) from fractions 14-22 (lanes 1-9) of the ion 
exchange eluant, were run on a 10% acrylamide SDS-PAGE gel and silver 
stained to detect the protein banding patterns. Lane 10 shows low 
molecular weight markers whilst samples of the pooled fractions were 
run in lanes 11 and 12; that run in lane 12 had been boiled for 2 
minutes. Approximate molecular weights in kDa are given on the right 
hand side.
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Figure 40. The distribution of low molecular weight proteinases of 
L .m .mexi cana amastigotes in fractions separated by ion exchange 
chromatography using a shallower than usual salt gradient
1____________2___ 3 4 5 6 7 8 9 10 11
Samples (75 pi) from fractions 15-24 (lanes 2-11) and the pooled 
fractions 15-24 of the ion exchange eluant, were run on a 10% 
acrylamide gelatin SDS-PAGE gel and the activity developed, after 
washing in 2.5% (v/v) Triton X100 for 1 hour, by incubation in 0.1 M 
acetate buffer at 37°C, pH 5.5. for 1 hour in the presence of 1 mM 
DTT. Approximate molecular weights, in kDa, are given on the right 
hand side.
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the point where these proteinases are normally eluted (see section 
2.10.3.). Analysis of the proteinases in the fractions by gelatin SDS- 
PAGE showed that a slightly better separation was achieved (see fig. 
40); although whether this could lead to the purification of 
individual isoenzymes remains an open question.
The fractions eluted using the standard ion-exchange 
chromatography procedure and which contained proteinase activity 
varied slightly between experiments but were always within the range 
14-24. It was these pooled fractions, concentrated as necessary, that 
were used as the purified proteinase preperation for subsequent 
studies including enzyme characterization. The overall enzyme recovery 
from the ion exchange chromatography step was 35%. The average 
specific activity was 1511 nmol min * mg protein'^, an approximate 8.5 
increase compared to the homogenate (see table 13).
3.8.2. The effect of different detection methods and boiling on the 
protein banding patterns obtained for the purified proteinases 
preparation
The results reported by Pupkis and Coombs (1984) showed a single 
protein in the purified proteinase preperation which was obtained 
using very similar procedures to those reported here. They used 
comassie blue to stain for protein, however, which is a much less 
sensitive protein detection method than silver staining. When comassie 
blue staining was used to detect the proteins in the purified enzyme 
preparation which had not been boiled, separated by SDS-PAGE, no 
protein bands could be detected. In contrast, boiling of the sample 
before electrophoresis led to the detection of a faint single band at 
31 kDa. When the same sample was silver stained, the banding pattern 
shown in figure 39 was observed. On this 10% acrylamide gel, two 
bands, corresponding with two of the proteinase bands, become
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more prominent. This would probably account for the detection of a 
single band on 7.5% acrylamide gels using comassie blue as found here 
and reported by Pupkis and Coombs (1984). The explanation for these 
changes was not investigated further.
3.8.3. Characterization of the amastigote low molecular weight 
proteinases
3.8.3.1. Sensitivity to inhibitors
The hydrolysis of L.m.mexicana amastigote proteins in detergent- 
lysed homogenates was investigated by measuring the amount of 
detectable protein, using the method of Sedmak and Grossberg (see 
section 2.11). This was carried out to quantify the wholesale protein 
breakdown first reported by Pupkis and Coombs (1984, 1986) and to
investigate the enzymes involved in this auto-hydrolysis. The effect 
of several proteinase inhibitors on this degredation was also studied. 
Homogenates were prepared as described in section 2.2.3., the 
appropriate inhibitor added and incubation at room temperature 
instigated. Protein content of samples, taken every 30 minutes for 2 
hours, was estimated. The specific activity of different samples 
towards BzPPANan were also determined at several time points.
The results, presented in figure 41, show that proteolysis 
occurred rapidly. An approximate half life of 90 minutes can be 
calculated from this data. Several proteinase inhibitors considerably 
reduced the rate of proteolysis with leupeptin having the greatest 
effect of those tested. The specific activities of samples towards 
BzPPANan increased concomitantly with proteolysis occurring, as is 
shown in table 14. This would indicate that the proteinases which 
account for the BzPPANan activity are being hydrolysed at a slow rate 
if at all compared to the other proteins in the sample.
The proteinase inhibitors chymostatin, leupeptin, antipa*
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Figure 41. The effect of proteinase inhibitors on the auto-degredation
of Triton X100-lysed L.m.mexicana amastigotes
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The rates of proteolysis in homogenates of L.m.mexicana 
amastigotes in the absence (^) or presence of (at 100 pg ml E64 
( A  ) . antipain ( ♦  ) , chymostatin ( • ) and leupeptin ( ■ ), was 
monitored by taking 10 pi aliquots every 30 minutes for 120 minutes 
and measuring the amount of protein. These are the results from a 
single experiment.
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Table 14. The effect of proteinase inhibitors on proteolysis in
L.m.mexicana amastigote homogenates
Activity towards BzPPANan
Time Lysate
(nmol * 
E64
min  ^mg protein
Antipain Leupeptin Chymostatin
0 163 - - -
30 207 7 0 6 10
60 252 8 2 11 14
90 312 - - -
120 293 13 2 11 14
Lysates were pre- incubated with the inhibitors (lOOpg ml *)
30 minutes at room temperature whilst the lysate without inhibitor was 
kept on ice. The experiment involving measurements of the specific 
activities towards BzPPANan commenced at time 0. Two 10 pi aliquots 
were taken from the samples at the different time points, one was used 
to measure the amount of protein in the sample and the other to 
determine the activity of the sample towards BzPPANan.
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E64 all totally inhibited the purified enzymes if used at 25 jig ml  ^
with a 30 minute pre-incubation at 37°C. Other inhibitors were also 
tested against the purified enzymes, with a 1 hour pre-incubation at 
room temperature with the sample before measuring its activity towards 
BzPPANan. The results are given in table 15. These inhibitor studies 
confirmed that the purified enzymes were of the cysteine proteinase 
type. This is consistent with the inhibition of the activity by TPCK, 
TLCK and IAA (see section 2.13.1.). The inhibitors phenanthroline, 
pepstatin and EDTA (which inhibit metal, aspartic and serine 
proteinases, respectively) had no effect on the hydrolysis of the 
substrate by the purified sample. The effect of DMSO and ethanol on 
the hydrolysis of BzPPANan by the purified enzymes was also 
quantified, a 32% inhibition of activity was achieved with a 5% DMSO 
concentration and a 46% inhibition with 10% ethanol under the above 
conditions.
The sensitivity to inhibition of the amastigote low molecular 
weight proteinases by the specific inhibitor of cysteine proteinases, 
E64, was also investigated using gelatin gels. Samples of amastigote 
homogenates were incubated with leupeptin, antipain, chymostatin or 
E64 (all at 100 jig ml"*) for 30 minutes at room temperature and then 
were subjected to electrophoresis using a gelatin 7.5% acrylamide gel 
under normal conditions and the proteinase activity developed without 
the presence of inhibitors in either the Triton X100 solution or the 
acetate buffer. The results are shown in figure 42. Only E64 resulted 
in inhibition of the low molecular weight proteinases, none of the 
other inhibitors used had any observable effect. The high molecular 
weight proteinases appeared unaffected by any of the inhibitors.
This procedure was also used to investigate the inhibitor 
sensitivity of proteinases of other stages and species. The use of 5%
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Table 15. Sensitivity of the amastigote low molecular weight
proteinases to inhibitors
Inhibitor
Phenanthroline
Pepstatin
TPCK
TLCK
EDTA
IAA
Specificity
metal/slight cysteine
aspartite
cysteine/serine
cysteine/serine
metal
cysteine
% Inhibition 
0 
0
87 + 6 
96 + 3 
0
79 + 12
Samples of the purified amastigote low molecular weight 
proteinases were incubated for 1 hour at room temperature with the 
appropriate inhibitor. All the inhibitors were at a final 
concentration of 1 mM except pepstatin which was at 100 jig ml After 
pre-incubation the rates of hydrolysis of BzPPANan by the different 
samples at 37°C were determined, and compared to that of a control. 
Each inhibitor was tested a minimum of two times and the results 
given are the means + standard deviations or ranges.
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Figure 42. The effect of proteinase inhibitors on the detection of
L.m.mexicana proteinases on gelatin SDS-PAGE gels
^ 1 . : -  : ■
Lysates of L.m.mexicana amastigotes were pre-incubated with the 
inhibitors (leupeptin, lane 2; antipain, lane 3; chymostatin, lane 4; 
E64, lane 5) for 30 minutes, at room temperature, and 20 pi samples 
were then run on a 10% acrylamide gelatin SDS-PAGE gel and compared to 
a control homogenate (lanes 1 and 6). The proteinase activity was 
developed, after washing in 2.5% (v/v) Triton X100 for 1 hour, by 
incubation in 0.1 M acetate buffer at 37°C, pH 5.5. for 1 hour in the 
presence of 1 mM DTT. Approximate molecular weights, in kDa, are given 
on the right hand side.
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acrylamide gels allowed reasonable separation of the proteinases of 
L.donovani, L. major and L.m.mexicana, as shown in figure 43. Pre­
incubation of the samples with E64 for 30 minutes at room temperature 
affected the banding patterns very little. Only the low molecular 
weight cysteine proteinases present in amastigotes of L.m.mexicana 
were clearly inhibited. If in addition to pre-incubation E64 was 
included in the post - electrophoresis incubation media partial 
inhibition of some of the higher molecular weight proteinase bands was 
obvious. Because of the expense of E64 only very small volumes of 
incubation media were used, this appeared to affect the development of 
the bands of proteinase activity giving poor definition and results 
that were not worth photographing.
3.8.3.2. Substrate competition studies
The effects of various amino acid esters and amino acid amides 
upon the hydrolysis of BzPPANan by the purified enzymes were 
determined in an attempt to characterize the substrate specificities 
of these enzymes and to investigate the reported protective activity 
of certain amino acid esters and amino acid amides against the anti- 
leishmanial activity of other amino acids and amides. The conditions 
used were as described in section 2.9.5., the enzyme sample was added 
to the buffer containing the appropriate ester or amide wherupon the 
substrate (BzPPANan) was immediately added, allowing direct 
competition between the BzPPANan and the amides or esters.
The results of these studies are given in table 16. Those amides 
or esters tested which are derivatives of basic amino acids, i.e. 
arginine and lysine, were relatively poor competitors. Derivatives of 
aliphatic or aromatic amino acids were more effective competitors, for 
example leucine and tryptophan (see fig. 44). There was little 
detectable difference in the % inhibition caused by methyl esters and
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Lysates of L.donovani, L.major and L.m.mexicana amastigotes with 
100 jig E64 ml * (lanes 1, 3 and 5, respectively) or without (lanes 2, 
4 and 6, respectively) were pre - incubated for 30 minutes at room 
temperature before being run on a 5% acrylamide gelatin SDS-PAGE mini 
gel. The proteinase activity was developed, after washing in 2.5% 
(v/v) Triton X100 for 30 minutes, by incubation in 0.1 M acetate 
buffer at 37°C, pH 5.5. for 30 minutes in the presence of 1 mM DTT. 
Approximate molecular weights, in kDa, are given on the right hand 
side.
Figure 43. The effect of E64 on the detection of proteinases of
different species of Leishmania amastigotes
151
Table 16. The effect of amino> acid esters and ;amino acid amides on the
hydrolysis of BzPPANan by the amastigote low molecular we ight
proteinases
Amino acid Concentration of esters and amides (mM)
ester or amide 50 40 30 20 10
Leucine methyl ester 67 + 10 67 + 10 59 -+ 8 54 + 6 41 ± 8
Leucinamide 64 + 6 58 + 9 54 ± 8 42 ± 14 34 ± 9
Leucine benzyl ester 93 89 83 83 -
Glycine benzyl ester 81 + 2 74 + 1 70 ± 1 65 ± 1 49 + 1
Tryptophan methyl ester 69 ± 8 67 + 8 55 ± 8 48 ± 4 29 ± 8
Tryptophanamide 68 ± 8 64 + 9 60 ± 10 53 ± 8 40 ± 9
Isoleucinamide 58 62 61 46 42
Isoleucine methyl ester 61 ± 7 59 + 9 51 ± 5 43 ± 9 25 ± 1
Arginamide 24 ± 17 20 + 6 17 + 7 14 ± 1 35 + 4
Arginine methyl ester 15 ± 6 21 + 8 12 ± 12 8 ± 11 6 ± 4
Lysine methyl ester 8 ± 4 7 + 8 8 ± 8 12 ± 4 5 ± 4
These studies were carried out by comparing the rates of
hydrolysis of BzPPANan by the purified enzymes in the presence and 
absence of different concentrations of esters and amides. Most 
experiments were carried out 3 times, those for which no standard 
deviation is given were carried out once or twice. The results are 
means and standard deviations expressed as the % inhibition of 
BzPPANan hydrolysis compared to that of the control over the same time 
period. For leucine benzyl ester the controls took into account the 
effect of the DMSO that the compound was initially dissolved in.
Figure 44. The effect of different amino acid esters and amides on the
hydrolysis of BzPPANan by the L.m.mexicana purified proteinases
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Direct competition studies using arginamide cjf) , lysine methyl 
ester (^T) » leucine methyl ester ( ▼ ) ,  isoleucinamide (J L ) , glycine 
benzyl ester ( ■ ) , and leucine benzyl ester (#) were carried out by 
comparing the rates of hydrolysis of BzPPANan by the purified enzymes 
in the presence and absence of different concentrations of these 
compounds. The results are expressed as the % inhibition of BZPPANan 
hydrolysis compared to that of a control over the same time period and 
is based on the data presented in table 15.
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amides of the same amino acid. The benzyl ester of leucine, however, 
was a considerably better competitor than leuOMe or leucinamide.
3.8.4. Hydrolysis of amino acid esters and amino acid amides by 
Leishmania extracts
3.8.4.1. Kinetics of hydrolysis of L-leucine methyl ester by the 
purified proteinases of L.m.mexicana
The hydrolysis of leuOMe by different species and stages of 
Leishmania was followed using paper electrophoresis to separate the 
products from hydrolysis of the amino acid ester. Figure 45 shows 
typical results. L-leucine methyl ester and leucine were clearly 
separated, also the dipeptide leucyl-leucine was distinguishable from 
leucine itself. Use of a range of concentrations of leucine showed 
that the method could be used quantitatively (see fig. 46) by eluting 
the leucine after electrophoresis. A standard curve was used to 
quantify the hydrolysis products of leuOMe separated by paper 
electrophoresis. The lower limit of detection was taken as 1.25 mM; 
i.e. 0.375 pmoles 0.3 ml
To optimise the conditions for the measurement of the hydrolysis 
of leuOMe, the length of time over which the reaction was linear and 
the pH optimum for the reaction had to be ascertained. To standardise 
the amount of enzyme being used, the amount of sample that would cause 
a change in absorbance of 0.1 per minute by hydrolysing BzPPANan, 
under the standard conditions described in section 2.10.1., was used. 
This, was for convenience, defined as 1 unit of enzyme activity.
The course of hydrolysis was followed using a purified enzyme 
sample under the conditions described previously (see section 2.13.3.) 
over a three hour period at pH 6.0. The results (see table 17) 
indicate that the reaction under these conditions and over this 
incubation period was approximately linear. Consequently a three hour 
incubation under these conditions was used as the standard for all
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Figure 45. Separation and detection of the hydrolysis products of 
leucine methyl ester
leucine
homogenate
E64
I L-leucine OMe
Samples of homogenates of L.m.mexicana amastigotes , produced by 
Triton X100 lysis, were incubated in 0.15 M phosphate buffer, pH 6.0, 
with 20 mM leuOMe in the presence of 1 mM DTT with or without 100 pg 
E64 ml’1 for 3 hours at 37°C. Controls of 20 mM leucine and 20 mM 
leuOMe were also incubated without any lysates. 40 pi aliquots were 
then applied to paper strips and the hydrolysis products separated by 
electrophoresis at 8 V cm"1 for 3 hours. The hydrolysis products were 
visualised by immersion in 0.2% ninhydrin in 75% acetone.
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Figure 46. Standard curve for the detection of L-leucine by paper 
electrophoresis
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Concentrations of leucine from 1.25 mM to 20 mM were made up in 
0.15 M phosphate buffer, pH 6.0, and 40 jil aliquots were then applied 
to paper strips which were subjected to electrophoresis at 8 V cm  ^
for 3 hours. The hydrolysis products were visualised by immersion in 
0.2% ninhydrin in 75% acetone. The area that contained the leucine was 
eluted for 30 minutes and the absorbance measured at 505 nm. These 
results are the means ± standard deviations from 3-4 experiments.
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Table 17. Hydrolysis of L-leucine methyl ester over 3 hours by the
L.m.mexicana amastigote low molecular weight purified enzymes
Time Absorbance Activity towards leuOMe
(nmoles min mg protein)
30 (N.D.)
60 (N.D.)
90 0.042 ± 0.006 1383 ± 192
120 0.056 ± 0.008 1372 ± 196
150 0.065 ± 0.002 1284 ± 49
180 0.079 + 0.004 1290 ± 65
Hydrolysis of leuOMe by the purified amastigote enzymes was 
followed over a 3 hour incubation at 37°C. The same enzyme activity 
towards BzPPANan (1 unit) was used in each case and incubated with 20 
mM leuOMe and 1 mM DTT in a total volume of 0.3 ml in 0.15 M sodium 
phosphate buffer, pH 6.0. Hydrolysis products were separated using 
paper electrophoresis and quantified by elution. Paper electrophoresis 
was performed immediately at the appropriate time points. The lower 
limits of detection of leucine was taken as 1.25 pM (0.375 pmoles 0.3 
ml*'*’) and levels of leucine below this were taken as not detectable 
(N.D.). The figures are the means ± standard deviations or ranges from 
2-3 experiments.
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subsequent work.
The pH optimum for the purified enzymes with BzPPANan as 
substrate was between pH 7-8, however with leuOMe as the substrate 
there appeared to be a sharp peak of activity at pH 6.0. (see table 
18). This differs from that found for BzPPANan but agrees with that 
reported by Pupkis and Coombs (1984) for the pH optimum of the 
activity of these cysteine proteinases towards azocaesin.
Using these standard conditions, the specific activities of 
different samples towards leuOMe were determined. A comparison of the 
activities towards leuOMe of the purified sample and homogenate shows 
an approximate 10-fold increase in specific activity, from 97 to 1290 
pmoles min  ^ mg protein This is similar to the increase in specific 
activity towards BzPPNan on purification of the low molecular weight 
proteinases (see table 13).
3.8.4.2. Hydrolysis of various amino acid esters and amino acid amides 
by different species and stages of Leishmania as well as the purified 
enzymes from L.m.mexicana amastigotes
The activities of different forms and species of Leishmania 
towards leuOMe and BzPPANan were measured using Triton X100 
solubilised homogenates. This was carried out to jLetermine if there was 
a correlation between the species and stage specificity of the 
antileishmanial activity of leuOMe (see section 3.5.) and the ability 
of these same species and stages to hydrolyse leuOMe and BzPPANan. The 
results are given in table 19. They demonstrated that the 
promastigotes of all species investigated had lower activities towards 
leuOMe and BzPPANan than the amastigotes of the same species. Of the 
amastigotes tested, L.m.mexicana had by far the highest activity 
towards leuOMe.
The activities of lysates of amastigotes of L.donovani, L.major 
and L.m.mexicana activities towards BzPPANan were inhibited 92%, 96%
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Table 18. pH optima for the hydrolysis of BzPPANan and L-leucine 
methyl ester by the amastigote purified proteinases
pH Activity towards leuOMe Activity towards BzPPANan
(nmoles min  ^ mg protein )
3 N.D. 59 + 14
4 N.D. 250 + 132
5 N.D. 403 + 25
6 1354 + 364 783 + 44
7 624 + 263 1347 ± 15
8 829 + 329 1448 + 188
Hydrolysis of leuOMe by the purified amastigote enzymes was 
followed over a 3 hour incubation at 37°C. The same enzyme activity 
towards BzPPANan (1 unit) was used in each case and incubated with 20 
mM leuOMe and 1 mM DTT in a total volume of 0.3 ml in the appropriate 
buffer. Hydrolysis products were separated using paper electrophoresis 
and quantified by elution. The lower limits of detection of leucine 
was taken as 1.25 mM (0.375 pmoles 0.3 ml and levels of leucine 
below this were taken as not detectable (N.D.). The specific activity 
towards BzPPANan was calculated by monitoring the change in absorbance 
at 505 nm of a sample in 1.2 ml buffer containing 1 mM DTT and 0.1 mM 
BzPPANan. The figures are the means + standard deviations or ranges 
from 2-3. experiments. The buffers used were citric acid buffer (0.1 
M) between pHs 3-6 and sodium phosphate buffer (0.1 M) between pHs 6- 
8 .
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Table 19. Rates of hydrolysis of L-leucine methyl ester and BzPPANan 
by homogenates of different species and stages of Leishmania
Species/stage Activity towards
leuOMe
Activity towards 
BzPPANan
L.major promastigotes 7.6 + 4.5 1 2 + 7
L.major amastigotes 41.6 + 9.6 170 ± 30
L.donovani promastigotes 9.4 1 4 + 7
L.donovani amastigotes 32.7 ± 10 6 9 + 6
L.m.mexicana promastigotes 8.8 1 4 + 7
L.m.mexicana amastigotes 97.2 175 + 35
The activities of Triton X100 lysates towards leuOMe was measured 
over a 3 hour incubation at 37°C. The same enzyme activity towards 
BzPPANan (1 unit) was used in each case and incubated with 20 mM 
leuOMe and 1 mM DTT in a total volume of 0.3 ml in 0.15 M sodium 
phosphate buffer, pH 6.0. Hydrolysis products were separated using 
paper electrophoresis and quantified by elution. The specific activity 
towards BzPPANan was calculated by monitoring the change in absorbance 
at 505 nm of a sample in 1.2 ml phosphate buffer, pH 6.0, containing 1 
mM DTT and 0.1 mM BzPPANan. The figures are the means ± standard 
deviations from 3-4 determinations. Those without standard deviations 
are from 2 determinations. The promastigotes used are all from 
stationary phase cultures and the L.major promastigotes were obtained 
using PNA agglutination to give a population of metacyclics.
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and 94% respectively, by the specific inhibitor of cysteine 
proteinases, E64 (100 pg ml ^). This would indcate that there are
cysteine proteinases present in both L.major and L.donovani which are 
responsible for the majority of these samples activity against 
BzPPANan; but that other enzymes are also hydrolysing the BzPPANan in 
the amastigotes of all three species.
The effect of inhibitors on the hydrolysis of leuOMe by lysates 
of amastigotes of L.donovani and L.m.mexicana as well as the purified 
enzymes from L.m.mexicana amastigotes were studied. The results are 
shown in table 20. The addition of E64 to L.m.mexicana amastigote 
homogenates inhibited the hydrolysis of leuOMe by 82%, while its use 
with the purified enzyme gave total inhibition. The proteinase 
inhibitors antipain and chymostatin also totally inhibited the 
activity of the purified enzyme while they gave a 91% and 62% 
inhibition, respectively, of L.donovani' s activity towards leuOMe. The 
absence of DTT resulted in a reduction of greater than 30% for the 
L.donovani and L.m.mexicana amastigote lysates and the purified 
enzymes.
Paper electrophoresis was also used to look qualitatively at the 
hydrolysis of a range of amino acid esters and amino acid amides by 
lysates of L.donovani and L.m.mexicana amastigotes as well as the
A
purified proteinases of L.m.mexicana amastigotes. The results of these 
studies are summarised in table 21. All of the compounds tested with 
L.m.mexicana amastigote lysates were hydrolysed to some extent, 
isoleucine methyl ester being the poorest substrate. With L.donovani 
lysates there was extensive hydrolyis of some of the compounds tested, 
for example leucine methyl ester and leucinamide. However many of the 
other compounds were hydrolysed poorly compared with their hydrolysis 
by L.m.mexicana. Using the purified amastigote proteinases, only 
leuOMe and leucinamide were hydrolysed detectably, although these were
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Table 20. The effect of inhibitors and DTT on the hydrolysis of L- 
leucine methyl ester by homogenates of L.donovani and L.m.mexicana 
amastigotes and the low molecular weight proteinases purified from 
L.m.mexicana amastigotes
Inhibitor
E64
Chymostatin 
Antipain 
No DTT
L.m. mexi cana 
82 ± 11
56 + 25
% Inhibition 
L.donovani
62 ± 15 
91 + 9 
35 ± 11
Purified enzyme 
100 
100 
100 
34 + 12
Hydrolysis of leuOMe was measured over a 3 hour incubation at 
37°C. The same enzyme activity towards BzPPANan (1 unit) was used in 
each case and incubated with 20 mM leuOMe and 1 mM DTT in a total 
volume of 0.3 ml in 0.15 M sodium phosphate buffer, pH 6.0. Hydrolysis 
products were separated using paper electrophoresis and quantified by 
elution. The Triton X100 lysates and the purified enzymes were pre­
incubated for 30 minutes with the different inhibitors at 100 pg ml  ^
at room temperature in a volume of 0.27 ml before the addition of 
leuOMe to give a final volume of 0.3 ml. The effect of the inhibitors 
or the exclusion of DTT was compared to a control under standard 
conditions. The results are means from two experiments ± the ranges, 
except with E64, which was carried out 3 times and the standard 
deviations are given. All of the results show the % inhibition 
compared with the control under standard conditions.
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Table 21. Qualitative assessment of the extent of hydrolysis of 
different amino acid esters and amino acid amides by homogenates of 
L.m.mexicana and L.donovani amastigotes and the low molecular weight 
proteinases purified from L.m.mexicana amastigotes
Compound L.m.mexicana L.donovani Purified enzyme
Leucine methyl ester ++++ +++ ++++
Leucinamide +++ +++ +++
Tryptophanmethyl ester ++ +++
Tryptophanamide +++ ++
Tyrosine methyl ester +++ +-
Arginine methyl ester ++ ++ . .
Arginamide ++ +
Lysine methyl ester ++ ++
Isoleucine methyl ester ++
Isoleucinamide + +
Glycine benzyl ester ++ +-
Hydrolysis of the different amino acid esters and amides by 
Triton X100 amastigote lysates or the purified enzymes was measured 
using a 3 hour incubation at 37°C. The same enzyme activity towards 
BzPPANan (1 unit) was used in each case and incubated with 20 mM
leuOMe and 1 mM DTT in a total volume of 0.3 ml in 0.15 M sodium 
phosphate buffer, pH 6.0. Hydrolysis products were separated using 
paper electrophoresis and visualised by immersion in 0.2% ninhydrin in 
75% acetone. Controls were carried out to estimate the amount of free
amino acids in each sample; this tended to be minimal under these
conditions. The extent of ester or amide hydrolysis was scored
qualitatively in comparison to the hydrolysis products produced with 
leuOMe (++++), (') represents no more hydrolysis products than found
in the control. These are the results from 3 determinations.
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broken down at a comparable rate as with amastigote lysates.
3.8.5. Studies on the relationship between the low molecular weight 
cysteine proteinases of L.m.mexicana amastigotes
Schiff's stain (see section 2.12) was used in an attempt to 
detect glycosylated proteins on SDS-PAGE gels. When the preperation of 
purified L.m.mexicana amastigote proteinases was used several faint 
pink bands were observed in a similar position to where the low 
molecular weight proteinases were detected using gelatin gels. This 
indicated that these proteinases are probably glycosylated. Similar 
bands were also detected when lysates of L.m.mexicana amastigotes were 
used as were two higher molecular weight bands 
of approximately 60 and 80 kDa. Fetuin and ovalbumin were used as 
positive controls, several intense bands occured with both. The nature 
of the staining did not lend itself to photographing.
Endoglycosidase F (see section 2.13.5.) was used in an attempt to 
deglycosylate the low molecular weight proteinases to determine if the 
multiple isoenzymes were caused by differing glycosylation. Treated 
and control samples were run on both standard and gelatin 10% 
acrylamide SDS-PAGE gels to investigate if the banding patterns of 
the purified proteinases changed after treatment with endoglycosidase 
F. These were then either silver or Schiff stained or developed for 
proteinase activity where appropriate. The results suggested that 
there were no apparent effect of the endoglycosidase F on the purified 
L.m.mexicana proteinases. Unfortunately, only limited amounts of 
endoglycosidase F were available which prevented the use of positive 
controls, using for instance, fetuin or ovalbumin.
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DISCUSSION
4.1. DRUG DELIVERY SYSTEMS IN THE TREATMENT OF LEISHMANIASIS
4.1.1. Vesicular systems for the delivery of sodium stibogluconate in 
the treatment of experimental leishmaniasis
The results have shown that the vesicular systems increase the 
efficacy of sodium stibogluconate approximately 10 fold, as compared 
to the free drug. The high efficacy of several drugs in liposomal form 
against visceral leishmaniasis in animal models has been well 
established (Black et al., 1977; Alving et al., 1978a,b; New et al., 
1978; Alving et al. , 1980; New et al. , 1981a,b; Berman et al., 1986b). 
This work has been recently reviewed by Alving (1986) and Croft 
(1988). In this model system the responses to free and carrier forms 
of sodium stibogluconate have been closely defined and so the relative 
efficacies of the vesicular formulations have been established. 
Surprisingly, however, the previously reported several 100 fold 
increase in drug efficacy brought about by the use of liposomes has 
not been achieved.
There are considerable differences in the methodologies 
previously used to investigate the use of liposomes to treat 
experimental leishmaniasis. Important variables include the size of 
the infective inoculum and hence challenge to the host, route of 
administration, volume inoculated, the timing of the treatment in 
relation to the infection and the strain of parasite and host animal 
used. These methodological differences may serve to explain, partially 
at least, the observed differences between these results and those 
reported by other workers. However, if the activities of the liposomal 
preparations are compared directly it is clear that these results are 
similar to those previously reported. Examination of the data of Black 
et al., (1977), Alving et al., (1978) and New et al. , (1978) shows
that all of their liposomal preparations were active in the range 1 to 
16 mg Sb kg *. For the 20 gram animals used in this study, this is
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equivalent to 20 to 320 pg Sb per mouse and thus is similar to the 
activities found for the liposomal and niosomal preparations used 
here. This implies that the efficacies of the different vesicular 
systems reported in the literature are similar to those used here, but 
that the free drug used in this study had a higher efficacy than those 
reported by other workers. Whether this is due to the methodological 
differences mentioned earlier or to the reported differences between 
batches of sodium stibogluconate (Berman and Grogl, 1988) needs 
further investigation.
The effect of vesicle cholesterol content on the efficacy of 
niosomes appeared to differ between surfacants I and II. Cholesterol 
condenses the phospholipid bilayers and increases the stability of the 
vesicles as well as reducing their permeabilty to entrapped solutes 
(Baillie et al., 1985) and so may give the vesicles longer lives in 
vivo. There was an observed increase in efficacy with cholesterol 
content with surfactant II in the Sb dose range 10 to 80 pg Sb per 
mouse. At greater Sb doses there did not appear to be any differences 
between vesicles with different cholesterol contents, although at 
these Sb levels large reductions in liver parasite burdens were 
achieved so that differences between vesicles were harder to detect. 
There did not appear to be any affect of cholesterol content on the 
efficacy of vesicles composed of surfactant III vesicles although why 
these vesicles should differ in this way from the vesicles composed of 
surfactant I and II is unclear.
The inclusion of the negatively charged ampiphile DCP did not 
appear to affect the efficacy of the niosomes or liposomes tested. 
Alving et al. (1978b) had shown that liposome charge influenced the 
efficacy of liposomal meglumine antimonate. In those experiments a 
range of different types of vesicles was used and although some of the
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results were contradictory it was generally found that neutral or
negatively-charged liposomes were slightly more effective than 
positively-charged liposomes. Other workers (Juliano and Stamp, 1975; 
Tagesson et al., 1977) have observed that negatively-charged vesicles 
are removed from the systemic circulation at a more rapid rate than 
neutral or positively-charged vesicles. This would indicate that 
although the manipulation of vesicle charge may affect the rate of
clearance of the vesicles from the circulation it does not have a
great affect on the drug effficacy and so has little effect on the
drug delivering ability of the vesicles.
One interesting result from the in vitro studies that was that 
the susceptibility of both L.m.mexicana and L.donovani-infected PECs 
to the vesicular forms of the drug were broadly similar, whereas their 
susceptibilities to the free drug differed markedly; L.donovani was 
much more susceptible than L.m.mexicana to treatment with free sodium 
stibogluconate. The reasons for the vesicular treatments overcoming 
species differences in susceptibility are unknown, although the role 
of the vesicle itself, for example in causing macrophage activation, 
cannot be ruled out especially as empty vesicles caused a degree of 
parasite supression in vivo.
The in vitro results support those obtained in vivo in that no 
differences between the carrier functions of liposomes and niosomes 
could be discerned. The antiparasite activity of these formulations in 
vitro is evidence for endocytotic uptake of the entrapped drug into 
infected macrophages. Such uptake probably explains the effective 
targetting of these forms of the drug in vivo. The pivotal role of the 
lysosomal environment in the performance of the stibogluconate carrier 
is suggested by the ratio of antileishmanial activities, vesicular 
form : free form, observed between the L.donovani and L.m.mexicana
systems. Whether this reflects differences between the conditions in
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the respective parasitiphorous vacuoles is open to conjecture. 
Using neutron activation analysis to follow the distribution of 
antimony in uninfected mice we have shown (Hunter et al. , 1987) that 
liver antimony levels were 5-6 times higher at 24 hours post - treatment 
when the drug was given in vesicular form (niosomes or liposomes) than 
when free drug was used. However in other organs, such as the lungs 
and spleen, there were also differences in the Sb levels when vesicles 
were used for drug delivery. There were no detectable antimony levels 
in the lungs and spleen when the mouse was treated with lipososmal 
drug whilst considerable levels could be detected when niosomal drug 
was used. In this study, however, there were large differences in the 
sizes of the vesicle used; the mean niosome diameter was 333 nm whilst 
that of the liposomes was 860 nm. Vesicle size does appear to be 
important in the treatment of sites of infection other than the liver. 
Carter et al. (1988) have shown that liposomes, niosomes and free drug 
doses used to clear parasites from the liver of Balb/c mice had little 
effect on the parasites in the spleen and bone marrow. These workers 
also found that decreasing vesicle size had little affect on the 
parasites in the other sites. These workers have subsequently reported 
(Carter et al. , 1989) that multiple dosing with < 100 nm vesicles did 
have an effect on the other sites of infection. However, even multiple 
dosing with small vesicles did not clear the bone marrow although a 
degree of suppression was achieved.
The importance of vesicle size for the delivery of drugs to 
different sites is well known and Scherphof et al. (1983) have shown 
that vesicles larger than 100 nm cannot pass easily through the 
fenestrations of the liver's sinusoidal epithilium so making it more 
likely that they are phagocytosed by the Kupffer cells of the liver. 
Smaller vesicles have a greater likelihood of passing through these
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fenestrations and so circulating to the spleen in appreciable numbers.
The data available so far is consistent with passive drug 
delivery to the infected liver. The similarity of both the efficacy 
and the tissue distribution data for the liposomes and niosomes, 
despite the differences in size, is consistent with passive vectoring 
of the vesicles to the liver. However whilst this passive vectoring is 
useful for the targetting of the liver it may prove to be a major 
difficulty if vesicles are to be used to treat other sites of 
infection. The use of techniques, such as hepatic blockade (Poznansky 
and Juliano, 1984), to bypass the liver may prove useful in the 
treatment of these other sites of infection.
4.1.2. The use of polyacryl starch microparticles as a delivery system 
for sodium stibogluconate in the treatment of experimental visceral 
leishmaniasis
The results obtained show that the polyacryl starch 
microparticles increase the efficacy in vivo of sodium stibogluconate 
and that there was a 10-fold and 100-fold increase in efficacy over 
that of the vesicular and free drug, respectively. Although the 
antimony tissue levels have not been determined following dosing with 
the microparticulate form of the drug, it seems reasonable to assume 
that higher levels of drug are attained in the infected RES using the 
carrier form of the drug than with the free drug. Laakso et al. (1986) 
have reported that there is a high uptake of this type of particle by 
the RES after i.v. administration. It seems likely that the 
microparticles are behaving in a similar manner to the vesicular 
systems in that they are probably acting as a passive vector and 
relying on the high phagocytic activity in the liver to remove them 
from the circulation.
Although the effect of microparticulate sodium stibogluconate in
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the in vitro PEC system was not investigated Stjarnkvist, et al. 
(1987) have reported that in a similar in vitro system 
microparticulate primaquine was active against L.donovani promastigote 
initiated infections, although less so than the free drug. This 
indicates that the efficacy of carrier mediated therapy is not just 
dependent on uptake into the infected cell but also on the release of 
the drug so that it can affect the parasite.
If the vesicular systems and the polyacryl starch microparticles 
are both acting as passive vectors for sodium stibogluconate, and as 
it appears that it is the total Sb dose that is important and not the 
efficacy of bead loading, then the reason for the approximate 10-fold 
difference between the efficacy of these systems must be addressed. 
The pharmacokinetics at the cellular level may have to be considered 
and, as far as sodium stibogluconate's antileishmanial activity is 
concerned, the lysosome is the important organelle. Phagocytosis of 
the drug-loaded carrier exposes it to the hostile lysosomal 
environment. Destabilisation of the liposome or niosome bilayer in 
this environment will increase the efflux of drug from the vesicles 
which, although available for antiparasite activity, will tend to 
diffuse down the concentration gradient and out of the lysosome. This 
will limit exposure time of parasite to drug and the lower activity of 
drug encapsulated in niosomes lacking cholesterol, which would 
stabilise the vesicles, tends to support this idea. By contrast, 
microparticulate stibogluconate is covalently bound to the carrier 
rather than simply entrapped and although polyacryl starch is degraded 
by lysosomal enzymes, some degradation products of molecular weight > 
200 remain in the lysosomal system (Laakso et al., 1986). Particulate 
material is excreted from the lysosomal compartment by exocytosis, but 
this is a slow process (Munniksma et al., 1980). Thus even after the 
degradation of the microparticle some of the drug may remain
covalently linked to the degradation products. This fraction of the 
total drug, would be less liable than free drug to diffuse from the 
lysosomal compartment, thus maintaining effective drug concentrations 
in the lysosomal compartment for longer periods. Laakso et al. (1987) 
have followed the tissue elimination of microparticles of the type 
used here and observed that total elimination does not occur from mice 
livers for up to 24 weeks after injection. Whilst this may represent 
an obstacle to the use of polyacryl starch microparticles clinically, 
it does suggest that one of the advantages of this delivery system is 
that it prolongs drug-parasite contact.
One other element of targetting should also be considered. As 
most of the vesicular and particulate drug is sequestered into the 
liver, not necessarily into infected cells, the slow release of the 
drug over time would maintain levels of free drug for a longer period. 
This liver depot effect may also partially explain the differences in 
efficacy between the vesicular and microparticulate systems.
The ideal drug delivery system for sodium stibogluconate should 
correct its innate pharmacokinetic difficiencies (see section 1.4.3.) 
by optimising its uptake by target tissues and slowly releasing the 
drug in situ, thus maintaining effective concentrations for 
an appropriate period of time. The results discussed here suggest that 
solid particles, such as polyacryl microparticles, may match this 
ideal more closely than the vesicular systems. However, factors such 
as toxicity, manufacture, storage and cost of different carrier 
systems must also be considered and although efficacy is a prime 
consideration the ultimate development of such formulations for 
clinical use, not just in the treatment of leishmaniasis, will 
acknowledge all of these factors.
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4.2. THE USE OF TUBERCIDIN IN CONJUNCTION WITH INHIBITORS OF 
NUCLEOSIDE TRANSPORT IN THE TREATMENT OF EXPERIMENTAL LEISHMANIASIS
The lack of activity of either dipyridamole or NBMPR in 
protecting promastigotes of L.m.mexicana or L.donovani against the 
toxicity of tubercidin is in agreement with the findings of Aronow et 
al. (1987), who reported that the two nucleoside transport systems of 
L.donovani promastigotes are not inhibited by either dipyridamole or 
NBMPR. These findings suggest that similar transport systems are
present in the promastigotes of L.m.mexicana and supports the
rationale behind this approach to the chemotherapy of leishmaniasis.
However infected and non-infected PECs were found to be protected 
from tubercidin by similar concentrations of the inibitors used (NBMPR 
and dipyridamole). These levels are similar to those previously
reported to protect cells in culture against toxic levels of
tubercidin (Paterson et al., 1979; Gero et al., 1988).
If infected cells were being targetted then, there should have 
been an increase in the percentage of uninfected cells, which was not 
obvious. There was little evidence for parasite clearance from 
infected cells, indicating that the tubercidin did not gain access to 
the parasite, at least at concentrations that would have an affect on 
the amastigote. Alternatively, the amastigote stage may have a 
nucleoside transport mechanism which differs from that of the 
promastigote and is closer to that of mammalian cells. If this is so, 
the parasite itself would be protected from the toxic effects of
tubercidin by dipyridamole and NBMPR. The situation should be
clarified by direct determination of the sensitivity of nucleoside 
uptake by amastigotes to the inhibitors.
The in vivo work confirms that NBMPR can be used to lessen the
toxicity of tubercidin when treating infected animals; although this
form of treatment proved more toxic than previously reported (Ogbunude
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and Ikediobi, 1982). However, there was little if any reduction in the 
parasite burden when this form of treatment was used, in contrast to 
the 80 % suppression achieved in the single surviving mouse treated 
with free tubercidin.
These results thus indicate that there do not appear to be 
changes in the mechanism of nucleoside transport when PECs are 
infected with leishmanias. Thus, the results of this study indicate 
that although the toxicity of tubercidin to the host can be overcome 
by the use of these inhibitors this approach to the chemotherapy of 
the leishmanias may not be fruitful. The major problem associated with 
this approach is the delivery of tubercidin, in high enough 
concentrations to kill the parasites, specifically to the 
parasitophorous vacuole. The use of drug delivery systems may be one 
method of overcoming this problem. Further investigations in this area 
should include the study of the nucleoside transport mechanism of the 
amastigote to ensure that this stage would be susceptible to this 
approach.
4.3. ADAPTATION OF LEISHMANIA TO ITS ENVIRONMENT
4.3.1. Manipulation of the parasitophorous vacuole of PECs infected 
with Leishmania species by the use of methylamine, ammonium chloride 
and dextran sulphate
The results reported in section 3.3. suggest that there is a 
difference in the environment of the parasitophorous vacuole of 
L.donovani and L.m.mexicana infected cells. L.donovani was found to be 
more sensitive than L.m.mexicana to changes in it's environment 
induced by methylamine and ammonium chloride than L.m.mexicana. 
However, it is not possible to conclude that this is due to the 
amastigotes of the two species being adapted to different environments 
as the extent the effects that methylamine and ammonium chloride are
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having on the parasites. These compounds not only raise lysosomal pH 
(Ohkuma and Poole, 1978) but also ammonium chloride and dextran
sulphate, but not methylamine, inhibit lysosomal movements (D'Arcy 
Hart et al., 1983) and phagosome - lysosome fusion (D'Arcy Hart and 
Young, 1979; Gordon et al. , 1980).
Chang (1980) attempted to measure the pH of the parasitophorous 
vacuole of both L.m.mexicana and L.donovani infected cells and
reported that he could detect no differences. This appears to 
contradict the hypothesis being tested here although it is possible 
that the pH of the vacuole of both L.m.mexicana and L.donovani is the 
same but that L.mexicana does not require such a low pH. Nevertheless 
a direct toxic effect on the amastigotes cannot be discounted, 
especially as the promastigotes of both species are affected by 
methylamine. However, if this was the case then it would be expected 
that the amastigotes of both species would be equally affected by 
methylamine and not by ammonium chloride or dextran sulphate neither 
of which inhibited promastigote growth. That the lysosomal system 
itself is affected, by the presence of methylamine, even after five 
days, was confirmed by the presence of large translucent vacuoles. 
Whether this is due to the long term accumulation of these
lysosomotrophic amines or to a decrease in membrane fluidity remains 
to be investigated. It has been reported that at 5 mM the effects of 
ammonium chloride on lysosomal movement and fusion begin to fade after 
4-5 hours continual treatment (D'Arcy Hart, et al., 1983). This may 
account for ammonium chloride not having as great an effect as
methylamine on L. donovani infections although the effects of long 
term treatment with methylamine on cell function remain unclear.
Alexander (1981) has reported that the use of poly-D-glutamic 
acid to inhibit phagosome -lysosome fusion in L.m.mexicana infected 
PECs increased parasite multiplication whilst the use of chloroquine
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to enhance fusion reduced growth. This affect was more pronounced when 
promastigotes rather than amastigotes were used to infect macrophages. 
However, chloroquine also raises lysosomal pH so the underlying mode 
of action remains unclear. These results, however, do suggest that the 
effect of methylamine and ammonium chloride on L.donovani in PECs is 
not based on the inhibition of phagosome -lysosome fusion.
Normally L.donovani is enclosed in a tight fitting vacuole but on 
treatment with methylamine, and to a lesser extent ammonium chloride, 
these vacuoles become much 'looser' and there is a striking similarity 
to the characteristically large phagolysosome found with L.m.mexicana- 
infected cells. A similar situation has been observed with the yeast 
Saccharomyces cerevisiae when ingested by PECs (D'Arcy Hart and Young, 
1979). The results suggest that inhibitors of phagosome-lysosome 
fusion evoke loose parasitophorous vacuoles around the yeasts through 
their effect on the fusion process. If compounds which enhanced 
phagosome-lysosome fusion were used this effect could be partially 
reversed. The authors suggest that the complexing of polyanions with 
calcium could reduce the intracellular levels of free calcium and so 
perturb the normal control mechanisms of fusion. Whether the large 
parasitophorous vacuoles found with L.m.mexicana infected macrophages 
are a result of it's survival mechanism and whether this mechanism 
differs from that of L.donovnai is still open to question.
Ammonium ions are also known to inhibit receptor-mediated 
endocytosis of mannose-glycoconjugates by inhibiting receptor 
recycling of this ligand which is involved in the function, synthesis, 
assembly and recirculation of lysosomal componments. Mannose receptor- 
mediated recognition and entry of glycoproteins have been shown to 
occur in macrophages infected with L.m.amazonensis (Rabinovitch et 
al., 1985; Shepherd et al., 1983) indicating that this parasite does 
not interfere with this particular aspect of host cell function. It
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would be interesting to investigate this further in other species of 
Leishmania and the effect of ammonium ions on receptor recycling in 
Leishmania infected cells.
Dextran sulphate also appears to have similar affects to those of 
the amines, especially in inhibiting phagosome -lysosome fusion, but is 
reported as lowering the intralysosomal pH of treated cells as well as 
decreasing the membrane fluidity of lysosomal membranes, presumably by 
interacting with the lipid or polypeptide moieties of the luminal face 
of the lysosome (Kielian and Cohn, 1982). Unlike the other compounds 
used in this study dextran sulphate is taken up by endocytosis and is 
reported as taking 3-5 days to exert its effect (D'Arcy Hart et al., 
1983; Kielian and Cohn, 1982). In the experiments involving dextran
sulphate the infected PECs were only exposed to this compound for 48 
hours so the precise effect of treatment is unclear. However, 
treatment did reduce the parasite load. Perhaps treatment for longer 
periods of time would result in a further decrease in parasite 
numbers. The use of dextran sulphate complexed to either serum
lipoproteins or human low density lipoproteins is one method to 
increase the rate of uptake of the dextran sulphate; such that
inhibition of phagolysosome fusion occurs within 4 hours instead of
taking 3-4 days (Kielian and Cohn, 1982). The use of lipoproteins to 
target dextran sulphate to Leishmania parasites is an interesting 
prospect and is similar in some respects to the proposal of Hart 
(section 1.5.2.1.). The possibility that dextran sulphate is having a 
direct affect on the parasites, by affecting their membrane fluidity 
for example, cannot be ruled out. However, the lack of effect of 
dextran sulphate on promastigotes suggests that this is not the case. 
It is interesting to speculate that the remains of parasites seen in 
infected cells treated with dextran sulphate is due to the inhibition 
of phagosome -lysosome fusion.
These results illustrate the potential for the use of compounds 
which manipulate the lysosomal environment in the investigation of the 
basic macrophage-parasite interactions in the phagolysosome. It also 
indicates the importance of further studies, which are now technically 
feasible, to look at the role of lysosomal pH and indeed the membrane 
fluidity of the phagolysosome. Attempts along these lines (see section 
3.4) proved unsuccessful; nevertheless this is an approach well worth 
pursuing.
4.3.2. The effect of pH on the uptake and incorporation of H leucine 
3and H adenosine by different stages and species of Leishmania
The data from the uptake experiments using promastigotes showed 
several interesting points. For L.donovani and L.m.mexicana 
promastigotes, uptake was maximal between pH 6 and 7. In a similar 
study on L.donovani promastigotes, Mukkada et al. (1985) found a 
distinct pH optimum at pH 7. However they were using cells harvested 
from the middle of the exponential growth phase, whilst the cells used 
in this study were from stationary phase cultures. There is a 
considerable difference in the pH of the growth medium at these 
different stages of the culture and by stationary phase the pH of the 
medium is between 6 and 7. This could account for the differences in 
the pH optimum found in this study and that by Mukkada et al. (1985) 
especially if promastigotes become adapted to the pH at which they are 
growing. This does not appear to be the case with the metacyclics of 
L.major. The pH optimum for nucleoside uptake of these cells was 
between pH 5 and 6, well below the measured pH of the growth medium. 
This may represent a preadaptation by these metacyclics to life in the
acidic enviroment of the parasitophorous vacuole.
3The results for the incorporation of H adenosine by amastigotes 
of L.donovani showed a sharp optimum at pH 5, in agreement with the
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results of Mukkada et al. (1985) for uridine and thymidine. However 
the results obtained using amastigotes of L.m.mexicana did not show as 
sharp a pH optimum with uptake being similar and high between pH 5 and 
6. Although this study was not extensive and the results should be 
interpreted with caution, the results give some more indications of a 
difference in the environments of L.donovani and L.m.mexicana.
This led to attempts to quantify the pH of the parasitophorous 
vacuole of cells infected with L.m.mexicana and compare them with 
uninfected cells. The approach followed was to use a fluorescence 
probe (FITC-labelled dextran sulphate) which is endocytosed and 
accumulates in lysosomes. The fluoresence spectrum of this compound 
changes in the pH range 3-8 and by using incident light at 620 nm and 
480 nm a ratio can be established which allows the pH of the 
environment to be estimated from a calibration curve (Ohkuma and 
Poole, 1978). Initial results indicated a difference between normal 
lysosomal pH and that of the parasitophorous vacuole, however the 
equipment was not sufficiently sensitive to quantify the preliminary 
results any further.
Further investigations of the parasitophorous vacuole environment 
are needed in order to understand fully the relationship between the 
parasite and its host cell and how the presence of a growing and 
multiplying intracellular parasite can affect host cell functions. 
This could give a greater insight into the survival mechanisms used 
by the leishmanias and may prove useful in the rational development of 
new chemotherapeutic strategies.
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4.4. INVESTIGATIONS INTO THE ANTI LEISHMANIAL ACTIVITY OF AMINO ACID 
ESTERS AND AMINO ACID AMIDES
4.4.1. Antileishmanial activity of L*leucine methyl ester and L- 
tryptophanamide
The MTT viability assay proved a useful method in this study. It 
was modified such that the parasites are incubated with MTT for only 
three hours instead of overnight; the shorter incubation avoids 
possible interference from other microorganisms and complications 
produced by promastigotes dividing. L-Tryptophanamide had a similar 
antileishmanial activity against promastigotes and amastigotes of 
L.donovani and L.m.mexicana as measured by the MTT viability assay. At 
the higher concentrations tested the growth of promastigotes was 
inhibited. Testing of this compound against Leishmania infections of 
PECs in vitro showed that both L.m.mexicana and L.donovani were 
susceptible to a similar degree to the activity of this compound. 
Under the conditions used the activity of this compound was time and 
concentration dependent. These results are in close agreement with the 
work of Rabinovitch and Zilberfarb (1988) using L.m.amazonensis- 
infected PECs.
The results for leuOMe showed that this compound was not equally 
active against all species and stages of Leishmania. The activity of 
leuOMe against L.m.mexicana amastigotes, both free and residing in 
PECs, are very similar to those previously reported (Rabinovitch et 
al. , 1986; Rabinovitch et al., 1987). Investigating the activity
against different species and stages of Leishmania has given a deeper 
insight into the antileishmanial activity of leuOMe. It has been 
confirmed that leuOMe acts directly against the parasite, but the 
findings that L.major and L.donovani amastigote infections of PECs are 
unaffected by leuOMe whereas L.m.mexicana is highly susceptible, and 
that this susceptibility appears only slowly after infection of PECs
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with promastigotes, are the most crucial. There is a distinct 
correlation with the presence of megasomes and the antileishmanial 
activity of leuOMe. Only the amastigotes of L.mexicana possess these 
lysosomal like organelles (see section 1.1.1.).
Unfortunately, in vivo activity of the compound was not detected 
and as there was considerable toxicity of both of these compounds in 
vitro and in vivo it seems unlikely that either could be useful 
clinically for the treatment of leismaniasis.
The spectrum of antileishmanial activity of L-tryptophanamide 
differs markedly from that of leuOMe. This suggests that although the 
amino acid ester and amino acid amide may exert their antileishmanial 
activity in a similar manner, involving hydrolysis to the amino acid 
which causes osmotic stress, they are activated by different enzymes. 
It is probable that the activation process is the key to stage and 
species specific activity of leuOMe.
4.4.2. The appearance of megasomes during the transformation in vitro 
of L.m.mexicana from promastigote to amastigote
Megasomes arise early in the transformation from promastigote to 
amastigote; they are present by 23 hours, before the loss of the 
flagellum, and by 48 hours the transforming parasite resembles 
amastigotes, at least structurally. The finding that the megasomes 
arise from the trans-golgi-network is in agreement with the proposals 
of Griffiths and Simons (1986) on the packaging of lysosomal enzymes. 
This observation further supports the proposal that these organelles 
are lysosomal in nature. However, no clathrin-coated vesicles believed 
to be responsible for the transport of enzymes in a mature lysosomal 
system (Griffiths and Simons, 1986) were observed.
The production of megasomes parallels the acquisition of 
sensitivity to leuOMe by L.m.mexicana promastigotes transforming to
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amastigotes in PECs in vitro (as discussed above). Interestingly 
Rabinovitch et al. (1987) pointed to the involvement of an acidified 
compartment within the amastigotes of L .m .amazonensis in the 
hydrolysis of amino acid esters. Recently Antoine et al (1988) showed 
that the megasomes of L .m. amazonensis were acidified. This in parallel 
with my own work clearly points to these unique organelles as the site 
of ester hydrolysis.
4.4.3. Esterases of Leishmania
The use of starch gel electrophoresis to try and identify the 
enzymes responsible for the hydrolysis of leuOMe showed several 
isoenzymes in the different species and stages of Leishmania. There 
are several common bands; a shared band between the promastigotes of 
L.m.mexicana, L.donovani, the metacyclics of L.major and the 
amastigotes of L.donovani; and a shared band between the amastigotes 
and promastigotes of L.m.mexicana. There were also several 
developmental changes in the transformation from promastigote to 
amastigote of both L.m.mexicana and L.donovani. In both species the 
promastigotes have two and three isoenzymes respectively, whilst the 
amastigotes have only a single isoenzyme. The role of these enzymes 
has not been elucidated. It was interesting to note that the inclusion 
of the proteinase inhibitor leupeptin allowed the detection of several 
other isoenzymes in the species treated, indicating the importance of 
proteolysis in these experiments. It would have been interesting to 
have looked at the banding patterns of all the stages tested with 
leupeptin included.
The assay developed to measure the amounts of phenol, potentially 
released by the hydrolysis of leucine benzyl ester worked well, being 
able to detect concentrations as low as lOuM phenol. The problems 
encountered with attempts to determine phenol production at pHs
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outwith the range 7.5-8.6 were overcome by the use in the incubations 
of buffers with a low molarity. The addition of higher molarity 
buffers of appropriate pH for the subsequent phenol determination 
avoided any problems of variable or inappropriate pH. This gave a 
potentially very useful assay which could measure the rates of 
hydrolysis of leucine benzl ester by parasite enzymes at a range of 
pHs. However, no such hydrolysis was observed either when using 
homogenates of L.m.mexicana amastigotes or the purified amastigote low 
molecular weight proteinases. Subsequent work with these enzymes 
showed them to be inhibited by high concentrations of DMSO and
ethanol, the two solvents that are used to dissolve the leucine benzyl 
ester. This could explain the lack of activity of the enzymes against 
the benzyl ester. The assay itself was shown to work well by the use of 
the arylesterase substrate phenylactate to detect esterase activity in 
horse serum. This gave satisfactory results.
4.4.4. The exploitation of L.m.mexicana cysteine proteinases as 
activators of pro-drugs
The original procedure of Pupkis and Coombs (1984) for the 
purification of these amastigote low molecular weight proteinases has 
been improved by the use of a two step procedure to give a 10 fold 
purification. The gelatin SDS-PAGE analysis of the proteinases 
separated by the different steps has confirmed the work of Lockwood et 
al. (1987) showing that there are at least seven of these low 
molecular weight proteinases. However, the use of silver staining to 
detect these proteins also revealed the presence of contaminating 
proteins. The application of further techniques, such as affinity 
chromatography, should lead to the purification of this group of 
enzymes and indeed the eventual isolation of each of the individual 
isoenzymes.
183
By using the partially purified enzymes and a range of proteinase 
inhibitors it was confirmed that these enzymes are cysteine 
proteinases. The previous work of Pupkis and Coombs (1984) 
demonstrated only one cysteine proteinase. This difference appears to 
be due to the use of a less sensitive protein detection method coupled 
with the effect of boiling on the samples. Why two of these bands 
should become more prominent on boiling is, at present, unknown.
Interestingly, the use of gelatin gels to analyse the 
chromtographic fractions from gel filtration have revealed a larger 
number of high molecular weight proteinases than has previously been 
reported (Lockwood et al., 1987; North et al., 1981). The comparison 
of freeze - thawed and detergent solubilised samples gave very different 
results in terms of the proteinase activity profiles, suggesting that 
several of the proteinases were membrane bound as they did not appear 
to be released by freeze-thaw but were released by detergent. Coombs 
(1982) indicated the presence of particulate proteinases in 
L.m.mexicana amastigotes and promastigotes. The relatively high leuOMe 
hydrolysing activity remaining in the pellet fraction from freeze- 
thawed cells suggested the possibility that some membrane bound 
enzymes may be involved in leuOMe hydrolysis. It is possible, however, 
that the results obtained are due to a failure of freeze-thaw to fully 
release soluble enzymes from cells that are notoriously hard to 
fractionate (Dwyer, 1980). This was not investigated further.
The high molecular weight proteinases present in amastigotes of 
L.m.mexicana were easily separated and distinguished from the lower 
molecular weight proteinases but also they differed from the high 
molecular weight proteinases found in promastigotes of L.m.mexicana 
(Lockwod et al., 1987). Interestngly North et al. (1988) reported that 
the high molecular weight proteinases found in all species and stages 
so far investigated do not appear to belong to any of the four well
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defined classes found in other organisms (see table 3). Only 
phenanthroline, normally a metalloproteinase inhibitor, appears to 
inhibit these enzymes, although there are instances of it acting as an 
inhibitor of cysteine proteinases. The recent finding that gp63 is a 
zinc metalloproteinase (see section 1.3.5.) suggests that the other 
high molecular weight proteinases may also belong to this category.
The extent of proteolysis within homogenates of L.m.mexicana 
amastigotes was quantified to some extent by the measurements of the 
amount of protein remaining after incubation at room temperature. This 
confirms the findings of Pupkis and Coombs (1986) that this is a rapid 
process. The use of various proteinase inhibitors slowed down this 
process considerably and the use of E64 indicated that other 
proteinases besides cysteine proteinases were involved in this 
process.
The high molecular weight proteinases remain interesting as their 
role in the leishmanias is unclear and little work has been carried 
out on them in terms of substrate specificity. The effect of the 
specific cysteine proteinase inhibitor E64 on the hydrolysis of 
BzPPANan by homogenates of different species and stages of Leishmania 
indicates that at least some of the proteinase activity in all the 
other species and stages was due to cysteine proteinases. However, 
attempts to detect cysteine proteinases on gelatin SDS-PAGE gels by 
first incubating the samples with E64 showed that only the low 
molecular weight proteinases of L.m.mexicana amastigotes were 
inhibited in this manner. The use of E64 in the buffers used to 
develop the proteinase activity did show some changes in the banding 
patterns of the other species and stages used but the results were 
unclear. Perhaps these proteinases have some cysteine proteinase type 
characteristics and need the E64 there at all times to be inhibited.
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The other proteinase inhibitors used did not inhibit the low molecular 
weight activities on gelatin gels when only preincubated with the 
extracts and this affect may be attributable to the reversible binding 
to these inhibitors to proteinases and the conditions they are 
subjected to during SDS-PAGE. For example, leupeptin is known to be a 
reversible inhibitor in contrast to E64 which irreversibly modifies 
the active thiol group to a thioether form (Shoji-Kasai et al. , 1988).
Although the use of paper electrophoresis to separate the 
hydrolysis products of leuOMe had its limitations, it allowed the 
analysis of the activity of the partially purified amastigote low 
molecular weight cysteine proteinases towards leuOMe as well as the 
relative activities of extracts of promastigotes and amastigotes of 
other species. It also allowed the qualitative assessment of the 
activity of L.donovani and L.m.mexicana amastigote homogenates against 
a series of other amino acid esters and amides. However, although the 
assay was shown to work adequately it was of limited use.
The results indicate that the low molecular weight cysteine 
proteinases are responsible for the majority of the hydrolysis of the 
leucine methyl ester by amastigotes of L.m.mexicana and so account for 
the toxicity of leuOMe towards these amastigotes. However, there do 
appear to be other enzymes involved in hydrolysing leuOMe although to 
a lesser degree. These may account for the lysis in other species of 
amastigotes and in promastigotes. This correlates with the findings 
that amastigotes of L. donovani and L.major both hydrolyse BzPPANan at 
significant rates;not as rapidly as amastigotes of L.m.mexicana, but 
higher than the promastigotes of any species.
Although the amastigotes of L.donovani and L.major can hydrolyse 
leuOMe at a low rate, they are not appreciably affected by this ester. 
It is interesting to speculate on why this is this case. It appears 
that a well developed lysosomal system and presumably a high hydrolytic
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activity towards the compound is needed for leuOMe to be toxic. This 
is highlighted by the prevention of murine graft-versus-host disease 
by a short exposure of the donor bone marrow cells to the dipeptide 
ester L-Leu-L-LeuOMe (Thiele et al., 1987). Other cells affected by 
treatment with leuOMe have also had well developed lysosomal systems, 
for example heart myocytes (Decker and Fuseler, 1984). The lysosomal 
systems of L.donovani and L.major are both poorly developed whilst the 
megasomes, where the low molecular weight cysteine proteinases are 
located, are very well developed, taking up to 15% of the cell volume 
(Pupkis et al. , 1986). Perhaps for toxicity to be apparent, leuOMe 
needs to accumulate in a compartment and thereby cause osmotic lysis. 
Even though there is a suitable compartment, the toxicity of these 
compounds does rely on their enzymatic hydrolysis. It seems likely
that it is a combination of the higher specific activity towards 
leuOMe found in L.mexicana amastigotes than in other species of 
Leishmania and the presence of these enzymes within a well developed 
lysosomal system that is responsible for the stage and species
specificity found.
Alfieri et al. (1988) reported that chymostatin proved to be the 
most effective inhibitor of leuOMe toxicity to L .m .amazonensis. 
Antipain and leupeptin were also effective, whereas pepstatin had no 
effect. All of the cysteine proteinase inhibitors do inactivate the 
low molecular enzymes whilst pepstatin, as expected, had no effect. 
The lack of reported protective activity of E64 with intracellular 
amastigotes (Alfieri et al., 1988) is not really surprising as this
inhibitor is not membrane-permeant (Shoji-Kasi et al. , 1988) and so
could not access the intracellular amastigotes. However, the use of
membrane-permeant analogues of E64 (Shoji-Kasi et al., 1988) should
antagonise the antileishmanial activity of leuOMe and indeed could
prove useful as antileishmanial agents.
Although the low molecular weight enzymes purified in this study 
appear to be responsible for the toxicity of leuOMe, their role in the 
toxicity of other amino acid esters and amino acid amides remains 
unclear. Certainly they do hydrolyse leucinamide at a comparable rate 
to leuOMe, but they do not appear to be responsible for the hydrolysis 
of the other esters and amides tested. Several of these other 
compounds are toxic to the amastigotes of L.m.amazonensis and are 
hydrolysed by homogenates of L.donovani and L.m. mexicana amastigotes. 
The enzymes responsible for this hydrolysis were not characterised in 
this work but need further investigation. Tryptophanamide is perhaps 
the most interesting compound as it poccesses a broader spectrum of 
antileishmanial activity than leuOMe and as such the basis behind its 
activity may prove useful in the design of antileishmanial drugs for 
the treatment of all forms of leishmaniasis. Unfortunately, however, 
it has a lower chemotherapeutic index as measured in vitro.
Previous work has shown that several amino acid esters and amino 
acid amides can also have a protective effect against some of the most 
toxic amides and esters, notably leuOMe and leucinamide but not 
tryptophanamide (Alfieri et al., 1987; Rabinovitch and Zilberfarb, 
1988). The results of using amino acid esters and amides to inhibit 
the purified proteinases activity towards BzPPANan showed that several 
of the protective amides and esters do inhibit these enzymes in a 
concentration dependent manner. It appears that esters and amides 
composed of basic amino acids, are poor competitors whilst those 
composed of either aromatic or aliphatic amino acids are much better 
competitors.
There are several apparent contradictions in the work of Alfieri 
et al. (1987), and some of the results presented in this study. Some 
of the esters which are reported as not having any protective activity 
against leuOMe do appear to be able to inhibit the purified enzymes to
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some degree. As this group have been working on L.mexicana amazonensis 
this may be one reason to account for these apparent differences. 
However, it seems more likely that whilst these amino acid esters and 
amino acid amides may inhibit the purified enzymes the concentrations 
necessary to achieve protective activity are not attained in the 
amastigotes. Whether this is due to them not being hydrolysed witin 
the parasite and so not being lysosomotrophic or not being able to 
cross the parasites membranes is unclear. Also some of the toxic 
amides and esters have a protective effect against leuOMe when they 
are used at low concentrations. This would indicate that there is a 
point at which the rates of hydrolysis of these compounds and the 
efflux of the amino acids produced are equal yet these compounds are 
still competing sufficiently with the leuOMe to give rise to an 
antagonism.
Only a few of the potential differences between the multiple 
isoenzyme forms of these low molecular weight cysteine proteinases 
were investigated. The results suggest that these enzymes may be 
glycosylated, although the lack of effect with endoglycosidase F did 
not support this. The importance of glycosylated proteins in the 
survival and virulence of Leishmania species has already been 
investigated (Dagger et al., 1984; Nolan and Farrell, 1985) and has 
recently been highlighted in L.m.amazonensis by Kink and Chang (1987).
Whether differences in how these proteinases are glycosylated 
accounts for their different molecular weights remains to be 
discovered. Recent work by Koehler and Ho (1988) has shown that 
similar differences between multiple cysteine proteinases are due to 
minor differences in the N-terminal sequence. The effect that these 
differences could have on the cellular processing of these proteinases 
and on their physiological role remain to be investigated. A possible 
role in the survival of L .mexicana species has been proposed on
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several occasions (see section 1.2.2. and 1.3.5.) and further 
characterisation of their substrate specificity may help in clarifying 
their physiological roles in the parasite.
Overall these results indicate that the concept of the design and 
use of pro-drugs in the treatment of leishmaniasis is not unrealistic. 
Leishmania specific pro-drugs (see section 1.5.2.1.) could involve the 
design of a non-toxic carrier molecule which when hydrolysed by 
leishmania specific proteinases would result in the release of a toxic 
drug within the parasite. This approach is reliant on the specific 
activation of the pro-drug by the parasite and not the host In leuOMe 
we have a compound which, because it is lysosomotrophic, is targetted 
to the host as well as the parasite lysosomal system. On hydrolysis by 
the parasite cysteine proteinases free leucine is released, which, 
under these circumstances, proves toxic to the parasite; so in effect 
leuOMe is acting as a pro-drug.
Although the activity of leuOMe appears to rely on the low 
molecular weight cysteine proteinases, which are specific to just some 
species of Leishmania, there are enzymes in other species capable of 
hydrolysing this type of compound. This highlights the potential for 
the design of similar but broader spectrum pro-drugs They need not 
rely on osmotic stress to kill the parasite, many types of released 
drug couldbe envisaged e.g. an inhibitor of the parasite's 
dihydrofolate reductase. It is also possible to envisage pro-drugs 
which have been designed to be species specific, perhaps relying on 
the different high molecular weight proteinases present in all species 
and stages to activate them. In all cases, however, good knowledge of 
the activating enzymes will be required as a prerequisite to drug 
design. These studies are simply a step in this direction.
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